Self-reported health outcomes in patients with obstructive sleep apnoea:Unraveling the role of bio-psycho-social factors by Timková, Vladimíra
 
 
 University of Groningen




IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2020
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Timková, V. (2020). Self-reported health outcomes in patients with obstructive sleep apnoea: Unraveling
the role of bio-psycho-social factors. University of Groningen. https://doi.org/10.33612/diss.136425533
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 26-12-2020
Self-reported health outcomes in patients  
with obstructive sleep apnoea




Thesis for the University of Groningen, the Netherlands – with summaries in Dutch 
and Slovak.
All rights reserved. No parts of this publication may be reproduced, stored in a retriev-
al system, or transmitted in any form or by any means electronic, mechanical, photo-




This work was supported by the Slovak Research and Development Agency under 
contracts APVV-15- 0719 (80%); and by the Agency of the Ministry for Education of 
the Slovak Republic for the Structural Funds of the European Union, Operational 
Programme Research and Development (Contract No. 034/2009/2.1/OPRandD) 
(20%).
The printing of this thesis was supported by the Graduate School for Health 
Research (SHARE), the Graduate School Kosice Institute for Society and Health 
(KISH), the University Medical Center Groningen (UMCG) and the University 
of Groningen (RUG).
Design and layout: Diana Matláková
Book cover: Diana Matláková
Artwork: Armando Bravo
Language corrections: David L. McLean
Press: Equilibria Košice, s.r.o.
Printed in Slovakia
ISBN: 978-80-8143-277-4
      
Self-reported health outcomes in 
patients with obstructive sleep 
apnoea
Unraveling the role of bio-psycho-social factors
PhD thesis
to obtain the degree of PhD at the
University of Groningen
on the authority of the
Rector Magnificus Prof. C. Wijmenga
and in accordance with
the decision by the College of Deans.
This thesis will be defended in public on 
Wednesday 11 November 2020 at 11.00 hours
by
                                                                              
Vladimira Timkova










Prof. G. J. Navis
Prof. P. J. Wijkstra
C h a p t e r  1
Introduction 9
C h a p t e r  2
Design of the study and data sources 43
C h a p t e r  3
Quality of life of obstructive sleep apnoea patients receiving continuous positive airway  
pressure treatment: a systematic review and meta-analysis 57
C h a p t e r  4
Are disease severity, sleep-related problems and anxiety associated  
with work functioning in patients with obstructive sleep apnoea? 91
C h a p t e r  5
Psychological distress in patients with obstructive sleep apnoea:  
the role of hostility and coping self-efficacy 117
C h a p t e r  6
Suicidal ideation in patients with obstructive sleep apnoea and its relationship  
with disease severity, sleep-related problems and social support 143
C h a p t e r  7
Social support, mastery, sleep-related problems and their association  
with functional status in untreated obstructive sleep apnoea patients 163
C h a p t e r  8
General discussion, implications, and conclusions 187
S um m a r y 223
S a m m e nva tt i g 227
Z h r n u t i e 231
A c k n o w l e d g e m e n t s 235
A b o u t  t h e  a u t h o r 237
S up p l e m e n t s 239
G ra d u a t e  S c h o o l  K o s i c e  In s t i t u t e  f o r  S o c i e t y  a n d  H e a l t h  (K I S H )  a n d  p r e v i o u s 
d i s s e r t a t i o n s 251
G r o n i n g e n  G ra d u a t e  S c h o o l  o f  Me d i c a l  S c i e n c e s  –  R e s e a r c h  In s t i t u t e  S H A R E 
a n d  p r e v i o u s  d i s s e r t a t i o n s 257
Contents
List of abbrevations
AHI  Apnoea-Hypopnoea Index
BAI  Beck Anxiety Inventory
CMHo  Cook Medley Hostility Scale
CPAP  Continuous Positive Airway Pressure 
CSE  Coping Self-Efficacy
ESS  Epworth Sleepiness Scale
FOSQ  Functional Outcomes of Sleep Questionnaire
GHQ-28  General Health Questionnaire
MFI  Multidimensional Fatigue Inventory
MLR  Multiple linear regression analyses
MSPSS  Multidimensional Scale of Perceived Social Support
OSA  Obstructive Sleep Apnoea
PMS  Pearlin Mastery Scale
PROMs’  Patients’ reported outcome measures 
PSG  Polysomnography
PSQI  Pittsburgh Sleep Quality Index
QoL  Quality of Life
RCTs  Randomised Controlled Trials
WRFQ 2.0 Work Role Functioning Questionnaire 2.0
8 CHAPTER 1 9
C h a p t e r  1
Introduction
“Sleep is the most 
innocent creature there 
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Obstructive sleep apnoea (OSA) is a common chronic disorder that often requires 
lifelong care (Force AOSAT and American Academy of Sleep Medicine, 2009). We 
aimed to extend current knowledge on the factors which may be closely related to 
the management of this chronic disease. Therefore, this study on OSA focuses on 
the bio-psycho-social factors that have been identified as key determinants of health 
outcomes in various chronic diseases, but for which less is known about their role 
in OSA. This chapter covers the theoretical background of the study, describes the 
theoretical model used for the study, presents the aims and the specific research 
questions, and concludes with the outline of the thesis. 
1.1   Obstructive sleep apnoea: definition, symptoms 
and epidemiology
OSA is defined as a repetitive, intermittent cessation of air flow at the nose and 
mouth during sleep. The clinical syndrome is characterized by repeated episodes 
of upper-airway occlusion during sleep, which can be complete (apnoea) or incom-
plete (hypopnoea) and of varying duration (Leung, 2019). Patients with OSA often 
snore and report daytime sleepiness (Manarino et al., 2012; Peppard et al., 2013) 
and fatigue (Manarino et al., 2012). 
OSA concerns 2–10% of the adult population (Leger et al., 2012); it is more 
prevalent in men compared with women and extremely rare in premenopausal 
women (Krystal et al., 1998). Most population-based studies have identified a 
gender-specificity in OSA prevalence, i.e. a 2- to 3-fold greater risk for males com-
pared to females (Strohl and Redline, 1996; Quintana-Gallego et al., 2004). OSA 
prevalence and severity have also been found to rise linearly with age (Bixler et al., 
1998; Gabbay and Lavie, 2012). Depending on age, the prevalence of moderate and 
severe OSA (apnoea-hypopnoea index; AHI ≥15) among men is 10–17% and among 
women 3–9% (Peppard et al., 2013). These estimated prevalence rates represent 
substantial increases over the last two decades, with relative increases of between 
14% and 55% (Peppard et al., 2013). 
Furthermore, the majority of people with OSA are typically unaware of ap-
noea/hypopnoea episodes. Although long-term consequences, such as fatigue, 
excessive daytime sleepiness, and increased cardiovascular and cerebrovascular 
risk, may be severe, symptoms often begin subtly and gradually and may remain 
underestimated for many years, noticed by bed partners only (Schmaling and Afari, 
2000). Previous studies have concluded that OSA affects approximately 20% of US 
adults (Young et al., 2002; Finkel et al., 2009), about 90% of whom may be undi-
agnosed (Finkel et al., 2009). Thus, OSA remains a largely underdiagnosed and 
undertreated problem, although its impact on both morbidity (Macey et al., 2010; 
Rottapel et al., 2019) and socio-economic costs (Leger et al., 1994; Wittmann and 
Rodenstein, 2004; Mulgrew et al., 2007; Leger et al., 2012) is enormous. 
Sleep-disordered breathing has major socioeconomic consequences for pa-
tients and their spouses both years before and after diagnosis (Jennum et al., 2014). 
Compared to healthy people, individuals suffering from OSA are less productive, 
have increased health care utilization, an increased likelihood of accidents (Karimi 
et al., 2015), reduced work capacity, and work participation (Mulgrew et al., 2007; 
Leger et al., 2012). Sleep loss among partners of OSA patients also results in frus-
tration, exhaustion, interference with work, and strained relationships (Luyster 
et al., 2016). It has been shown that untreated OSA patients have up to two-times 
greater health care costs when compared with controls without OSA (Wittmann 
and Rodenstein, 2004). Costs of undiagnosed people with OSA include direct 
costs due to possible consequences, such as driving accidents, as well as the de-
velopment of comorbidities such as cardiovascular diseases, diabetes, metabolic 
syndrome, and an increased overall mortality rate (Tkacova and Dorkova, 2010; 
Leger et al., 2012; Pack et al., 2012; Ayas et al., 2014). Although the exact costs 
are difficult to calculate, data from 106 countries showed that increased healthcare 
spending to treat undiagnosed OSA varies between 1,950 and 3,899 dollars per pa-
tient per year, which represents approximately a total of 3.4 billion dollars per year 
(Knauert et al., 2015). These costs are usually caused by more frequent practitioner 
visits, increased hospitalizations, and the development of comorbidities (Wittmann 
and Rodenstein, 2004). 
OSA-related symptoms such as sleep disruption, snoring, sleep-related chok-
ing, insomnia, nocturia, disruption of bedpartner’s sleep, morning headaches, 
impairments in productivity, poor-quality relationships, and daytime fatigue have 
been shown to have a negative impact on patients’ psychological well-being, qual-
ity of life (QoL), and functional status (Young et al., 2002; Sharafkhaneh et al., 
2005; Mulgrew et al., 2007; Tsara et al., 2009; Antic et al., 2011; Weaver, 2013; 
Rezaeitalab et al., 2014; Patil et al., 2019). Besides physical impacts, OSA is as-
sociated with a higher prevalence of neuropsychiatric comorbidities or symptoms 
(Sharafkhaneh et al., 2005; Tkacova and Dorkova, 2010; Lin and Winkelman 2012; 
Kang et al., 2012), such as anxiety (Sharafkhaneh et al., 2005; Krakow et al., 2015), 
depression, posttraumatic stress disorder, psychosis, or dementia (Sharafkhaneh et 
al., 2005). Choi et al. (2015) reported an increased prevalence of suicidal ideation 
in OSA patients when compared to the general population. Moreover, psychologi-
cal distress may reversely influence the progress of OSA-related physical symptoms 
(e.g. Hall et al., 2004; Krakow et al., 2015). 
Another source of concern is that diagnosing OSA may often represent a diffi-
cult task for health care professionals because of the patient’s unawareness and the 
variations in presentation (Lurie, 2011; Peppard et al., 2013). Moreover, patients 
presenting with fatigue or daytime sleepiness may be misdiagnosed with depression 
or other illness (Lin et al., 2008). 
1.2   Measuring self-reported health outcomes in 
obstructive sleep apnoea
In many areas of medicine, patient-reported outcome measures (PROMs) are gain-
ing substantial attention as priority components to assess when gauging the effect 
of treatment for all manner of diseases (Tam et al., 2014; Pang et al., 2016; Appleby 
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et al., 2016). OSA disabling symptoms pose multiple challenges on patients’ 
health outcomes, such as well-being, QoL, and functional status (Antic et al., 2011; 
Weaver, 2013; Jackson et al., 2018). Therefore, along with an increase of OSA, the 
assessment of self-reported health outcomes has gained attention and become an 
important construct in this chronic disease (Kushida et al., 2012; Tam et al., 2014). 
The gold standard diagnostic test for OSA is the overnight polysomnography 
(PSG) (Epstein et al., 2009). During an overnight polysomnogram, the frequency 
of obstructive events is reported as the apnoea-hypopnoea index (AHI). The se-
verity of OSA is based on the number of apnoea and hypopnoea events per hour 
(American Academy of Sleep Medicine, 2005). However, there is a discrepancy be-
tween the AHI levels used to denote outcomes of therapy and real-world outcomes, 
such as QoL, functional status, patient perception of disease, cardiovascular meas-
ures, or survival (Tam et al., 2014). Some previous studies on continuous positive 
airway pressure (CPAP) treatment effectiveness (Weaver et al., 2005; Kushida et 
al., 2012; Tam et al., 2014) also favour the usage of QoL and functional status meas-
ures together with AHI; yet in the case of OSA, the AHI remains persistent as the 
primary, and frequently the only, outcome measure reported in the vast majority of 
research and clinical practice (Pang et al., 2016). 
Therefore, screening PROMs based on self-reported symptoms of OSA is im-
portant for gaining information on the prevalence and comorbid conditions of OSA 
or on CPAP treatment effectiveness (Weaver et al. 2005; Sivertsen et al., 2008; 
Kushida et al., 2012). Moreover, patients’ self-reported outcomes represent any 
assement coming directly from patients, without interperetation by a health care 
professional or others, about how they function or feel in relation to their health 
condition. Thus, identifying issues faced by patients and their families about living 
with an illness can generate knowledge that may consequently impact treatment de-
cisions and adherence. In general, the use of PROMs may enhance the understand-
ing of how health-practitioners can affect health outcomes (Krabbe et al., 2017).  
1 . 2 . 1   Fun c t i o na l  s t a tu s  
Recent studies have emphasized the importance of studying patients’ functional 
status in sleep medicine research, because of its ability to provide insights that may 
go beyond the pathophysiology of commonly investigated OSA-related symptoms 
(Boccabella and Malouf, 2017). Functional status is defined as an individual’s abil-
ity to perform normal daily activities or tasks that are essential to meet basic needs 
and fulfill usual roles (Wilson and Cleary, 1995). The concept of functional status 
consists of two main domains: capacity and performance. Functional capacity can 
be defined as a person’s maximum ability to perform daily activities in the physical, 
psychological, and social domains of life, whereas functional performance refers to 
what people actually do in the course of their daily living (Leidy, 1994). Both do-
mains can be influenced by biological or physiological impairment, symptoms, and 
mood impairments but also by health perceptions (Krabbe, 2017). There is general 
consensus that physical function, social function, role function, and psychological 
function represent the minimum required to define and measure functional status 
(Sherbourne et al., 1992). 
Previous research has shown an impairment of functional status (Reishtein et 
al., 2006; Perimenis et al., 2007; Weaver et al., 2007; Tippin et al., 2016), includ-
ing impairment of work functioning, in OSA patients (Wittmann and Rodenstein, 
2004; Mulgrew et al., 2007; Reuveni et al., 2008; Sivertsen et al., 2008; Leger et 
al., 2012). Furthermore, the current studies show that the treatment response is 
inadequate to return OSA patients to the functional level of healthy individuals who 
are asymptomatic of sleep-disordered breathing, and that CPAP treatment may not 
improve function in a dose-response manner (Weaver, 2013; Tippin et al., 2016; 
Jackson et al., 2018).
1 . 2 . 2   Wo r k  f un c t i o n i n g
The prevalence of OSA is high; the disease affects 9% of the female and 24% of 
the male working-age population (Young et al., 2009). While OSA is a non-occu-
pational disease, given its frequency, comorbidities, and potential to impair work 
functioning, it is inevitable that it may manifest as an important health and safety 
issue in the workplace (Kales and Czeisler, 2016). Sleep disturbances, excessive 
daytime sleepiness and frequent awakeness showed to be a risk factors with respect 
to occupational accidents (Cappuccio et al., 2010). Moreover, the economic costs 
of OSA on health care systems, as well as on individuals and their households, have 
also substantial relevance. Previous studies have focused mainly on the economic 
impact of OSA on public health systems (Wittmann and Rodenstein, 2004; Reuveni 
et al., 2008) and occupational accidents (e.g. Garbarino et al. 2016), while the as-
sessement of work functioning was not prominent. Some studies have evaluated 
work performance in patients with OSA, but results have been disputed (Jurado-
Gámez et al., 2015). Few previous studies showed a significant impairment of work 
functioning in patients with OSA (Mulgrew et al., 2007; Sivertsen et al., 2008; 
Omachi et al., 2009). According to Reishtein, OSA patients have difficulties to 
complete a task at work, feel a lack of trust from coworkers and report subsequent 
embarrassment (Reishtein et al., 2006). Working OSA patients were also found to 
have low productivity levels and a high rate of psychological distress (Jurado-Gámez 
et al., 2015).
1 . 2 . 3   H ea l t h  re la te d  q u a l i t y  o f  l i f e
The main goal for the treatment of OSA is to prevent complications and comorbidi-
ties, while preserving a good quality of life (QoL). Knowledge about the role of bio-
psycho-social factors and their associations with patients’ health outcomes is there-
fore of great importance (Haslam et al., 2018). The World Health Organisation 
Quality of Life (WHOQoL) group defined QoL as ´an individual’s perception of 
their position in life, in context of the culture and values in which they live and in 
relation to their goals, expectations, standards and concerns´ (WHOQoL Group, 
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1994). QoL has several domains, like functional competence, health-related com-
plaints and psychological and social functioning. Health-related quality of life 
(HRQoL) is considered to be an integral domain of QoL. When QoL is discussed 
in relation to health or diseases, it almost always means HRQoL, unless specified 
otherwise (Dutt et al., 2016). HRQoL is increasingly used as an outcome of treat-
ment effectiveness. In broad terms, HRQoL serves as a restricted definition of QoL 
in the sense that it was designed to exclude externalities, such as housing, financial 
situation, living conditions, or spirituality. HRQoL is associated with an expanded 
concept of health status, one embracing social interaction as well as emotional 
and psychological well-being (Krabbe, 2017). According to Schipper (1992) QoL 
in clinical medicine represents the functional effects of illness and its consequent 
treatment upon patient, as perceived by the patient. Because  the concepts of QoL 
and HRQoL are closely tied to each other (Dutt et al., 2016), we will use them in 
this paper interchangeably, with omission of external domains such as spirituality, 
or living conditions. 
1 . 2 .4   P s y c h o l o g i c a l  d i s t re s s
Psychological distress is understood as the opposite continuum to psychological 
well-being (Goldberg and Hillier, 1979; Spiteri et al., 2013). The World Health 
Organisation (WHO, 2012) states that ´well-being exists in two dimensions, subjec-
tive and objective. It comprises an individual’s experience of their life as well as a 
comparison of life circumstances with social norms and values´. Health is projected 
as an integral component of well-being, while good health represents a necessary 
condition for attaining the highest possible levels in all other aspects of well-being 
(Salomon et al., 2003). The relationship between health and well-being is interde-
pendent; health influences well-being and well-being itself influences health. There 
are a number of associations between psychological well-being and physical health 
outcomes, such as improved immune system response, higher pain tolerance, in-
creased longevity, improved cardiovascular health, or slower disease progression 
(Howell et al., 2007; Steptoe et al., 2015). 
1 . 2 .4 . 1  Su i c i da l  i d ea t i o n
Suicide and attempted suicide are major public health concerns with complex 
aetiologies which encompass a multifaceted array of risk and protective factors 
(O’Connor, 2017). Suicide is an important cause of death worldwide. Globally, 
more than 800,000 people take their life every year, and there are many more 
suicide attempts (World Health Organization, 2016). Suicidal ideation and suicidal 
behaviours have been conceptualised to lie on a continuum, whereby those who 
experience suicidal ideation may progress to make suicide plans and then, subse-
quently, make an attempt or die by suicide (Tarrier et al., 2013). Indeed, data from 
a cross-national study of 17 countries estimated that 33.6% of individuals who expe-
rience suicidal ideation will subsequently develop a suicide plan, and 56% of those 
with a plan will make a suicide attempt (Nock et al., 2008). Therefore, identifying 
and intervening at the start of this trajectory is imperative for developing effective 
suicide prevention strategies. Recent approaches have defined suicide as a health 
behaviour, in the sense that a person makes a decision to take his/her own life, so an 
appreciation of the psychology of the suicidal mind is crucial to suicide prevention 
(O’Connor, 2017). One of the key developments in the field of suicide theory and 
research is the ideation-to-action framework, which stipulates that the development 
of suicidal ideation and the progression from suicidal ideation to suicidal behaviour 
are distinct phenomena with distinct explanations and predictors (Klonsky, 2016). 
Moreover, there is growing recognition that we need to move beyond psychiatric 
categories to further understand the pathways leading from suicidal ideation to sui-
cidal behaviour (O’Connor, 2017). 
Suicidal ideation is a common health concern in primary care (Rückert-
Eheberget al., 2019). The findings of previous studies support the need to screen 
for suicidality in general medical settings, over and above the use of general depres-
sion instruments (Druss and Pincus, 2000; Krakow et al., 2011). A significant as-
sociation was found between chronic medical conditions and suicidality, and it per-
sisted after adjusting for depressive disorder or alcohol abuse (Druss and Pincus, 
2000). A total of 25.2% of individuals with a general medical condition and 35.0% 
of those with two or more medical illnesses reported lifetime suicidal ideation 
(Tang and Crane, 2006). The lifetime prevalence of suicide attempts was between 
5 and 14% in individuals with chronic pain, and the prevalence of suicidal ideation 
was 20% (Tang and Crane, 2006). 
A growing body of research indicates that sleep disturbances are associated 
with suicidal ideation and suicidal behaviors. To date, however, the majority of the 
research has focused on insomnia. Sleep disorders differentially affect functioning, 
and the relationship between OSA and suicide has yet to be established. OSA, in 
contrast to insomnia, is characterized by frequent awakenings that disrupt the natu-
ral progression of sleep cycles and sleep architecture. Thus, patient with OSA may 
in fact obtain more total sleep time than the typical insomnia patient; however, the 
sleep of the OSA patient may be less restorative. Because of this etiologic differ-
ence, it is unclear what aspect of generalized sleep disturbance contributes to sui-
cide risk. For example, if the association between sleep and suicide only represents 
a function of the loss of total sleep time, then sleep disorders such as OSA, that do 
not significantly reduce total sleep time, should not be associated with increased su-
icide risk. However, if the association between sleep and suicide is related to other 
aspects of sleep disturbances (e.g. hypersomnolence, fatigue, or neurophysiologic 
changes), then OSA and other sleep disorders may emerge as being associated with 
increased suicide risk (Bishop, et al., 2018).
Recently, an increased suicidal ideation has been observed in patients treated 
in medical sleep centres (Krakow et al., 2011), including patients with OSA (Choi 
et al., 2015). Sleep-related problems were found to pose multiple challenges for 
mental and physical functioning. Poor night-time sleep quality was found to be 
associated with an increased risk of committing suicide in one decade even when 
adjusted for depressive symptomatology (Bernert et al., 2014). Krakow et al. (2011) 
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found an association between sleep-related problems and suicidal ideation in pa-
tients treated in medical sleep centres, which remained significant after controlling 
for depression. In 2015, Choi et al. reported a suicidal ideation prevalence of 20.5% 
in a Korean population among OSA patients, but information about the prevalence 
of suicidal ideation in OSA patients in other countries is lacking. Consequently, 
it is important to understand the associations between sleep-related problems, 
suicidal ideation, and suicidal behaviour. Another source of concern is that people 
with sleep problems suffering from psychological distress rarely seek formal mental 
health care (Weissman et al., 1997; Wojnar et al., 2009). Therefore, the idea of 
depending solely on the available psychological and psychiatric care to detect in-
dividuals at risk of suicidal ideation may be insufficient for early suicide prevention 
efforts, especially for people with chronic diseases such as OSA. 
1.3   Biomedical factors and their associations with 
self-reported health outcomes
Of all approaches to health, the biomedical approach is unquestionably considered 
to be the most influential. This approach understands health primarily through the 
lens of disease, and it attributes the cause of ill health to breakdown in normal bio-
logical and physiological functioning. In so doing, it gives a clear direction in how 
best to manage health – and this is to focus on treating the source of breakdown in 
the body (Haslam et al., 2018).  Relevant and potentially modifiable biological factors 
in the prediction of health in this study concerned OSA severity (assessed by AHI) 
and sleep-related problems (including night-time sleep quality, daytime sleepiness, 
and fatigue). Another biomedical factor in this study concerned CPAP treatment.  
1 . 3 . 1   O S A  s e v e r i t y  a n d  s l e e p - re la te d  p ro b l e m s 
Since OSA is diagnosed according to a cut-off in the Apnoea-Hypopnoea Index 
(AHI), a logical assumption is that higher AHI is associated with higher OSA-
related symptoms, including sleep-related problems. However, previous research 
has shown that AHI may not correlate well with the presence or degree of daytime 
sleepiness (e.g. Bixler et al., 2005; Roure et al., 2008; Macey et al., 2010; Dündar 
et al., 2015), sleep quality (Macey et al., 2010), anxiety, or depressive symptomatol-
ogy (Macey et al., 2010; Asghari et al., 2012; Rezaeitalab et al., 2014).
Although excessive daytime sleepiness is considered a cardinal symptom 
of OSA, the association between daytime sleepiness and OSA severity is unclear 
(Adams et al., 2016). In the Sleep Heart Health Study and the Wisconsin Sleep 
Cohort Study, daytime sleepiness was found to be associated with OSA severity 
(Kapur et al., 2005; Young et al., 2009). On the contrary, some recent studies 
showed that the presence of daytime sleepiness may represent an unreliable indica-
tor of OSA (Adams et al., 2016; Al Houqani and Arora, 2019). Furthermore, ap-
proximately 50% of OSA patients deny daytime sleepiness (Roure et al., 2008). 
The subjective evaluation of daytime sleepiness is also often complicated by the 
fact that patients may report complaints regarding lack of energy or depressive 
symptomatology (Lin et al., 2008) rather than sleepiness itself (Chervin, 2000). 
Moreover, the phenomenon of residual sleepiness, e.g. excessive daytime sleepi-
ness in OSA patients treated effectively with CPAP, implies that the underlying 
pathology of daytime sleepiness may be different from that of OSA per se (More et 
al., 2019). As this particular area of the associations between OSA severity, sleep-
related problems and health-outcomes remains unclear, our studies may be useful 
in enhancing our understanding of these relationships.
1 . 3 . 2   C o n t i n u o u s  p o s i t i v e  a i r way  p re s sure  t rea t m e n t 
In terms of treatment, CPAP represents the first treatment of choice in most pa-
tients with OSA (American Academy of Sleep Medicine, 2008; Patil, 2019). To 
date, CPAP represents the most effective intervention for managing OSA; however, 
adherence may be poor (Aloia et al., 2004; Weaver and Grunstein, 2008; Rakel, 
2009; Weaver and Sawyer, 2010; Barrata et al., 2018), with rates ranging from 29% 
to 81% (Weaver and Grunstein, 2008). Approximately, one fourth of all CPAP us-
ers discontinue its usage within the first year for reasons that range from discomfort 
and a feeling of claustrophobia from the mask, to inconvenience and its interfer-
ence with travel (Aloia et al., 2004). The majority of OSA patients who continue 
using CPAP do not use it consistently or for the number of recommended hours 
each night (Aloia et al., 2004). Moreover, some interventions employed to improve 
CPAP adherence (e.g. education and telephone follow-up calls), were found to have 
only a limited success (Sawyer et al., 2011). 
Some previous studies showed that patients’ reports of improvement with 
CPAP treatment were often found to be discordant with PSG results. Thus, other 
clinically important health-related outcomes including QoL and functional status, 
are recommended to be used as complementary part in the evaluation of CPAP treat-
ment response (Weaver et al., 2005). Some studies have concluded that OSA pa-
tients, even with a good CPAP compliance level, are not able to achieve their normal 
functional status and QoL when compared to general population levels of function-
ing (Perimenis et al., 2007; Weaver et al., 2007; Antic et al., 2011; Weaver, 2013; 
Tippin et al., 2016; Jackson et al., 2018). Poor CPAP treatment effects on health 
outcomes were especially profound in patients with psychological symptomatology 
(Kjelsberg  et al. 2005; Hussain et al., 2014; Jackson et al., 2018). Moreover, results 
on CPAP treatment effectiveness were also found to be inconclusive regarding ob-
jective health outcomes, such as a decrease in blood pressure among OSA patients 
(e.g. Dimsdale et al., 2000; Pepperell et al., 2002; Bazzano et al., 2007; Bratton 
et al., 2014). 
Nevertheless, CPAP therapy represents the gold standard treatment option 
and should be offered to OSA patients as a first choice treatment. Although improv-
ing CPAP treatment to maximize adherence is important, there is also a need for 
novel strategies which may be helpful in OSA management. Thus, present research 
and clinical practice should focus not only on the standard treatment of OSA, but 
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also on ensuring that symptoms such as poor sleep quality, daytime sleepiness, fa-
tigue, or psychological symptoms are managed. To do that, we first need to under-
stand how these biomedical and psycho-social factors relate to health outcomes in 
untreated OSA patients. 
1.4   Psycho-social factors and their associations with 
self-reported health outcomes
About 40 years ago Engel (1978) authored the bio-psycho-social model and, in so 
doing, tried to reverse the dehumanization of health sciences and disempowerment 
of patients (Smith et al. 2013). The bio-psycho-social model considers the need to 
include not only the characteristics and normative functioning of biological systems 
(Haslam et al., 2018), but also the consideration of individuals’ experience, daily 
functioning, productivity, emotional stability, performance of social roles, and so-
cial determinants (Fava and Sonino, 2007; Haslam et al., 2018). 
The psychological and social factors assessed in this thesis have been studied 
for their positive association with health outcomes in various chronic illnesses, such 
as multiple sclerosis (Krokavcova et al., 2008a; Mikula et al., 2014; Mikula et al., 
2016), chronic obstructive pulmonary disease (Tiemensma et al., 2016), cardiovas-
cular diseases (Silarova et al., 2012; Silarova et al., 2014; Silarova et al., 2016), or 
insomnia (Troxel et al., 2010), but some of them are less known in OSA. Social 
factors related to external resources accessed from others were operationalized as 
perceived social support and coping self-efficacy for the ability to get support from 
family and friends. Psychological factors included anxiety and hostility together 
with intra-individual psychological resources such as coping self-efficacy for the 
ability to stop unpleasant emotions and thoughts, problem-focused coping-self-
efficacy, and mastery over one’s life and circumstances. 
1 .4 . 1   A n x i e t y
In addition to physical disorders, OSA patients may experience mental impairment. 
Many OSA patients suffer from anxiety symptoms (Yue et al., 2003; Shapiro et al., 
2014; Krakow et al., 2015), but these are rarely systematically studied (Shapiro et 
al., 2014; Krakow et al., 2015). Anxiety includes a large spectrum of conditions 
varying from psychiatric diagnoses (e.g. generalised anxiety disorder, social pho-
bia, or obsessive compulsive disorder) to threshold symptoms. Anxiety, especially 
at severe and panic levels, may have a major impact on sleep and breathing (Shapiro 
et al., 2014). Anxiety may contribute to poor treatment acceptance and adherence 
(Aloia et al., 2004) and, consequently, to an overall worsening of OSA symptoms 
and an increased risk of morbidity (Shapiro et al., 2014). Furthermore, comorbid 
anxiety in OSA patients has been found to have pathophysiological implications; 
i.e. permanent neurological alterations in brain areas regulating emotions were 
noted using magnetic resonance in anxious OSA patients compared to no signifi-
cant change in non-axious OSA patients and controls (Kumar et al., 2009). A more 
nuanced theory suggests that OSA itself may represent a direct cause of anxiety, 
because virtually anything that disrupts breathing (e.g. asthma, bronchitis, chronic 
obstructive pulmonary disease) easily causes or aggravates symptoms of anxiety 
(Krakow et al., 2015). 
1 .4 . 2   H o s t i l i t y
Previous research has shown that various chronic diseases and an increased risk 
of illness were associated with hostility (Nabi et al., 2008), with strong evidence 
for cardiovascular diseases (Nabi et al., 2008; Silarova et al., 2014; Silarova et al., 
2016). Affective consequences of OSA were also found to include elevated rates of 
hostility (Yue et al., 2003).  Hostility is defined as a negative cynical attitude toward 
others, with a propensity for anger, aggression (Cook and Medley, 1954), mistrust, 
and cynicism (Barefoot et al., 1989). Previous research has identified hostility to be 
a risk factor for impaired psychological QoL in patients with cardiovascular diseases 
(Nabi et al., 2008; Silarova et al., 2014; Silarova et al., 2016). Hostility may be linked 
to increased negative emotionality (Brissette and Cohen, 2002) and psychological 
symptoms, such as sleep disruption (Brissette and Cohen, 2002; Tsuchiyama et al., 
2013), depression (Heponiemi et al., 2006), suicidal ideation, and suicidal attempts 
(Brezo et al., 2006; Lemogne et al., 2011). In their review, Baglioni et al. (2010) 
concluded that hostility correlates with poor sleep quality, both in subclinical and 
clinical samples. Recently,  Xiao et al. (2016) reported a strong association between 
hostility and decreased night-time sleep quality in patients with OSA. Moreover, 
hostility was found to be related to an attenuated decline in night-time blood pres-
sure (Hall et al., 2004), which may potentiate the negative health consequences 
of OSA-related cardiovascular symptomatology. Individuals with high hostility may 
have a delayed onset of sleep due to rumination or elevated arousal following their 
daily interactions (Hall et al., 1997). Thus, negative experiences during the day may 
hinder physiological recovery at night, resulting in difficulties initiating sleep and a 
blunted decline in blood pressure (Hall et al., 2004).
However, evidence for a relationship between hostility and sleep-related 
problems is still scarce (Granö et al., 2008; Sadeh et al., 2011). Some studies and 
clinical observations hypothesize that sleep loss reduces affective stability and in-
creases emotional reactivity (Anderson and Platten, 2011), aggression, and hostility 
(Kamphuis et al., 2012). Booth et al. (2006) found a correlation between daytime 
sleepiness and anger, as measured by the Bussy-Perry subscale, in sex-offenders 
with diagnosed OSA. Following CPAP treatment, OSA patients reported a lower 
level of hostility. Other authors define the role of hostility as the main cause of sleep 
problems; for example, Granö et al. (2008) in their longitudinal study concluded 
that transient, but not trait hostility may predispose for a shorter duration of sleep 
in the general population even when adjusted for psychiatric disorders. 
1 .4 . 3   C o p i n g  s e l f - e f f i c a c y
Coping may be a determinant of both recovery and adaptation to disability (Lo 
Buono et al., 2017). Effective coping strategies may be beneficial in handling chronic 
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diseases, including OSA (Bardwell et al., 2001; Gassara et al., 2017). In general 
terms, coping can be defined as an effort to manage a situation and involves vari-
ous cognitive and behavioural strategies to overcome external or internal demands 
which are appraised as either taxing or exceeding the person’s resources (Folkman 
et al., 1986). The terms coping and coping self-efficacy are closely linked to each 
other (Park and Folkman, 1997; Bandura et al. 1999; Chesnay et al., 2006; Mikula 
et al., 2014; Mikula et al., 2016). The concept of coping self-efficacy is based on an 
integration of two well established theories within health research: the self-efficacy 
theory of Bandura (1999) and the coping theory of Lazarus and Folkman (1984). In 
the framework of these theories, coping-self efficacy addresses the second phase 
of coping, which represents how a person reacts to a stressful situation and most 
importantly which coping strategy he or she will apply based on the perceived self-
efficacy. The choice and level of coping self-efficacy in a particular circumstance 
reflects prior relevant experiences (Bandura et al., 1977). During the process of 
secondary appraisal, the individual judges that an outcome is controllable through 
coping and addresses the question of whether person believes that he or she can 
carry out the requisite coping strategy (Lazarus and Folkman, 1984). Coping self-
efficacy contributes to this judgment, which is an important prerequisite to coping 
behaviour (Park and Folkman, 1997). The ability to regulate emotions is crucial in 
diminishing psychological distress; however, healthy emotion-regulation may not 
merely be about using the “right” strategies (Haines et al. 2016). 
According to the strategy-situation-fit hypothesis, emotion-regulation strat-
egies are able to diminish psychological distress only when used in appropriate 
contexts (Bonanno and Burton, 2013; Haines et al. 2016). When dealing with their 
health conditions, patients use various coping strategies which may have differ-
ent effects on their psychological well-being. When people obtain a ‘fit’ between 
stressful events and their coping strategies, they experience less psychological dis-
tress than when there is a lack of such a fit (Park et al., 2001). As such, greater levels 
of coping self-efficacy are associated with more effective regulation of emotional 
distress (Luberto et al., 2014). Previous research has focused on the effect of cop-
ing self-efficacy and coping behaviour on patients’ self-reported health outcomes in 
various diseases, such as heart failure (Graven and Grant, 2013), multiple sclerosis 
(Mikula et al., 2016), or chronic obstructive pulmonary disease (Tiemensma et al., 
2016). A higher level of coping self-efficacy was associated with a better adjustment 
to various chronic diseases (Chesney et al. 2006; Benka et al., 2014; Mikula et al., 
2014; Mikula et al., 2016). Only a few studies have so far addressed this concept, 
but those that have showed that coping self-efficacy was associated with lower level 
of psychological distress (Chesney et al., 2006; Benka et al., 2014) and better QoL 
(Mikula et al., 2014; Mikula et al., 2016) in the context of chronic diseases. Overall, 
these results suggest that coping self-efficacy has direct effects on distress/well-
being outcomes, beyond the impact of clinical and personality variables. 
Some studies indicate that problem-focused coping was the most beneficial 
in handling disease (Scharloo et al., 2000; Graven and Grant, 2013; Tiemensma 
et al., 2016), especially in the mental health domain (Scharloo et al., 2000). In 
other studies, problem-focused coping was generally unrelated to illness adjust-
ment (Bombardier et al., 1990). The emotion-focused coping triad, consisting of 
wishful thinking, self blame, and avoidance, was also found to be a maladaptive 
strategy when coping with chronic medical conditions (Bombardier et al., 1990). 
Nevertheless, in some studies, avoidance coping or more passive coping strategies, 
such as coping self-efficacy for stopping unpleasant emotions and thoughts, were 
defined as most effective (Mackay et al., 2012; Harmell et al., 2011; Mikula et al., 
2016). Recent studies have concluded that the more active and less passive coping 
strategies reported by OSA patients, the lower the level of depressive symptoms 
experienced by patients (Bardwell et al., 2001; Gassara et al., 2017). 
1 .4 .4   Mas te r y  o v e r  o n e ’s  l i f e  a n d  c i rc um s t a n c e s
As patients with OSA have very little control over the symptoms of their disease 
and have to learn how to live with it, mastery may help them to reduce the stress 
that breathing difficulties and sleep-related symptoms bring about and may thus 
improve their health outcomes. Mastery is defined as a general sense of control over 
one’s life and circumstances (Pearlin and Schooler, 1978). A higher level of mastery 
has been found to be associated with better health in people with chronic disease 
or disability (Cott et al., 1999). A diminished sense of mastery was associated with 
a decrease in physical, mental, and social functioning and with increased mortality 
rates in patients with chronic conditions (Surtees et al., 2006; Krokavcova et al., 
2008a; Sloan et al., 2009). In OSA patients with comorbid insomnia, the positive 
associations between mastery and both physical and mental QoL remained signifi-
cant even after adjustment for age, obesity, chronic diseases, erectile dysfunction, 
sleepiness, mood, and financial strain (Lang et al., 2016). Mastery as a part of pa-
tient empowerment (Aujoulat et al., 2008) was also found to be associated with in-
dividuals’ capacity to make decisions about their health behaviour and to have or to 
take control over aspects of their lives that are related to health (McAllister et al., 
2012). Research has also shown that people with a higher level of mastery are more 
likely to seek treatment at an early stage of disease, and to use health care services 
more efficiently (Menec and  Chipperfield, 1997). 
1 .4 . 5   S o c ia l  sup p o r t
Social support is a very important aspect in the treatment of chronic and incapaci-
tating diseases (Günbey and Karabulut, 2014). There is some evidence that having 
adequate psychosocial support may lead to an improvement of perceived QoL and 
reduced morbidity (Barefoot et al., 2005), while the absence of positive relation-
ships was found to be a significant risk factor for morbidity and mortality (Cacioppo 
and Cacioppo, 2014). Lack of social support has a significant impact on health-
related behaviour and risk for illness (Alemi et al., 2003); i.e. poor social support 
was associated with poorer self-rated health in patients with acute myocardial in-
farction (Bucholz et al., 2014), higher levels of blood pressure (Piferi et al., 2006), 
chronic arthritis pain (Lee et al., 2016), and multiple sclerosis (Krokavcova et al., 
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2008b). Social support also had a positive influence on sleep in people with insom-
nia (Troxel et al., 2010). 
Therefore, social support may be an important, though under-investigated, 
protective factor associated with healthier sleep, better QoL, and daytime function-
ing also in OSA patients. There are several plausible pathways that may link social 
support with sleep, including attenuating stress responses, encouraging healthy 
sleep behaviours, and entraining circadian rhythms (Troxel et al., 2010). OSA pa-
tients may experience lower levels of social support compared to other populations 
with chronic diseases. Some previous studies explained that OSA-related symp-
toms can negatively impact the partners’ sleep and daytime functioning (Luyster, 
2017) or engagement in social activities (Luyster et al. 2016). Recently, a significant 
negative impact of perceived OSA symptoms on marital satisfaction was described 
(Tramonti et al., 2017). Another indication for lower levels of social support in 
patients with OSA may be the association between poor social support and sleep 
disordered breathing symptoms (Glenn et al., 2015). Moreover, a low level of social 
support was independently associated with short sleep duration when controlled 
for sociodemographic variables (Glenn et al., 2015). 
With a few exceptions (e.g. Troxel et al., 2010; Choi et al., 2015), previous 
research on sleep disorders has focused mainly on the association between social 
support and self-reported sleep disturbances (Troxel et al., 2010). Furthermore, 
very little is known about the role of social support in OSA. To our knowledge, 
only one study by Choi et al. (2015) focused on social support in OSA patients (i.e. 
in the association with suicidal ideation). Recently, supportive relationships were 
found to be associated with CPAP treatment adherence in female patients with OSA 
(Baron et al., 2017). Insufficient emotional (e.g., encouragement) and instrumental 
(e.g. help with putting on mask, verbal reminders) support from partners of OSA 
patients was further identified as a barrier for CPAP adherence (Broström et al., 
2010; Luyster et al., 2016). There are two dimensions of social support, namely per-
ceived social support and received social support (Dunkel-Schetter and Bennett, 
1990). Perceived social support is defined as ‘the perception of an individual about 
the amount and quality of support received from his/her social network’, while 
received social support is defined as ‘the objective quantification of the help and 
aid the person receives from his/her social network’ (Kim et al., 2017). Perceived 
social support was identified as a stronger predictor of individual well-being than 
received social support. Furthermore, perceived social support was found to be 
more strongly associated with personality traits such as self-esteem (Goodwin et 
al., 2004). 
1.5   Health model
In the context of the bio-psycho-social approach (Engel, 1978), our study design 
is partially based on the model proposed by Wilson and Cleary (1995) (Figure 
1.1). The proposed model represents a taxonomy or classification scheme for dif-
ferent measures of health outcomes. These outcomes are divided into four levels: 
symptoms, functional status, general health perceptions, and overall quality of life 
(QoL) (Wilson and Cleary 1995; Krabbe, 2017). In addition to classifying these 
outcome measures, the authors proposed specific causal relationships between 
them that link traditional clinical variables to measures of HRQoL. “As one moves 
from left to the right in the model, one moves outward from the cell to the individual 
and to the interaction of the individual as a member of society” (Wilson and Cleary, 
1995). The model captures the factors affecting health as experienced by individu-
als (Wilson and Cleary, 1995; Krabbe, 2017). The main purpose of the proposed 
model was to distinguish between conceptually distinct measures of health-related 
QoL outcomes and to make the dominant relationships explicit. Therefore, the dis-
played direction of the arrows do not imply that reciprocal relationships are absent. 
Neither does the absence of arrows between non-adjacent levels imply that the as-
sociations are completely missing (Krabbe, 2017). 
Figure 1.1: Relationships among measures of patient outcome in a health-related 
quality of life. Conceptual model by Wilson and Cleary 1995. Linking clinical vari-
ables with health-related quality of life: a conceptual model of patient outcomes. The 
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1.6   Aim of the thesis and research questions
This thesis aims to provide insights in the associations between biomedical, psycho-
logical, and social factors and self-reported health outcomes in patients with OSA. 
It builds on previous studies describing populations with various chronic diseases 
and adds knowledge to previous research by focusing on OSA patients. Figure 1.2 
provides a visual overview of the associations examined in this thesis. 
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Research question 1 (Chapter 3)
Does Continuous Positive Airway Pressure (CPAP) treatment have a positive effect 
on quality of life in OSA patients when compared to sham CPAP, placebo pills, and 
conservative treatment? 
Research question 2 (Chapter 4)
Are OSA-severity, sleep-related problems, and anxiety associated with work func-
tioning in OSA patients when controlled for age, gender, and type of occupation? 
Research question 2a (Chapter 4)
Does anxiety moderate the association between sleep-related problems and work 
functioning? 
Research question 3 (Chapter 5)
Are hostility and coping self-efficacy dimensions associated with psychological dis-
tress in OSA patients when controlled for sociodemographic, clinical, and sleep-re-
lated variables? 
Research question 3a (Chapter 5)
Do coping self-efficacy dimensions mediate the association between hostility and 
psychological distress? 
Research question 4 (Chapter 6)
What is the prevalence of suicidal ideation in OSA patients? Are OSA severity, 
sleep-related problems, and social support related to suicidal ideation in OSA pa-
tients? 
Research question 5 (Chapter 7)
Is there an association between social support, mastery, sleep-related problems and 
functional status in OSA patients when controlled for sociodemographic and clini-
cal variables?  
Research question 5a (Chapter 7)
Do social support and mastery mediate the association between sleep-related prob-
lems and functional status? 
1.7   Outline of the thesis
This thesis contains eight chapters.
Chapter 1: “Introduction” provides a general introduction into the associations be-
tween the key theoretical constucts of the thesis: OSA, CPAP treatment, self-re-
ported health-related outcomes (functional status, work functioning, QoL and psy-
chological distress, including suicidal ideation), sleep-related problems, anxiety, 
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hostility, coping self-efficacy, mastery, and social support. It also introduces the 
conceptual framework and research questions. 
Chapter 2: “Design of the study and data sources” presents information about the 
study design. It describes the sample and procedure of the data collection and the 
study design and setting used in the thesis. It also provides a description of the 
measures and statistical analyses used. 
Chapter 3: “Quality of life of obstructive sleep apnoea patients receiving continuous 
positive airway pressure treatment: a systematic review and meta-analysis” investi-
gates the question of the effect of real CPAP treatment on QoL when compared to 
placebo pills, sham CPAP, and conservative treatment.  
Chapter 4: “Are disease severity, sleep-related problems and anxiety associated 
with work functioning in patients with obstructive sleep apnoea?”examines whether 
OSA-severity, sleep-related problems, and anxiety are associated with work func-
tioning in OSA patients. It also investigates whether anxiety moderates the associa-
tions between sleep-related problems and work functioning. 
Chapter 5: “Psychological distress in patients with obstructive sleep apnoea. The 
role of hostility and coping self-efficacy” examines whether hostility and coping 
self-efficacy dimensions are associated with psychological distress in OSA patients. 
Additionally, it explores whether coping self-efficacy dimensions mediate the as-
sociation between hostility and psychological distress. 
Chapter 6: “Suicidal ideation in patients with obstructive sleep apnoea and its rela-
tionship with disease severity, sleep-related problems and social support” presents 
the prevalence of suicidal ideation in OSA patients and examines the relationships 
between OSA severity, sleep-related problems, social support and suicidal ideation 
in OSA patients.
Chapter 7: “Social support, mastery, sleep-related problems and their association 
with functional status in untreated obstructive sleep apnoea patients” examines the 
associations between social support, mastery, sleep-related problems and function-
al status in OSA patients. It also explores the mediating role of social support and 
mastery in the association between sleep-related problems and functional status. 
Chapter 8: “General discussion, implications, and conclusions” summarizes and 
discusses the main findings of the thesis, its strengths, limitations and implications 
for practice and future research. At last, conclusions are drawn in the final section.
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This chapter provides a general overview of the study design, the origin of the data 
sources, and the statistical analyses used in this study. 
2.1   Study design and setting
This cross-sectional study was conducted at the Department of Pneumology and 
Phtiseology, L. Pasteur University Hospital, and the Medical Faculty of PJ Safarik 
University in Kosice, Slovak Republic. All patients who visited the Department for 
a one-night polysomnography (PSG) between July 2013 and June 2016 and under-
went PSG were eligible for the study. In line with ethical principles, we explained 
the purpose of the study to all participants and guaranteed confidentiality. We also 
explained that the collected data would only be used for the purposes of this study. 
All patients completed and signed an informed consent form prior to their partici-
pation in the study, which was fully voluntary and included no incentives for partici-
pation. The study was approved by the Ethics Committee of PJ Safarik University 
(approval no. 115/2011).
2.2   Sample and procedure
The Indication for a PSG was based on a general practitioner referral form. OSA 
was diagnosed based on an overnight sleep examination. Only OSA patients be-
tween 18 and 65 years of age were included due to possible functional changes, in-
creased vulnerability and a decline in abilities and performance related to age. The 
study sample comprised patients with an Apnoea Hypopnoea Index (AHI; number 
of apnoeas+ hypopnoeas per hour of sleep) score of 5 or more, (American Academy 
of Sleep Medicine, 2005) who had no previous continuous positive airway pressure 
(CPAP) therapy or other OSA treatment, were Slovak-speaking and had no major 
comorbidities. Out of 263 eligible patients, 41 patients who underwent PSG refused to 
participate in the study, yielding a total response rate of 84.0%.  Another 72 patients 
were excluded because of major comorbidities. The final study population comprised 
N=150 patients.  The reasons for exclusion were major comorbidities related to sleep 
(a coexisting sleep disorder, such as insomnia, narcolepsy or circadian rhythm sleep 
disorder), major cardiovascular diseases (e.g. myocardial infarction, angina pectoris, 
primary pulmonary hypertension); pulmonary conditions (e.g. chronic obstructive 
pulmonary disease, Pickwick syndrome) and a history of cancer in the past twelve 
months. Neurological and psychological comorbidities included a neurological condi-
tion (e.g. stroke, epilepsy), a major psychiatric diagnosis (e.g. psychotic disorders, 
major depression) in the medical record, and/or current usage of psychiatric medi-
cations which may affect cognitive functions (e.g. benzodiazepines, antipsychotics, 
or antidepressants), drug abuse in the past six months and regular shift work in the 
past six months. Due to the assessment of health outcomes related to intimate relation-
ships and sexual functioning, we excluded patients with diabetes and those using hy-
potensive medication, which may affect sexual function (following Hoekema et al., 
2007). The screening for comorbidities was based on medical data and an initial clinical 
interview prior to data collection. The clinical diagnoses were established according 
to the standard International Classification of Diseases-10 revision Codes. Medical 
examinations of patients were conducted by a pulmonologist specialized in sleep-
disordered breathing. Patients with non-respiratory sleep-related complaints (e.g. 
narcolepsy, insomnia) were routinely referred to another group of clinical special-
ists. The invitation letter, the informed consent and the questionnaire was sent to 
participants by postal mail three weeks before the medical examination. One week 
before the medical examination, patients were reminded about the questionnaire by 
a phone call. Patients completed the self-report questionnaire at home.
The final study sample comprised 150 OSA patients (AHI≥5). The sample had 
a mean age of 48.9±9.5 years and consisted of 68% men. More detailed information 
on each particular sample is described in the separate Chapters 3-7. The process of 
sample formation is depicted in Figure 2.1. 
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2.3   Measures
The Work Role Functioning Questionnaire (WRFQ 2.0) and the Functional 
Outcomes of Sleep Questionnaire (FOSQ) were systematically translated from the 
original language. A forward-backward translation was conducted to ensure that no 
original meaning was lost in the translation. Final changes in the translated versions 
were made accordingly. The measures used in the Chapters 3-7 are described below. 
Functional status 
Functional status was assessed using the Functional Outcomes of Sleep 
Questionnaire (FOSQ) (Weaver et al., 1997; Weaver et al., 2007). The FOSQ is 
a 30-item self-report, disease-specific measure designed to assess the impact of 
sleep disorders of excessive daytime sleepiness on multiple activities of function-
al outcomes relevant to daily behaviour and QoL. Functional status, as a measure 
of QoL, assesses those activities performed routinely in meeting basic needs and 
fulfilling essential roles (Leidy, 1994). The FOSQ has five subscales: activity level, 
vigilance, intimacy and sexual relationships, general productivity, and social out-
comes. Patients have to rate the difficulty of performing a given activity on a 4-point 
scale (no difficulty to extreme difficulty). Responses were averaged (excluding 
missing responses) to create a subscale score of 1 to 4, and then the subscale scores 
were summed for the total score (5-20), with higher scores indicating less effect of 
sleepiness on daily life (Billings et al., 2014). In our sample, the Cronbach’s alphas 
were 0.90 for the total scale, 0.90 for the activity level, 0.84 for vigilance, 0.95 for 
intimacy and sexual relationships, 0.90 for the general productivity, and 0.82 for 
the social outcomes subscale, respectively.
Work functioning 
Work functioning was assessed using the Work Role Functioning Questionnaire 
(WRFQ 2.0) (Abma et al., 2013). The WRFQ measures the perceived difficulties in 
performing work demands among workers, given their emotional or physical health 
problems. The WRFQ consists of 27 items divided into subscales: work schedul-
ing demands and output demands, physical demands, mental and social demands, 
and flexibility demands. In addition, a total score can be calculated. Items are an-
swered on a five-point scale: 0= difficult all the time (100%), 1= difficult most of the 
time (75%), 2= difficult half of the time (50%), 3= difficult some of the time (25%), 
4= difficult none of the time (0%). The scores on ‘Does not apply to my job’ are 
transformed into missing values (Abma et al., 2013). The total score is calculated 
by adding all the answers and dividing by the number of items and then multiplying 
by 25 to obtain percentages between 0 and 100. Higher scores indicate better work 
functioning. To identify the prevalence of impaired work functioning, we used the 
cut-off value (<90) according Amick et al. (2004). In our sample, the Cronbach’s 
alphas were 0.93 for the total scale, 0.97 for the work scheduling and output de-
mands, 0.90 for the physical demands, 0.90 for the flexibility demands, and 0.94 
for the mental and social demands subscale, respectively.
Psychological distress 
Psychological distress was assessed using the General Health Questionnaire 
(GHQ-28) (Goldberg and Hillier, 1979). The GHQ-28 is a 28-item measure of psy-
chological distress in the general population and within community or non-psychi-
atric clinical settings, such as among primary care or general medical out-patients. 
The GHQ-28 was developed as a screening tool to detect those likely to be at risk of 
developing psychiatric disorders. The questionnaire is divided into four subscales: 
somatic symptoms (items 1–7); anxiety/insomnia (items 8–14); social dysfunction 
(items 15–21) and severe depression (items 22–28) (Goldberg and Hillier, 1979). 
The items were assessed on a continuous scale (0-3), with the total score ranging 
from 0 to 84. Higher scores indicated a higher level of psychological distress. A 
total score of 23/24 represents the threshold for the presence of psychological dis-
tress (Goldberg and Hillier, 1979).  In our sample the Cronbach’s alpha for the total 
GHQ-28 scale was 0.83. 
Suicidal ideation
Suicidal ideation was assessed using the General Health Questionnaire (GHQ-28) 
(Goldberg and Hillier, 1979). Four items directly dealing with suicidal ideation 
were used: “Have you thought about the possibility of killing yourself?”; “Do you 
wish to be dead and far away from everything? ”; “Do you have continual thoughts 
about ending your life?”; and “Do you have the impression that life is not worth of 
living?” The validated four-item suicidal ideation subscale of the GHQ-28 has been 
previously used to assess suicidal ideation (Gili-Planas et al., 2001; Watson et al., 
2001). In some previous studies the threshold of SI≥1 was used to assess the pres-
ence of suicidal ideation (Gili-Planas et al., 2001; Biddle et al., 2004). The GHQ 
threshold is partly determined by the prevalence of multiple diagnoses, with higher 
thresholds being associated by higher rates of both single and multiple diagnosis 
(Goldberg, et al. 1998). Thus, we assessed suicidal ideation in a binary manner to 
determine the prevalence of suicidal ideation, with a cut off of SI≥2, with the nega-
tive responses, given a score of zero, and the positive responses a score of one. 
The sum-score of the four items of suicidal ideation ranged from 0 to 4. Suicidal 
ideation was also used as continuous variable (1-4) in structural equation modelling, 
with a range from 4 to 16. Higher scores indicated a higher level of suicidal ideation. 
In our sample the Cronbach’s alpha was 0.83. 
Anxiety
Anxiety was measured using the 21-item Beck Anxiety Inventory (BAI), defining the 
most common anxiety symptoms (Beck and Steer, 1990). The BAI is a brief meas-
ure of anxiety with a focus on somatic symptoms. It was developed as an efficient 
measure to discriminate between anxiety and depression (Beck et al., 1988). Scores 
range from 0 to 63, with higher scores indicating a higher anxiety level. The follow-
ing categories were defined: no anxiety symptoms (score 0-9), mild anxiety (score 
10-18), severe anxiety (score 19-29), and very severe anxiety (score 30-63) (Beck 
and Steer, 1990). The Cronbach’s alpha in our sample was 0.90.
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Hostility 
Hostility was measured by the abbreviated 27-item version of the Cook-Medley 
Hostility Scale (CMHo) (Cook and Medley, 1954). The CMHo scale is a widely 
used self-report measure of the trait hostility. The scale primarily assesses the cog-
nitive aspects of hostility, cynicism and mistrust. Cynicism items are defined as 
statements of belief; aggressive response items reflect behaviour, and hostile affect 
items reflect emotional experiences. Each item was rated on a dichotomised scale 
(1=“true”, 0=“false”). The score ranges from 0 to 27, with a higher score indicating 
a higher level of symptoms (Cook and Medley, 1954). The Cronbach’s alpha for the 
total scale in our sample was 0.85. 
Coping self-efficacy
Coping self-efficacy (CSE) was measured using the 26-item CSE Scale developed 
specifically for people suffering from chronic disease (Chesney et al., 2006). The 
CSE scale represents a measure of an individual’s confidence in performing coping 
behaviours when faced with life challenges. The term CSE relates to the tendency 
to make certain attributions about control not in one context but many (Lazarus 
and Folkman, 1984). The CSE scale advances our ability to explore the theoretical 
links between the secondary appraisal of stress, which asks ‘what can I do?’, and 
the major coping functions postulated by stress and coping theory – the regulation 
of distress and the management of underlying problems (Chesney et al., 2006). 
Coping self-efficacy and coping behaviour are closely linked to each other (Park and 
Folkman, 1997; Bandura, 1999; Chesnay et al., 2006; Mikula et al., 2014; Mikula et 
al., 2018). The term coping self-efficacy is understood as a prerequisite for using 
actual coping strategies, as people need to be sure that they can perform coping 
actions before they act upon them (Chesney et al., 2006). Patients were asked to 
respond to the following question: ‘When things are not going well for you, or when 
you are having problems, how confident or certain are you that you can do the fol-
lowing’: ‘sort out what can be changed, and what cannot be changed’, ‘break an 
upsetting problem down into smaller parts’, ‘look for something good in a nega-
tive situation’, and ‘get emotional support from friends and family’, or ‘take your 
mind off unpleasant thoughts’. The CSE consists of three subscales representing 
self-efficacy for the use of ‘problem-focused coping’ strategies (ranging from 0 to 
120), ‘ability to get support from friends and family’ (ranging from 0 to 50) and the 
‘ability to stop unpleasant emotions and thoughts’ (ranging from 0 to 90). Coping 
self-efficacy for the use of ‘problem-focused coping’ consists of items that measure 
an individual’s self-efficacy with respect to overcoming problems by analysing the 
nature of the problem and employing cognitive strategies to make the respondent’s 
perception of the problem less severe (e.g. ‘break an upsetting problem down into 
smaller parts’). Coping self-efficacy for the ‘ability to stop unpleasant emotions and 
thoughts’ measures a respondent’s self-efficacy with respect to trying not to dwell 
on negative feelings and altering the emotional response to an unsettling event or 
problem rather than addressing the characteristics of the problem itself (e.g. ‘take 
your mind off negative thoughts’). The ‘ability to get support from friends and 
family’ represents a set of items that captures a social dimension by tapping the 
respondent’s perception of their ability to seek help from friends and family to cope 
with problems (e.g. ‘get emotional support from friends and family’) (Chesney et 
al., 2006). The three factors in the CSE scale are consistent with the three major 
aspects of coping – problem-focused coping, emotion-focused coping, and social 
support. Although the scales are correlated, the results of the concurrent validity 
analyses indicate that the scales assess self-efficacy with respect to different types 
of coping and lend support to using the factors separately (Chesney et al., 2006). 
Respondents answered on an 11-point scale. A higher score indicates a higher abil-
ity to cope with a particular situation (Chesney et al., 2006). In our sample, the 
Cronbach’s alphas were 0.94 for self-efficacy for the use of problem-focused cop-
ing strategies, 0.86 for coping self-efficacy focused on getting support, and 0.93 
for stopping unpleasant emotions and thoughts, respectively. 
Mastery
Mastery was measured using the Pearlin Mastery Scale (PMS) (Pearlin and Schooler, 
1978). The PMS measures an individual’s level of mastery, a psychological resource 
that has been defined as “the extent to which one regards one’s life-chances as be-
ing under one’s own control in contrast to being fatalistically ruled” (Pearlin and 
Schooler, 1978). The scale includes 7 items (five negatively worded items and two 
positively worded items), e.g. “You have little control over the things that happen to 
you”, and “What happens to you in the future mostly depends upon you”. The neg-
atively worded items require reverse coding prior to scoring, resulting in a score 
range of 7 to 35, with higher scores indicating higher levels of mastery (Pearlin and 
Schooler, 1978). The Cronbach’s alpha of the scale was 0.85. 
Social support 
The Multidimensional Scale of Perceived Social Support (MSPSS) is a 12-item self-
report measure of social support (Zimet et al., 1988). It uses a seven-point Likert-
type scale, with scores ranging from ‘very strongly disagree’ (1) to ‘very strongly 
agree’ (7), so the total score ranges from 12 to 84, with higher scores indicating 
greater social support (Zimet et al., 1988). The MSPSS has three subscales: signifi-
cant others, family, and friends. In our sample, the Cronbach’s alpha was 0.90 for all 
three separate subscales, and 0.94 for the total scale, respectively. 
Sleep-related problems 
Sleep-related problems concerned night-time sleep quality, daytime sleepiness and 
fatigue. Night-time sleep quality was measured using the Pittsburgh Sleep Quality 
Index (PSQI) (Buysse et al., 1989). The PSQI is a self-rated questionnaire to assess 
sleep quality and disturbances over a one-month time interval. The PSQI consists 
of 19 self-report questions covering seven domains: subjective sleep quality, sleep 
latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep 
medication, and daytime dysfunction. The score ranges from 0 to 21, with higher 
scores reflecting poor night-time sleep quality. A cut-off score of 5 separates good 
from poor sleepers (Buysse et al., 1989). Results of some previous studies suggest-
ed that the seven PSQI domains are best represented by three latent factors (e.g. 
50 CHAPTER 2 51
Cole et al., 2006; Casement et al., 2012). The empirical examination of the factor 
structure of the PSQI identified distinct factors for perceived sleep quality, sleep ef-
ficiency, and daily disturbances (Cole et al., 2006). The PSQI subscales subjective 
sleep quality, sleep medications, and sleep latency loaded on the latent variable per-
ceived sleep quality; the PSQI subscales sleep duration and habitual sleep efficiency 
loaded on the latent variable sleep efficiency; and the PSQI subscales sleep distur-
bances and daytime dysfunction loaded on the latent variable daily disturbances 
(Cole et al., 2006). Sleep efficiency is closely related to sleep quantity (Casement et 
al., 2012), while daily disturbances reflect sleep-related daytime impairment (i.e., 
trouble performing daytime activities) and interruptions in sleep due to physical or 
psychological symptoms (Casement et al., 2012). In our sample, the Cronbach’s 
alpha was 0.85 for the total PSQI scale. 
Daytime sleepiness was measured using the self-report Epworth Sleepiness 
Scale (ESS), an eight-item questionnaire assessing the tendency to fall asleep in 
various daytime scenarios (Miletin and Hanly, 2003). The score ranges from 0 to 
24, with higher scores indicating greater daytime sleepiness. An ESS total score 
greater than 10 indicates excessive daytime sleepiness (Miletin and Hanly, 2003). 
The Cronbach’s alpha in our sample was 0.86. 
Fatigue was measured using the Multidimensional Fatigue Inventory (MFI-20) 
(Smets et al., 1995). It consists of 20 items that measure five dimensions of fatigue: 
general fatigue, physical fatigue, reduced activity, reduced motivation, and mental 
fatigue. Each dimension contains four items with a five-point response format; the 
total score in each dimension ranges from 4 (no fatigue) to 20 (highest possible 
fatigue). The Cronbach’s alphas were 0.80 for general fatigue, 0.89 for physical 
fatigue, 0.75 for reduced activity, 0.81 for reduced motivation, and 0.83 for mental 
fatigue, respectively.
Sociodemographic and clinical data  
Information on age, gender, and marital status was obtained from patient records. 
Patients were asked to identify the one industry that best characterized their cur-
rent employment (over the last 24 months) from a list of International Standard 
Classification of Occupations (International Labour Office, 1990). Patients were 
also asked to specify their occupation to reduce incorrect or inconsistent informa-
tion. OSA patients in the following industries were classified as blue-collar work-
ers: primary resource industry, construction industry, manufacturing industry, 
warehousing, transportation, and trade. Patients employed in public administra-
tion, armed forces, government and the service sector (including tourism, business 
services, education, healthcare, legislators, managerial occupations, professional 
and utilities) were classified as white-collar workers. Body Mass Index (BMI; height 
and weight) was assessed by a physician. BMI was categorized into: underweight 
(<18.50), normal (18.50-24.99), overweight (25.00-29.99) and obese (≥30.00). 
PSG was used to determine whether the diagnosis of OSA was present and to iden-
tify the severity of the disorder. OSA severity was determined based on the AHI 
(American Academy of Sleep Medicine, 2005) score, with three categories: mild 
OSA (AHI ≥5 and ≤15), moderate OSA (AHI >15 and ≤30) and severe OSA (AHI 
>30). OSA severity was used as a continuous variable measured by AHI. OSA se-
verity was determined using PSG and was based on an AHI (number of apnoeas + 
hypopnoeas per hour of sleep) score of 5 or more, according to standard criteria 
(American Academy of Sleep Medicine, 2005). An obstructive apnoea or hypo-
pnoea can be defined as an event that lasts for ≥ 10 s and is characterized by an 
absence or a decrease from baseline in the amplitude of a valid measure of breath-
ing during sleep that either reaches >50% with an oxygen desaturation of 3% or an 
arousal (alternatively a 30% reduction with 4% desaturation) (American Academy 
of Sleep Medicine, 2005). PSG consisted of the overnight recording of left and 
right electrooculograms, standard central and occipital electroencephalogram, 
submental electromyogram (EMG), bilateral tibialis EMG, nasal and oral airflow 
using a thermistor and thoracic, and abdominal excursions using respiratory induc-
tive plethysmography, which directly monitor and quantify the number of respira-
tory events, related hypoxemia and arousals. 
2.4   Statistical analyses
Several statistical methods were used for data analyses. The majority of the analyses 
were performed using the Statistical Package for the Social Sciences (IBM SPSS 23), 
MedGraph, and ModGraph. Data management in the meta-analyses was conducted 
as proposed by Neyeloff et al. (2012). Additionally, Structural Equation Modelling 
(SEM) was performed (Chapter 6) with Mplus 7.1 (Muthén and Muthén, 2015). We 
described the background characteristics of the sample and calculated means and 
standard deviations (SD) for the total sample for continuous variables (Chapter 4-7) 
and stratified by variables under study, including gender (Chapter 7) and suicidal 
ideation (Chapter 6). Descriptive procedures included frequencies and percent-
ages for categorical variables. T-tests were conducted to assess differences in the 
continuous variables. Differences in the categorical variables were analysed using 
Chi-square tests. Before we proceeded with more complex analyses, we investigat-
ed the bivariate correlations between the variables under study (Chapter 4, 5, 7). 
Partial correlations were used to control for sociodemographic variables (Chapter 
6, Chapter 7). We applied an enter method in linear regression in Chapters 4, 5, 
and 7. We used G*Power 3 (Faul et al., 2009) to analyse different types of power 
in different statistical tests with medium effect size at α=0.05. Multicollinearity was 
assessed using the variance inflation factor (VIF<2.0). Missing data were expressed 
as percentage of total number of patients for each variable. A p-value of <0.05 was 
considered statistically significant. Finally, we performed mediation (Chapter 5 
and Chapter 7) and moderation analyses (Chapter 4). The proportion of the effect 
which is mediated was calculated as the indirect effect divided by the total effect 
and multiplied by 100, while the as-advised standardized total effect was at least 
±0.2 (Kenny, 2016).  Sobel z-tests were used to examine the mediating effects in 
Chapters 5 and 7. To test the moderation effects (Chapter 4), the interaction terms 
between independent variables were added into the equation (Baron and Kenny, 
1986). Detailed information about statistical analyses performed can be found in 
the “Statistical analyses” section of each chapter. 
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And now you're mine. 
 Rest with your dream 
in my dream.
Love and pain and work 
should all sleep, now.
The night turns on its 
invisible wheels,
and you are pure beside me 
as a sleeping ember.
Pablo NERUDA
3
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Abstract 
B a c k g ro un d 
Previous studies have shown conflicting results on the effect of continuous positive 
airway pressure (CPAP) on quality of life (QoL) in obstructive sleep apnoea (OSA) 
patients.
O b j e c t i v e s
To systematically evaluate the effect of CPAP on QoL in OSA patients compared to 
sham CPAP, placebo pills, and conservative treatment. 
Me t h o d s 
Studies were identified via Web of Knowledge, PubMed, PsychInfo, CINAHL, 
EMBASE, OpenGrey, and the Cochrane Library. Effect sizes and effect summaries 
were used for estimation of CPAP treatment effect. Subgroup analyses and sensitiv-
ity analyses were conducted to assess the robustness of the findings. 
R e su l t s 
Meta-analysis of 13 randomised controlled trials showed no significant differences 
in overall and psychological QoL comparing values of CPAP treated patients with 
controls; however, physical QoL improved. CPAP significantly affected the overall 
QoL in studies with controls receiving sham CPAP, parallel design, low risk of bias, 
and mild OSA patients.
C o n c l u s i o n
Medical treatment of OSA may help to improve physical symptoms of OSA, where-
as impaired psychological QoL still cannot be successfully alleviated with CPAP 
treatment. 
Introduction
Obstructive sleep apnoea (OSA) is an incapacitating chronic disease characterized 
by repetitive sleep-related episodes of complete (apnoea) or partial (hypopnoea) 
breathing pauses. It is a prevalent disorder associated with a multitude of adverse 
outcomes (Aurora et al., 2015). Symptoms of OSA include snoring, sleepiness, and 
fatigue (Manarino et al., 2012). Most studies have found that OSA concerns 2–10% 
of the adult population (Stradling and Davies, 2004; Leger et al., 2012). The preva-
lence of undiagnosed OSA syndrome in Western countries is up to 5% (Young et 
al., 2002). The impact of OSA on both morbidity and socioeconomic costs is enor-
mous. Costs concern, in particular, health care expenditures and reduced work ca-
pacity and work participation (Stradling and Davies, 2004; Mulgrew et al, 2007). 
Although the exact costs are difficult to calculate, data from 106 countries showed 
that increased healthcare spending to treat undiagnosed OSA varies between 1,950 
and 3,899 dollars per patient per year (Knauert et al., 2015).
OSA is associated with poor quality of life (QoL) (Sharafkhaneh et al., 2005; 
Mulgrew et al., 2007; Weaver, 2013) and has been linked to severe public health 
issues, such as obesity, diabetes, metabolic syndrome, cardio-vascular diseases 
(Stradling and Davies, 2004; Tkacova and Dorkova, 2010), and neuropsychiatric 
problems (Tkacova and Dorkova, 2010). The occurrence of an impairment in cog-
nitive functioning, reduced vigilance (Kang et al., 2012), microsleeps or accidents 
is typical in people with OSA (Tregear et al., 2009). Sharafkhaneh et al. (2005) 
showed a significantly higher prevalence of mood disorders, posttraumatic stress 
disorder, psychosis and dementia among OSA patients. Some studies report an in-
creased prevalence of suicidal ideation in OSA patients (Choi et al., 2015) when 
compared to the general population.
In terms of treatment, continuous positive airway pressure (CPAP) is the first 
treatment of choice in most OSA patients (American Academy of Sleep Medicine, 
2008). CPAP has been reported to be effective in reducing OSA symptoms, car-
diovascular morbidity and mortality, neurocognitive consequences and sleepiness, 
and in improving QoL (Moyer et al., 2001; Giles et al., 2006; Ye et al., 2009; Kuhn 
et al., 2017). Krahn et al. (2008) described a decrease in depression and suicidal 
ideation in untreated OSA patients immediately after the initiation of CPAP treat-
ment. In recent years, increasing attention has been paid to the effectiveness of 
CPAP treatment on QoL improvement. The efficiency of OSA treatment has typi-
cally been judged based on polysomnography (PSG) outcomes. However, patients’ 
reports of improvement were often found to be discordant with PSG results. Thus, 
other clinically important outcomes, including QoL and functional status, have 
been recommended as complementary outcomes in the evaluation of treatment re-
sponse (Weaver et al., 2005).
Previous systematic reviews (Moyer et al., 2001; Merino et al., 2017) and meta-
analyses (Jing et al., 2008; Kuhn et al., 2017; Patil et al., 2019) have shown conflict-
ing results on the effect of CPAP treatment on QoL in OSA patients. The findings 
vary from improvement of QoL after receiving CPAP treatment (Moyer et al., 2001; 
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Merino et al., 2017) to improvement in the physical QoL domain only (Jing et al. 
2008), or overall QoL improvement only when disease specific QoL measures 
(Patil et al., 2019), and also when all prospective studies, i.e. not only randomised 
controlled trials (RCTs) (Kuhn et al., 2017), were included.
Furthermore, earlier meta-analyses of RCTs included only one type of QoL 
measure (Kuhn et al., 2017); analysed studies focusing exclusively on elderly OSA 
patients (Jing et al., 2008; Kuhn et al., 2017; Merino et al., 2017) and included stud-
ies where the whole sample of OSA patients suffered from major comorbidities, 
such as stroke or heart failure (Jing et al., 2008; Kuhn et al., 2017; Patil et al., 2019), 
or studies of a combination of CPAP treatment with conservative treatment (Jing et 
al., 2008; Patil et al., 2019). We therefore aimed to systematically evaluate the effect 
of CPAP treatment on QoL in OSA patients compared to sham CPAP, placebo pills, 
and conservative treatment. Our systematic review and meta-analysis was restricted 
to RCTs only, with the exclusion of studies having a clear focus on major comor-
bidities, populations of children or elderly OSA patients, and studies that combined 
CPAP treatment with conservative treatment. 
Methods
A systematic literature review was conducted in accordance with the current guide-
lines for systematic reviews and meta-analyses (Higgins and Green, 2011). The mul-
tidisciplinary systematic review team consisted of six reviewers (VT, IN, SAR, RT, 
JPvD, and UB). Two authors had expertise in psychology (VT, IN), one in pulmo-
nology, tuberculosis and respiratory diseases (RT), and three authors were trained 
in epidemiological methods and public health (SAR, JPvD, and UB). 
Formulation of the research question 
The research question was formulated according to the PICO method (Higgins and 
Green, 2011), i.e.: ‘In obstructive sleep apnoea patients, what is the effect of CPAP 
treatment on QoL compared to placebo pills, sham CPAP, and conservative treat-
ment?’ The anticipated outcome was improved overall QoL as well as the improve-
ment in psychological and physical QoL after CPAP treatment. 
Search strategy and study identification
Studies were identified via Web of Knowledge, PubMed, PsychInfo, CINAHL, 
EMBASE, and the Cochrane Library from the inception date of the databases to 
March 2019. OpenGrey database was searched for any resources that might have 
been missed. Previous systematic reviews, meta-analyses, and guidelines were 
sought, and their reference lists were scanned. We did not include dissertations, 
economical evaluations, technical reports, conference abstracts, case studies, and 
letters. We did not use any language restrictions. Titles and abstracts were screened 
to identify potentially relevant studies. If the suitability of an article was uncertain, 
the full text was reviewed. We used keywords (Table 3.1) according to the PICO 
method (Higgings and Green, 2011). The detailed literature search strings for each 
of the databases can be found in Supplement 3.1 (Table S3.2). Inclusion criteria 
were: RCTs examining the effect of CPAP treatment on QoL in OSA patients com-
pared to controls using placebo pills, sham CPAP, or conservative treatment. 
Table 3.1 Description of used keywords according to the PICO method 
P=population/patients/problem ´sleep apnea´, ´sleep apnoea´, ´OSA´
I=intervention ´continuous positive airway pressure´, ´CPAP´
C= comparison/control ´placebo pills´, ´sham CPAP´, ´conservative treatment´
O=outcome ´quality of life´, ´health status´, ´self-rated health´,  ´self-perceived health´, ´functional status´ 
Exclusion criteria 
We excluded reviews, meta-analyses, studies focusing only on compliance with 
CPAP treatment or side effects of CPAP and different healthcare services, studies 
including only baseline comparison without a control group, and studies focusing 
on other types of treatment, or a combination of CPAP treatment with conservative 
treatment, such as lifestyle interventions. Studies including children, adolescents 
(<18), and elderly OSA patients (≥65 years of age) only were also excluded because 
of a possible increased vulnerability, functional changes, and a decline in abilities 
and/or performance related to age. Since major comorbidities may influence QoL, 
sleep, and affective symptomatology (Macey et al., 2010), studies including a pri-
mary study sample with an acute or severe comorbid medical illness, such as stroke, 
neurological disorders, heart failure, myocardial infarction, cognitive decline, or 
psychiatric diagnoses, were also excluded. The verification of the presence of major 
comorbidities in the full sample of OSA patients was based on Title, Abstract, and 
full-text screening. 
We developed a form to standardize the first selection of relevant studies, 
based on the following criteria: 1) the study is an RCT, quantitative, and interven-
tional; 2) the study population consists of adult OSA patients diagnosed by a medi-
cal professional; 3) the intervention is CPAP, and a control condition is present; 
and 4) generic or disease-specific QoL is measured. The title, abstract, and full-text 
screening were conducted independently by VT and IN. Disagreements were re-
solved by reaching a consensus of opinion. A third author (UB) was invited if con-
sensus could not be achieved. Full-text screening was conducted by VT. 
Types of studies
We included RCTs with parallel (Jenkinson et al., 1999; Barbé et al., 2001; 
Montserrat et al., 2001; Chakravorty et al., 2002; Siccoli et al., 2008; Weaver et 
al., 2012; Batool-Anwar et al., 2016) and crossover design (Engleman et al., 1997; 
Engleman et al., 1998; Engleman et al., 1999; Faccenda et al., 2001; Barnes et al., 
2004; Marshall et al., 2005). 
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Type of participants
Included were OSA patients newly diagnosed by a medical professional using noc-
turnal, laboratory-based PSG or oximetry. The standard criterion of five or more 
apnoeas/hypopnoeas per hour of sleep was used to diagnose OSA by PSG. OSA 
patients were diagnosed as mild, moderate and severe, with an AHI greater than 5/
hr, 15/hr, and 30/hr, respectively (Iber et al., 2007).  In oximetry, an apnoea was 
defined as a minimum of 10 seconds of airflow cessation, and a hypopnoea was de-
termined by a 30% reduction in airflow preceding a period of normal breathing for a 
minimum of 10 seconds and oxyhemoglobin desaturation (decrease in SpO2 ≥ 4%) 
(Berry et al., 2012). Severity of OSA was measured by the number of falls in arterial 
oxygen saturation (SaO2) of more than 4% in each hour of study (Jenkinson et al., 
1999). All participants were treatment naïve at the start of the research. Controls/
comparisons were defined as placebo pills, sham CPAP, and conservative treatment.
The intervention
The intervention was defined as CPAP treatment with a duration of at least two 
weeks. CPAP devices were titrated to an effective pressure to overcome respiratory 
disturbances. 
Concept of quality of life and health-related quality of life
The World Health Organization Quality of Life (WHOQoL) group defined QoL as 
‘an individual’s perception of their position in life, in the context of the culture and 
values in which they live and in relation to their goals, expectations, standards and 
concerns’ (WHOQoL Group, 1994). QoL has several domains, such as functional 
competence, health-related complaints, and psycho-social functioning. Health-
related QoL (HRQoL) is understood as an integral QoL domain and is increasingly 
used as an outcome of treatment effectiveness. In broad terms, HRQoL serves as 
a restricted QoL definition, as it was designed to exclude external domains, such as 
housing, financial situation, living conditions or spirituality. HRQoL is associated 
with an expanded concept of health status, embracing social interaction as well as 
emotional and psychological well-being (Krabbe, 2017). The concepts of QoL and 
HRQoL are closely tied to each other (Dutt et al., 2016). When QoL is discussed 
in relation to health or diseases, it almost always means HRQoL, unless specified 
otherwise (Dutt et al., 2016). According to Schipper (1992), QoL in clinical medi-
cine represents the functional effect of disease and its consequent treatment upon 
patient, as perceived by the patient. It is concluded that the concept of HRQoL as 
used now is confusing as most of the definitions fail to distinguish between HRQoL 
and health or between HRQoL and QoL (Carlozzi and Tulsky, 2013; Karimi and 
Brazier, 2016). Perhaps more reasonable is the variant of the definition, where 
HRQoL is the aspects of QoL the most significantly affected by ill health. However, 
in practice, this definition may not eliminate the number of QoL domains much 
because it is problematic to define ‘most’ (Karimi and Brazier, 2016). Furthermore, 
most of the previous systematic reviews and meta-analyses (Moyer et al., 2001; Jing 
et al., 2008; Schwartz et al., 2018; Patil et al., 2019) as well as all RCTs included in 
our meta-analysis used the term QoL, while one RCT used both terms interchange-
bly (Chakravorty et al., 2002). Thus, we will use in this paper the term QoL, with 
omission of external domains, such as spirituality or living conditions. 
Main comparisons
Based on the type of QoL scales we aimed to conduct the following comparisons: a) 
the effect of CPAP treatment on overall QoL (using general QoL scales); b) the ef-
fect of CPAP treatment on psychological QoL (using psychological QoL subscales); 
c) the effect of CPAP treatment on physical QoL (using physical QoL subscales).  
Sensitivity analyses
We conducted sensitivity analyses to reveal the potential sources of heterogene-
ity, such as the number of participants in analysed studies, the duration of CPAP 
treatment, the level of compliance with CPAP treatment, and risk of bias (RoB). We 
repeated the analyses with restrcitions regarding: a) number of participants N>100 
(the effect of CPAP treatment on overall/psychological/physical QoL in RCTs 
involving participants of N>100 (following Dechartres, 2013; Grainge, 2015)); b) 
duration of CPAP treatment >6 weeks (the effect of CPAP treatment on overall/psy-
chological/physical QoL in RCTs with duration of CPAP treatment of more than 6 
weeks); c) compliance level ≥4 h/night (the effect of CPAP treatment on overall/
psychological/physical QoL in RCTs involving participants with CPAP compliance 
level of ≥4h/night); and d) low RoB (the effect of CPAP treatment on overall/psy-
chological/physical QoL restricted to RCTs with low RoB). 
Subgroup analyses
We analysed how the CPAP treatment effect varies across different subgroups of 
patients or trials. The covariates included type of control group, OSA severity, 
study design, and type of QoL measures. The following subgroup comparisons 
were conducted based on: a) type of control group (the separate analyses of the ef-
fect of CPAP treatment on overall/psychological/physical QoL in RCTs involving 
controls using placebo pills, sham CPAP, and conservative treatment); b) OSA se-
verity (the separate analyses of the effect of CPAP treatment on overall/psychologi-
cal/physical QoL in RCTs involving patients with mild OSA and moderate to severe 
OSA); c) study design (the separate analyses of the effect of CPAP treatment on 
overall/psychological/physical QoL in RCTs with a crossover design and parallel 
design); d) type of Qol measures (the separate analyses of the effect of CPAP treat-
ment on overall/psychological/physical QoL in RCTs using generic QoL meas-
ures and disease-specific measures). 
Data extraction and management
Two authors (VT, IN) extracted the following information from each study: a) gen-
eral: title, country, language of publication, year of publication; b) methods: study 
design, setting, inclusion and exclusion criteria, follow-up, standardized QoL in-
struments, QoL domains; c) participants: OSA diagnosis, adult population (age of 
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the whole group > 18 years, ≤ 65 years), no focus on major comorbidid diseases 
other than OSA (such as stroke, myocardial infarction, neuropsychiatric disorder), 
age, sex distribution; d) intervention per treatment group: use of CPAP treatment, 
duration of CPAP treatment; compliance with CPAP treatment; e) controls/com-
parisons: placebo pills, sham CPAP, conservative treatment; f) outcomes: QoL im-
provement, overall QoL scores, and psychological/physical QoL; g) results: CPAP 
treatment effect on QoL improvement in OSA patients. In case of disagreement in 
data extraction, consensus was achieved by discussion between the two review au-
thors (VT, IN). If needed, a third author (UB) was invited to resolve disputes. Mean 
differences between the groups for the continuous outcomes, and standard devia-
tions/standard errors of the group differences were extracted for the meta-analysis. 
Dealing with missing data
When information for the meta-analysis was missing, we asked the author to pro-
vide the information. If the author did not reply, or the information was no longer 
available, the study was not included in the meta-analysis. 
Assessment of risk of bias 
The risk of bias (RoB) was assessed by two authors (VT, UB) using the Cochrane 
Collaboration tool for assessing RoB, as described in the Cochrane Handbook 
for the Systematic Review of Interventions, version 5.1.0 (Higgins and Green, 
2011). The following nine criteria were assessed: Random sequence generation, 
Allocation concealment, Blinding of participants, Blinding of personnel, Blinding 
of outcome assessment, Co-interventions avoided, Treatment fidelity, Incomplete 
outcome data and Selective outcome reporting. We scored the criteria as ‘low RoB, 
‘high RoB’, or ‘unclear RoB’ (Higgins and Green, 2011). When the two independ-
ent authors disagreed about the RoB, they tried to reach a consensus. If consensus 
could not be achieved, a third author (IN) was invited in. Key domains for sum-
mary RoB assessment were identified, such as random sequence generation, allo-
cation concealment, and incomplete outcome data (Nieuwenhuijsen et al, 2014). 
We judged studies to have a high RoB when one or more key domains were rated 
as high RoB. We judged studies to have an unclear RoB when one or more key do-
mains were rated as “unclear”. We judged studies to have a low RoB when all the 
key domains were rated as low RoB (Higgins and Green, 2011; Nieuwenhuijsen et 
al, 2014). Subsequently, we calculated the proportion of items that were scored as 
having low, unclear, or high RoB. 
Assessment of heterogeneity 
Heterogeneity was investigated using Cochrane’s Q statistic and I2 statistics. Due 
to differences in sample sizes of the included studies, we used random-effects mod-
els, as study weights were defined to be more balanced under the random-effects 
model than under the fixed-effects model (Borenstein et al., 2009). Furthermore, 
when studies are gathered from the published literature, the random-effects mod-
el is found to be generally a more plausible match (Borenstein et al., 2009). As 
Cochrane’s Q is considered to be vulnerable to small sample sizes, the I2 provided 
an estimate of the proportion of real variance caused by extraneous study variables. 
I2 thresholds have been proposed (Higgins et al., 2003), with 25, 50, and 75% rep-
resenting low, moderate, and high variance, respectively. 
Assessment of reporting biases
Visual inspection with funnel plots and the Egger test (Egger et al., 1997) were used 
to evaluate publication bias in the reviewed studies.
Quality of the evidence
We applied GRADE criteria (Ryan and Hill, 2016) to assess the confidence in the 
estimated effects within the studies. Two reviewers (VT, IN) worked independently 
to assess the quality of the evidence and resolve disagreements. At the start of the 
GRADE assessment we assumed the presence of high quality for all included stud-
ies. We downgraded a starting rating of “high quality” evidence by one level (or by 
two levels for very serious concerns) for RoB, inconsistency, indirectness, impreci-
sion, and publication bias (Ryan and Hill, 2016). 
We considered random sequence generation, allocation concealment, and in-
complete outcome data as prerequisites for high quality (following Nieuwenhuijsen 
et al., 2014). We only considered studies with low risks on these items to have a low 
RoB. To assess the RoB for a comparison, we considered the RoB for each study 
included in that comparison (following Ryan and Hill, 2016). For each comparison 
we downgraded the quality due to the RoB (-1) if most of the outcome information 
was from studies at low or unclear RoB, as this could seriously alter the results. We 
applied a -2 downgrade in case of a high RoB for one criterion, or multiple criteria, 
that were considered as likely to very seriously alter the results. For inconsistency, 
we considered an I2 value of 50% to 75% downgrade (-1). Indirectness of the evidence 
was not an issue in our review, as all comparisons in the included studies directly ad-
dressed the comparison. For imprecision of results, we judged serious imprecision 
leading to downgrading (-1) if a comparison either included less than 400 partici-
pants or a wide CI around the effect estimate. For a non-significant effect, we con-
sidered a CI to be wide if it included an effect size of both 0 and a moderate effect size 
(>0.5 or <-0.5). For a significant effect, we considered a CI to be wide if it included 
both a small and large effect size (small=0.2 or -0.2; large=0.8 or -0.8). We applied 
a -2 downgrade in case of imprecision based on the both assessed points. 
In the GRADE system, the quality of evidence for each outcome is scored 
as high, moderate, low, or very low. In high quality studies, further research is 
very unlikely to change our confidence in the estimate of effect. In studies with 
moderate quality, further research is likely to have an important impact on our 
confidence in the estimate of effect and may change the estimate. Low quality of 
evidence means that further research is very likely to have an important impact 
on our confidence in the estimate of effect and is likely to change the estimate. In 
studies with very low quality of the evidence any estimate of effect is very uncertain 
(Ryan and Hill, 2016).  
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Measures of treatment effect and data synthesis 
A total of 13 RCTs were included in the MA. The analyses were performed using 
the Statistical Package for the Social Sciences (IBM SPSS 23) and Microsoft Office 
Excel, following Neyeloff et al. (2012). We used random-effects models by calcu-
lating the Cohen’s d effect sizes (ES) with their standard errors (SE) as the stand-
ardized outcome of the CPAP treatment effect (Hedges and Olkin 2014). ES was 
calculated for each QoL outcome for which a complete assessment was possible. 
ESs were calculated from means and standard deviations (SD). When the SD was 
not available it was calculated from the SE of the mean using the following formula: 
SD = SE√N. Cohen’s d ES was calculated according to the following formula: 
ES was positive, if the mean difference was in the predicted direction and 
favoured real CPAP treatment (where 0.20-0.40 means a small ES; 0.50-0.70 a 
medium ES; and 0.80 or higher a large ES). The comparison of CPAP treatment 
effect vs. the control group was described as: ‘negative direction of ES’ for differ-
ences favouring the control group; and ‘positive direction of ES’ for differences 
favouring the real CPAP treatment group. Finally, the effect summary ( ) was 
computed using a random effects model by calculating a new weight (wv) for each 
QoL outcome adjusted with the constant (v).  was calculated using the follow-
ing formula:
Additionally, the confidence intervals (CIs) for the ES of each study and ( ) 
were computed with the 95% confidence coefficient used as the default, following 
Hedges and Olkin (2014). CIs were calculated with the formula CI =ES±1.96.SE. 
Forest plots were used for graphical representations of the MA. 
Results
Results of the search process 
After title, abstract, and full-text screening, 13 RCTs describing the effectiveness 
of CPAP treatment met the inclusion criteria (see flowchart Figure 3.1). One of the 
eligible studies (Campos-Rodrigues et al., 2016) was excluded from our MA, as we 


























Studies were excluded by title,  
abstract and/or full text screening (n=1411) 
 - not RCT
- OSA suspected but not diagnosed by PSG
 - population consisted of children, adolescents or  
a full sample of elderly OSA patients 
 - no QoL component
 - no CPAP intervention
 - focusing on side effects of CPAP treatment
 - focusing on compliance improvement strategies
 - focusing on health care services
 - focusing on other chronic disease
 - full sample of OSA patients had major comorbidities
 - combination of CPAP with conservative treatment
 - duration of CPAP of less than 2 weeks
 - focusing on other types of treatment
 - no full text available (e. g. abstracts, letters)
 - review studies and MA
- duplicate study sample recruited from  
the same participants 
 - missing data needed for MA
Duplicates were removed 
(n=748) 
Additional records identified  
through other sources (n=0)
Studies remained after removing 
duplicates (n=1424)
2172 references were identified by  
computer-aided search:
 - Web of Knowledge (n=95)
 - Pubmed (n=678)
 - PsycINFO (n=117)
 - Cochrane Library (n=322)
  -EMBASE (n=434)
  -CINAHL (n=493)
 - OpenGrey (n=33) 
Studies remained for meta-analyses 
after the full-text screening (n=13) 
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Description of included studies
All studies included in our meta-analysis investigated whether real CPAP treat-
ment affected QoL more significantly compared to the control condition. Seven 
RCTs had a parallel design and six RCTs had a crossover design. As the study by 
Montserrat et al. (2001) combined a partial crossover and parallel design, we ana-
lysed the parallel comparisions only. The duration of CPAP treatment ranged be-
tween 3 and 24 weeks. Most of the studies used only one treatment centre, two stud-
ies were multi-centre studies (Barbé et al., 2001; Batool-Anwar et al., 2016). Data in 
all the studies were collected during the patients’ clinical visits. 
A total of 678 participants formed the control group and 795 participants re-
ceived real CPAP treatment. The number of participants in the reviewed studies 
varied between 8 (Engleman et al., 1997) and 409 (Batool-Anwar et al., 2016). The 
reported ages of the patients ranged from 25 to 72 years. The number of female pa-
tients varied from 0 to 103. Two studies (Jenkinson et al., 1999; Siccoli et al., 2008) 
included only male OSA patients. In all included RCTs, all subjects underwent a 
baseline assessment with PSG first and were then randomised to CPAP, treatment 
with placebo pills, sham CPAP, or conservative treatment (Table 3.3). Oximetry 
was used to diagnose OSA in one study by Jenkinson et al. (1999). Patients suffered 
from mild to severe OSA. 
Five crossover studies (Engleman et al., 1997; Engleman et al., 1998; Engleman 
et al., 1999; Faccenda et al., 2001; Barnes et al., 2004) compared CPAP treatment 
with placebo pills. With the permission of local ethic comitee, patients were in-
formed that the oral placebo tablet (Glaxo pills, UK) may improve their daytime 
function in total of three studies (Engleman et al., 1997; Engleman et al., 1998; 
Engleman et al., 1999). In two studies (Faccenda et al., 2001; Barnes et al., 2004) 
no specific information on placebo pills was provided. 
Six parallel (Jenkinson et al., 1999; Montserrat et al., 2001; Siccoli et al., 2008; 
Barbé et al., 2001; Weaver et al., 2012; Batool-Anwar, 2016) and one crossover 
study (Marshall et al., 2005)  used a machine set at subtherapeutic pressure, con-
nected to a mask with holes to produce a leak as placebo (sham CPAP). Chakravorty 
et al. (2002) conducted a study with parallel design and used conservative treat-
ment, including weight loss and sleep hygiene, to compare with CPAP treatment.
When a repeated measures design was used (Batool-Anwar et al., 2016), the 
longer duration of CPAP treatment on QoL was analysed. If possible, we also in-
cluded groups of participants with a higher compliance level (≥4 hours/night) 
(Engleman et al., 1997; Batool-Anwar et al., 2016) and a longer treatment duration 
(Batool-Anwar et al., 2016) in the final meta-analysis. If more than one similar QoL 
estimator was used (Chakravorty et al., 2002; Siccoli et al., 2008), we used the 
estimator that could provide us with the most comprehensive information related 
to QoL. More detailed information about the study design, number of included 
participants, disease severity, type of control group, duration of the intervention, 
and instruments used to measure QoL is provided in Table 3.3. The criteria for 
inclusion and exclusion of the participants in the particular study type, sociodemo-
graphic data, clinical data, and mean values of CPAP compliance are presented in 
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Quality of life measures
QoL was measured using generic questionnaires – the Short Form 36 Health 
Survey – (SF-36), the Nottingham Health Profile (NHP), the European Quality 
of Life Questionnaire (EuroQoL) and disease specific QoL questionnaires – the 
Calgary Sleep Apnea Quality of Life Index (SAQLI) and the Functional Outcomes 
of Sleep Questionnaire (FOSQ). Out of the 13 analysed RCTs, 12 studies measured 
overall QoL and four studies assessed the level of psychological and physical QoL. 
Risk of bias in the included studies 
As shown in Table 3.4, we considered the overall RoB to be high in three studies 
(Chakravorty et al., 2002; Barnes et al., 2004; Siccoli et al., 2008). These studies 
had either unclear (Chakravorty et al., 2002; Barnes et al., 2004) or inadequate 
(Siccoli et al., 2008) allocation concealment. Two (Chakravorty et al., 2002; Barnes 
et al., 2004) of these three studies also had incomplete outcome data. We consid-
ered seven studies to have an overall unclear RoB (Engleman et al., 1997; Engleman 
et al., 1998; Jenkinson et al., 1999; Barbé et al., 2001; Montserrat et al., 2001; 
Weaver et al., 2012; Batool-Anwar et al., 2016). We judged three studies to have low 
RoB (Engleman et al., 1999; Faccenda et al., 2001; Marshall et al., 2005). Figure 3.2 
shows the proportion of items that were scored as low, unclear, or high RoB. 
Table 3.4 Risk of bias assessment  
Study ID Level of RoB* a b c d e f g h i
Engleman  
et al., 1997 unclear ? ? - - ? + + + +
Engleman  
et al., 1998 unclear + ? + - - + + + +
Engleman 
et al., 1999 low + + - - ? + + + +
Jenkinson 
et al., 1999 unclear + ? + + ? + ? + +
Barbé 
et al., 2001 unclear + ? + + + + + + +
Faccenda 
et al., 2001 low + + - ? + + ? + +
Montserrat 
 et al., 2001   unclear + ? + ? + - + + +
Chakravorty 
et al., 2002 high + ? - - ? + ? - +
Barnes 
et al., 2004 high + ? - - ? + + - +
Marshall 
 et al., 2005 low + + - + ? + + + +
Siccoli 
et al., 2008 high + - + + - + + + +
Weaver 
et al., 2012 unclear ? ? + + + ? + ? +
Batool-Anwar 
et al., 2016 unclear + ? + + ? + + + +
+ Low risk of bias; - High risk of bias; ? Unclear risk of bias; a. Random sequence generation, b. Allocation concealment, c. Blinding 
of participants; d. Blinding of personnel; e. Blinding of outcome assessment; f. Co-interventions avoided; g. Treatment fidelity; h. 
Incomplete outcome data; i. Selective outcome reporting; *Level of RoB per study based on a, b, and h. 
Figure 3.2 Flow chart of the risk of bias graph: judgements about each risk of bias 
item presented as percentages across all the included studies
Assessment of reporting biases
A  total of three estimators favoured the control group, and two estimators showed 
no difference in CPAP treatment effects when compared to controls (Figure 3.3 a, 
b, c). In general, the funnel plots showed a low possibility of publication bias. The 
results of the Egger tests for publication bias were not significant for the overall 
QoL (p=0.59), the psychological QoL domain (p=0.44), and the physical Qol do-
main (p=0.29). 
Figure 3.3 a Funnel plot of publication bias for overall QoL
a.  Random sequence generation
b.  Allocation concealment
c.  Blinding of participants
d.  Blinding of personnel
e.  Blinding of outcome assessment
f.  Co-interventions avoided
f.  Treatment fidelity
h. Incomplete outcome data
i  Selective outcome reporting
Overall RoB
 Low RoB  Unclear RoB  High RoB
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Figure 3.3 b Funnel plot of publication bias for psychological QoL
Figure 3.3 c Funnel plot of publication bias for physical QoL








































Meta-analyses were conducted with 13 RCTs. ESs were computed for overall QoL 
and the physical and psychological domains.  was used as the standardized 
outcome of the CPAP treatment effect. The forest plots show the ESs with CIs for 
scales and subscales and the final  obtained by using a random effects model. 
Overall QoL score
The effect of CPAP treatment compared to placebo pills, sham CPAP treatment, 
and conservative treatment was examined in 12 RCTs. The meta-analysis demon-
strated a negligible improvement in overall QoL score with CPAP treatment (0.18; 
95%CI=0.10, 0.26) in OSA patients compared to controls. A moderate I2 (68%) 
was found (Figure 3.4 a). 
Figure 3.4 a Meta-analysis of CPAP treatment effect on improvement in overall QoL 
score; effect sizes and 95% confidence intervals 
Psychological QoL score 
CPAP did not show significant superiority to controls in terms of psychological 
QoL (0.25; 95%CI=-0.23; 0.72). A low I2 (31%) was found (Figure 3.4 b).
Study and QoL measures Effect size dCohen (95%CI)
Engleman et al., 1997, NHP
Engleman et al., 1998, NHP
Engleman et al., 1999, NHP
Barbé et al., 2001, FOSQ
Faccenda et al., 2001, FOSQ
Montserrat et al., 2001, FOSQ
Chakravorty et al., 2002, EuroQoL (Usq)
Barnes et al., 2004, FOSQ
Marshall et al., 2005, FOSQ
Siccoli et al., 2008, SAQLI
Weaver et al., 2012, FOSQ





1.07; 95%CI (-0.72; 2.14)
0.09; 95%CI (-0.73; 0.91)
0.24; 95%CI (-0.43; 0.92)
-0.27; 95%CI (-0.73; 0.54)
0.16; 95%CI (-0.30; 0.60)
0.52; 95%CI (-0.08; 1.11)
0.00; 95%CI (-0.07; 0.07)
0.00; 95%CI (-0.48; 0.48)
0.30; 95%CI (-0.50; 1.10)
0.44; 95%CI (-0.12; 0.99)
0.41; 95%CI (0.14; 0.67)
0.14; 95%CI (-0.06; 0.34)
0.18; 95%CI (0.10; 0.26)
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Figure 3.4 b Meta-analysis of CPAP treatment effect on improvement in psychologi-
cal QoL score; effect sizes and 95% confidence intervals 
Physical QoL score
The meta-analysis demonstrated a small, but significant improvement in physical 
QoL (0.20; 95%CI=0.04, 0.35) with CPAP treatment in OSA patients compared 
to controls. A low I2 (26%) was observed (Figure 3.4 c).
Figure 3.4 c Meta-analysis of CPAP treatment effect on improvement in physical 
QoL score; effect sizes and 95% confidence intervals 
Sensitivity analyses 
We performed sensitivity analyses to assess the effect of CPAP treatment on overall 
QoL when controlled for the number of included participants, duration of inter-
vention, level of compliance with CPAP treatment, and RoB. As the studies meas-
uring psychological and physical QoL (Jenkinson et al., 1999; Barbé et al., 2001; 
Montserrat et al., 2001; Siccoli et al., 2008) were homogenous in terms of the 
number of included participants (N≤100), duration of intervention (≤ 6 weeks), 
Jenkinson et al., 1999, SF-36 physical component
Barbé et al., 2001, SF-36 physical component
Montserrat et al., 2001, SF-36 physical component





0.38; 95%CI (0.01; 0.76)
0.19; 95%CI (-0.34; 0.73)
0.21; 95%CI (-0.38; 0.79)
0.04; 95%CI (-0.35; 0.44)
0.20; 95%CI (0.04; 0.35)
Study and QoL measures Effect size dCohen (95%CI)
1.00; 95%CI (0.46; 1.25)
-0.10; 95%CI (-0.63; 0.44)
-0.30; 95%CI (-0.89; 0.29)
0.42; 95%CI (-0.14; 0.97)
0.25; 95%CI (-0.23; 0.72)
Study and QoL measures Effect size dCohen (95%CI)
Jenkinson et al., 1999, SF-36 mental component
Barbé et al., 2001, SF-36 mental component
Montserrat et al., 2001, SF-36 mental component





compliance level (≥4 hours/night), and RoB, not enough data were available to 
conduct sensitivity analyses for psychological and physical QoL. 
The effect of CPAP treatment on overall QoL controlled for number of participants 
(N>100) 
Sensitivity analysis of four studies (Faccenda et al., 2001; Barnes et al., 2004; 
Weaver et al., 2012; Batool-Anwar et al., 2016), controlled for the number of partic-
ipants (N>100), showed small, non-significant improvement in overall QoL score 
with CPAP treatment (0.19; 95%CI =-0.01; 0.38; I2=4%). 
The effect of CPAP treatment on overall QoL controlled for duration of CPAP (>6 
weeks)
CPAP did not show superiority to controls in terms of effect on overall QoL score 
(0.13; 95%CI =0.03; 0.22; I2=31%) in the four studies (Chakravorty et al., 2002; 
Barnes et al., 2004; Weaver et al., 2012; Batool-Anwar et al., 2016) with a treatment 
duration of more than 6 weeks. 
The effect of CPAP treatment on overall QoL controlled for compliance with CPAP 
treatment (≥4.0 hrs/night)
We found no significant difference in overall QoL comparing CPAP treated pa-
tients with controls (0.32; 95%CI =-0.20; 0.79; I2=10%) in four studies with a 
CPAP compliance level of at least 4 hours per night (Engleman et al., 1997; Barbé et 
al., 2001; Marshall et al., 2005; Siccoli et al., 2008). 
The effect of CPAP treatment on overall QoL controlled for risk of bias
CPAP showed superiority to controls in terms of the effect on overall QoL score 
(0.20; 95%CI= 0.12; 0.27; I2=13%) in three studies with low RoB (Engleman et al., 
1999; Faccenda et al., 2001; Marshall et al., 2005).
Subgroup analyses 
We performed subgroup analyses to investigate whether the effect of CPAP treat-
ment on overall QoL varies across different subgroups of patients or trials. We ana-
lysed subgroups based on the type of control group, OSA severity, study design, 
and type of QoL measures. As studies measuring psychological and physical QoL 
(Jenkinson et al., 1999; Barbé et al., 2001; Montserrat et al., 2001; Siccoli et al., 
2008)  were homogenous in terms of the type of the control group (sham CPAP), 
OSA severity (moderate to severe), study design (parallel), and type of QoL meas-
ures (generic), not enough data were available for the predefined subgroup com-
parisons. 
The effect of CPAP treatment on overall QoL controlled for type of control group
We found a small but significant improvement in overall QoL in subgroup analy-
ses of six studies (Barbé et al., 2001; Montserrat et al., 2001; Marshall et al., 2005; 
Siccoli et al., 2008; Weaver et al., 2012; Batool-Anwar et al., 2016) using sham 
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CPAP as a control condition (0.25; 95%CI =0.04; 0.46). A value of 32% indicated 
moderate heterogeneity. CPAP led to negligible improvement in overall QoL in 
the subgroup analyses of five studies (Engleman et al., 1997; Engleman et al., 1998; 
Engleman et al., 1999; Faccenda et al., 2001; Barnes et al., 2004) using placebo 
pills (0.14; 95%CI=0.03; 0.25). A value of 52% indicated moderate heterogene-
ity. CPAP did not show superiority to controls receiving conservative treatment in 
terms of effect on overall QoL score (0.00; 95%CI=-0.07; 0.07) in a single study 
by Chakravorty et al. (2002).  
The effect of CPAP treatment on overall QoL controlled for OSA severity
Subgroup analyses of mild OSA patients showed small CPAP treatment effect on 
overall QoL (0.31; 95%CI=0.13; 0.50; I2=27%) in four studies (Engleman et al. 
1997; Engleman et al. 1999; Marshall et al., 2005; Batool-Anwar et al., 2016). A 
negligible improvement in overall QoL was found in subgroup analyses of six stud-
ies (Engleman et al. 1998; Barbé et al., 2001; Faccenda et al., 2001; Montserrat et 
al., 2001; Sicoli et al., 2008; Batool-Anwar et al., 2016) with participants suffering 
from moderate to severe OSA (0.19; 95%CI=0.03; 0.34; I2=53%).  
The effect of CPAP treatment on overall QoL controlled for study design
CPAP led to a small but significant improvement in overall QoL score (0.22; 
95%CI=0.07, 0.38; I2=70%) in six studies with a parallel design (Montserrat et al. 
2001; Barbé et al., 2001;  Chakravorty et al., 2002; Siccoli et al., 2008; Weaver et 
al., 2012; Batool-Anwar et al., 2016). CPAP did not show superiority to controls in 
terms of the effect on overall QoL (0.16; 95%CI=0.10, 0.26; I2=35%) in subgroup 
analyses of six studies with a crossover design (Engleman et al. 1997; Engleman et 
al. 1998; Engleman et al. 1999; Faccenda et al., 2001; Barnes et al., 2004; Marshall 
et al., 2005).  
The effect of CPAP treatment on overall QoL score controlled for the type of QoL 
measures
A total of four studies (Engleman et al. 1997; Engleman et al. 1998; Engleman et al. 
1999; Chakravorty et al., 2002) using generic QoL questionnaires showed non-signif-
icant improvement in overall QoL with CPAP treatment (0.13; 95%CI=-0.001; 0.28; 
I2=53%). A negligible improvement in overall QoL score was found in eight studies 
(Barbé et al., 2001; Faccenda et al., 2001; Montserrat et al., 2001; Barnes et al., 2004; 
Marshall et al., 2005; Siccoli et al., 2008; Weaver et al., 2012; Batool-Anwar et al., 
2016) using OSA-specific QoL questionnaires (0.14; 95%CI=0.04, 0.24; I2=64%).
Summary of the quality of the findings
The quality of the evidence within the studies was assessed based on levels of RoB, 
inconsistency, indirectness, and imprecision (Ryan and Hill, 2016). The evidence 
for improvement in overall QoL was of low quality and was downgraded by one 
level, as most of the studies had an unclear selection bias. For inconsistency, we 
considered an I2 value of 68% to downgrade by one level. 
The meta-analysis of psychological QoL provided very low quality of evidence. 
The evidence for psychological QoL was downgraded by one level due to a small 
number of included studies, and an unclear allocation concealment in most of the 
included studies. We also downrated the quality of evidence by two levels for impre-
cision due to a small sample size (N<400) and a wide CI around effect estimate that 
included an effect size of 0 and moderate effect size. 
The evidence for physical QoL provided low quality of evidence. The evidence 
for improvement in physical QoL was downgraded by one level due to a small num-
ber of included studies and an unclear allocation concealment in most of the includ-
ed studies. We also downrated the quality of evidence by one level for imprecision 
due to a small sample size (N<400). 
Discussion 
The aim of this study was to systematically evaluate the effect of continuous positive 
airway pressure (CPAP) treatment on quality of life (QoL) in patients with obstruc-
tive sleep apnoea (OSA) compared to sham CPAP, placebo pills, and conservative 
treatment. We found no significant differences in overall and psychological QoL 
between CPAP treated patients and controls. However, physical QoL improved in 
CPAP treated patients compared with control treatments. Furthermore, subgroup 
analyses and sensitivity analyses showed that the type of control group, the study 
design, OSA severity, and risk of bias (RoB) may be relevant in capturing the effect 
of CPAP on QoL. 
We found that patients undergoing CPAP treatment reported signi ficantly 
higher physical QoL compared to controls. This result provided additional support 
for the effect of CPAP on physical QoL revealed in an earlier meta-analysis by Jing 
et al. (2008). These findings may be of clinical importance, as physical QoL was 
found to be related to nocturnal parameters indicating sleep disruption (Sforza et 
al., 2003; Jing et al., 2008). However, no treatment effect of CPAP compared to 
controls was found for psychological QoL. This finding may be explained by the 
low severity of psychological symptoms at baseline. As we excluded studies with 
focus on major comorbidities, it is possible that the occurence or severity of some 
confounders related to comorbid medical illnesses that could negatively affect psy-
chological QoL in OSA patients may have been low. Furthermore, meta-analysis by 
Huang et al. (2017) demonstrated the significant alterations of brain structural and 
functional response in OSA patients possibly explaining psychic disorders. Patients 
with OSA showed both decreased grey matter volume and functional response in 
orbital frontal cortex compared to healthy controls, while the cerebellum VI bilater-
al anterior (para)cingulate gyri and the amygdala/hipocampus exhibited atrophy of 
grey matter volume but increased activity. These changes suggest that early diagno-
sis and treatment are crucial (Huang et al., 2019). However, recent histopathologi-
cal investigations of autopsy of brain tissue from OSA patients further indicate that 
myelin in OSA patients is impacted and not protected by CPAP treatment (Owen 
et al., 2018). Therefore, the suboptimal effect of CPAP treatment on psychological 
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QoL may also be explained by the irreversible OSA-related brain injuries, that may 
further contribute to the development of the psychological symptomatology in OSA 
patients (Owen et al., 2018; Huang et al., 2019). 
Subgroup analyses showed non-significant improvements in overall QoL with 
CPAP treatment when controlled for type of QoL measures. The results of the sub-
group comparisons are not particularly surprising given the fact that disease-specif-
ic and generic QoL measures in OSA patients were found to be highly correlated 
(Flemons and Reimer, 2002; Silva et al., 2016). However, recent meta-analysis by 
Patil et al. (2019) identified significant effect of CPAP treatment on QoL using dis-
ease specific measures. The explanation for this inconsistence in results may be that 
Patil et al. (2019) included only studies with longer duration of CPAP treatment (6 
weeks), while we used cut-off of 2 weeks. 
We found a significant improvement in overall QoL when controlled for OSA 
severity. This result may be surprising as self-reported health outcomes are usually 
discordant with polysomnography (PSG) measures of OSA severity (Weaver et al., 
2005). Issues such as abbreviated PSG monitoring, night-to-night variability, or 
the ‘‘first-night effect’’ of the PSG may partly explain the variability of OSA sever-
ity across different studies (Punjabi, 2008). Nevertheless, the significant effect of 
CPAP treatment on QoL in patients with mild OSA may also be caused by the low 
RoB in two (Engelman et al., 1999; Marshall et al., 2005) of the four studies in-
cluded in subgroup analysis. 
In line with the meta-analysis by Jing et al. (2008) we found only a negligible 
CPAP treatment effect on overall QoL scores in studies with a crossover design 
compared to a small but significant effect revealed in studies with a parallel design. 
This result is consistent with previous research, as long-term parallel-group trials 
were found to be more efficient at capturing the important information regarding 
the benefits of CPAP treatment (Richens, 2001; Jing et al., 2008). Furthermore, the 
crossover study design was found to be less effective in assessment of CPAP treat-
ment effects, as the washout period is usually too short to eliminate the effects of 
first treatment (Richens, 2001). The washout period in crossover studies included 
in our meta-analysis ranged from 0 to 2 weeks (Engleman et al., 1997; Engleman et 
al., 1998; Engleman et al., 1999; Faccenda et al., 1999; Barnes et al., 2004; Marshall 
et al., 2005). Consequently, it is understandable that these short washout periods 
could not eliminate CPAP treatment effects. 
Subgroup analyses also showed that CPAP led to a small but significant im-
provement in overall QoL in studies with controls receiving sham CPAP compared 
to the negligible improvement revealed in controls using placebo pills. This result 
is surprising, as sham CPAP is supposed to worsen both sleep and gas exchange 
(Sanner et al., 2000; Engleman et al., 1999). An explanation may be that most of 
the studies that used placebo pills as a control condition also had a very low number 
of participants (Engleman et al.1997; Engleman et al. 1998; Engleman et al. 1999). 
Furthermore, all studies with placebo pills as a control condition had a crosso-
ver design, identified as less sensitive in capturing the effect of CPAP treatment 
(Richens et al., 2001). 
Sensitivity analyses that controlled for the number of included participants, 
duration of intervention, and compliance level showed only small, non-significant 
effects of CPAP treatment on overall QoL scores. The results of our meta-analysis 
may be explained by the relatively small sample sizes, the short durations of the in-
terventions, and the relatively low CPAP compliance level (with the highest value of 
5.0 hours per night) in the included studies. For example, a compliance of ≥4 hours 
per night has been considered acceptable (e.g. Masa and Corral-Peñafiel, 2014). 
However, the adequate use of CPAP treatment may vary for different outcomes. For 
instance, to obtain an improvement in daytime sleepiness, at least 4 hours per night 
of compliance with CPAP are required (Weaver et al., 2007); 6 hours per night 
are needed for memory improvement (Zimmerman et al., 2006) and 7.5 hours per 
night is considered to be adequate for improvement in sleep-related quality of life 
(Weaver et al., 2007). But, there are individuals who are not able to achieve normal 
functional status or remain excessively sleepy despite optimal CPAP treatment of 
more than 7 hours per night (Weaver et al., 2007; Antic et al., 2011; Jackson et al., 
2018). As adherence with CPAP treatment appears to be associated with positive 
changes in QoL (Lynch et al., 2019), future research and clinical practice should 
examine strategies for its improvement. More attention should be given to edu-
cational and behavioural intervention strategies that were found to be efficient in 
improving adherence with CPAP (Sawyer et al., 2011), while device improvements 
were found to have only modest impact on adherence with CPAP treatment (Smith 
et al., 2009). 
Finally, we found a small, non-significant effect of CPAP treatment when con-
trolled for the number of included participants. This result is not surprising as cut-
offs based on study size introduce an extra element of subjectivity and thus may not 
ameliorate bias if the large studies are insuficiently critiqued (Turner et al., 2009). 
Although we stated the cut-off value of 100 participants following previous recom-
mendations (Dechartres, 2013; Grainge, 2015), the concept of single threshold to 
distinguish small trials from large trials in the area of medical interventions is not 
straightforward. A solution may therefore be to make a separate exclusion of stud-
ies with high and unclear RoB. In line with this assumption, we found a small but 
significant CPAP treatment effect on QoL in studies with low RoB (Engleman et al., 
1999; Faccenda et al., 2001; Marshall et al., 2005).
Strengths and limitations 
The strenght of this review and meta-analysis is that randomised controlled trials 
(RCTs) were conducted in different countries, which adds to the generalizability of 
our results. The results of our study are applicable to adult patients of both genders 
with mild to severe OSA. We tried to avoid meta-bias by searching in multiple da-
tabases. As most of the participants in the included studies were diagnosed by PSG 
in the same way, misclassification based on differences in sensitivity and specific-
ity of diagnostic measures can be excluded. All studies included in our review and 
meta-analysis used the SF-36 to measure psychological and physical QoL. Despite 
some limitations, the mental health component of the SF-36, and in particular the 
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“vitality” domain, is still considered to be the most suitable generic health-related 
QoL measure for OSA patients (Abma et al., 2016). However, a potential drawback 
may be that the questions of the SF-36 related to daily activities or social function-
ing are assessed by asking about limitations due to “emotional problems” or “phys-
ical health”. Moreover, neither of these categories is considered to clearly cover the 
main reasons for impaired functioning that OSA patients experience (i.e., fatigue, 
sleepiness, or poor sleep quality) (Abma et al., 2016). One of the eligible studies 
was excluded from our MA, as we did not receive the missing, additional informa-
tion. However, the results of the excluded study were consistent with our findings, 
i.e. QoL improvement was found only in the physical QoL domain and not in the 
psychological QoL domain (Campos-Rodriguez et al., 2016). We also have to be 
careful in the interpretation of the results, as many studies had a high or unclear 
RoB. Next, the studies in our review consistently rated poorly on allocation conceal-
ment and blinding. Because inadequately concealed trials and lack of proper blind-
ing may show even more favourable treatment effects than adequately blinded and 
concealed studies (Wood et al., 2008; Higgins and Green, 2011), careful attention 
must be paid when interpreting CPAP treatment effect on QoL in OSA patients. 
We also tried to avoid biases in the assessment of CPAP treatment effect on QoL by 
exclusion of studies with full samples of OSA patients with major comorbidities that 
may affect QoL; i.e. heart failure, stroke, or comorbid sleep disorders. However, 
the limitation of our study may be that comorbidities may not be fully eliminated 
as the exclusion criteria in analysed studies varied from not specified (Barnes et 
al., 2004), to less strict (Engleman et al., 1997; Engleman et al., 1998; Engleman 
et al., 1999; Jenkinson et al., 1999; Faccenda et al., 2001; Montserrat et al., 2001; 
Chakravorty et al., 2002; Siccoli et al., 2008); or led to exclusion of all chronic con-
ditions (Barbé et al., 2001; Weaver et al., 2012; Batool-Anwar et al., 2016). Finally, 
since the reported treatment duration ranged from three weeks to six months, this 
review cannot conclude on the long-term effects of CPAP treatment. 
Implications and recommendations for practice and future research
More high-quality RCTs with larger samples are needed to learn more about the ef-
fectiveness of CPAP treatment on QoL improvement. Most of the studies included 
in our review had a moderate duration of CPAP treatment; thus, repetitions with 
longer treatment duration is recommended. Future RCTs should also consider 
evaluating secondary outcome measures, such as sleep-related problems. 
Conclusion
In conclusion, when comparing CPAP with control treatment, our meta-analysis 
showed no significant impact of CPAP on overall and psychological QOL. However, 
CPAP was found to improve physical QoL compared with control treatments. 
Moreover, we found that CPAP may significantly affect overall QoL in studies with 
sham CPAP controls, parallel design, low risk of bias, and mild OSA patients. More 
high-quality trials are needed for further investigation of the effects of CPAP treat-
ment on QoL improvement. 
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Abstract 
B a c k g ro un d  a n d  a i m
Obstructive Sleep Apnoea (OSA) has a substantial economic impact on healthcare 
systems as well as on individuals. We aimed to examine whether OSA severity, 
sleep-related problems, and anxiety are associated with work functioning in OSA 
patients when controlled for age, gender, and type of occupation. We also aimed 
to investigate whether anxiety moderates the associations between sleep-related 
problems and work functioning
Me t h o d s
We included 105 OSA patients (70% male; mean age 46.62±9.79 years). All pa-
tients completed the Pittsburgh Sleep Quality Index, the Epworth Sleepiness Scale, 
the Beck Anxiety Inventory, and the Work Role Functioning Questionnaire-2.0. 
R e su l t s
OSA severity, poor night-time sleep quality, and anxiety were univariately associ-
ated with impaired work functioning. Multivariate analyses revealed that poor per-
ceived sleep quality was more strongly associated with work functioning than sleep 
efficiency and daily disturbances. Anxiety was strongly associated with impaired 
work functioning. After adding anxiety, the explained variance in work functioning 
increased from 20% to 25%. Anxiety moderated the association between low and 
medium level of night-time sleep quality problems and work functioning. 
C o n c l u s i o n
Poor perceived sleep quality and anxiety were strongly associated with impaired 
work functioning in OSA patients. These findings may help to optimize manage-
ment, standard treatment and work functioning in people with OSA when con-
firmed in longitudinal studies. 
Introduction 
Obstructive Sleep Apnoea (OSA) is an incapacitating chronic disease caused by 
pharyngeal collapse during sleep (Manarino et al., 2012). OSA is considered to be 
one of the most prevalent sleep disorders (Manarino et al., 2012), with an estimated 
prevalence of 2–10% among the adult population (Leger et al., 2012). The disease 
is characterized by repeated breathing pauses which cause frequent awakenings, 
fragmented sleep and, consequently, excessive sleepiness and fatigue (Tippin et al., 
2016). Besides physical disorders, OSA patients may also have substantial mental 
health problems, such as depression, anxiety (Borak et al., 1996; Sharafkhaneh et 
al., 2005; Kang et al., 2012; Lin and Winkelman, 2012; Krakow et al., 2015), post-
traumatic stress syndrome (Sharafkhaneh et al., 2005) or panic attacks (Su et al., 
2015). OSA has a substantial economic impact on healthcare systems as well as on 
individuals and their households. Studies show a significant impairment of func-
tional status, including work functioning, in these patients; i.e. undiagnosed OSA 
is associated with notable increases in healthcare costs (Wittmann and Rodenstein, 
2004; Reuveni et al., 2008) but also with reduced work capacity and work disability 
(Leger et al., 2012, Mulgrew et al., 2007; Sivertsen et al., 2008). 
Earlier studies report an impairment of work functioning in OSA patients 
(Mulgrew et al., 2007; Sivertsen et al., 2008; Omachi et al., 2009). Tregear et al. 
(2009) described the occurrence of microsleeps and accidents, while Sivertsen et 
al. (2008) showed that self-reported OSA symptoms were an independent risk fac-
tor for subsequent long-term sick leave and permanent work disability. The associa-
tion between OSA severity and the individual experience of work limitations was 
dependent on job type (Mulgrew et al., 2007); i.e. OSA severity did not affect work 
performance (time management, physical, mental-interpersonal, and output de-
mands) in white-collar workers, while it did in blue-collar workers. Most of the pre-
vious research on work correlates in OSA patients has quantified the outcomes us-
ing objective variables, such as absenteeism (Sivertsen et al., 2008) or occupational 
accidents (Noda et al., 1998; Pizza et al., 2009), which may be lower-incidence 
events when compared to work functioning impairment. Others have assessed 
the economic impact of OSA on public health systems (Wittman and Rodenstein, 
2004; Reuveni et al., 2008). Furthermore, some older studies on work functioning 
in OSA patients did not use polysomnography (PSG) to diagnose OSA (Sivertsen 
et al. 2008; Ulfberg et al; 1996), nor did they use validated measures of work role 
performance (Ulfberg et al; 1996; Grunstein et al., 1995). Thus, more studies are 
needed in which OSA is diagnosed with reliable methods and occupational vari-
ables are assessed with standardized and validated questionnaires (Guglielmi et al., 
2015). 
Moreover, despite the acceptance of continuous positive airway pressure as the 
standard OSA treatment, there is a lack of consensus regarding the positive evi-
dence of continuous positive airway pressure treatment effect on functional status 
(Tippin et al., 2016; Weaver et al., 2007; Weaver et al., 2013). Furthermore, a large 
proportion of the population is at risk of experiencing a sleep disorder (Hiestand et 
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al., 2005); thus, it is important to quantify work-related outcomes in these persons. 
Sleep-related OSA symptoms were also found to contribute to decreased employee 
productivity (Rosekind et al., 2010; Nena et al., 2010) and are related to high costs 
for employers (Rosekind et al., 2010). According to Swanson et al. (2011), sleep 
disorders adversely affect work performance, while mood and affective symptoms 
impact relationships with co-workers and presenteeism. 
Many OSA patients suffer from anxiety symptoms (Borak et al., 1996; Krakow 
et al., 2015; Yue et al., 2003; Li et al. 2004; Shapiro et al., 2014), but these are 
rarely studied systematically (Krakow et al., 2015; Shapiro et al., 2014). The omis-
sion of anxiety associated with OSA symptomatology may contribute to poor treat-
ment acceptance and adherence (Aloia et al., 2004), and consequently, to an overall 
worsening of OSA symptoms and increased risk of morbidity (Shapiro et al., 2014). 
Although previous research on OSA patients suggests that there may be a consider-
able association between sleep-related problems and anxiety (Borak et al., 1996), 
these may also occur separately from each other (Krakow et al., 2015). Anxiety can 
have a major impact on functional status and may interfere with work productivity 
(Erickson et al., 2009). However, the findings are inconclusive; e.g. Mughal et al. 
(1996) found that employees with high trait anxiety exerted greater work effort than 
those with low trait anxiety, which resulted in better work performance.
We sought to address several gaps in the existing literature, because to the best 
of our knowledge, no studies have investigated the associations between night-time 
sleep quality, anxiety and work functioning in OSA patients. Increased awareness 
of the associations between OSA and affective problems might improve diagnostic 
accuracy as well as treatment outcomes (Krakow et al., 2015; Schroder and O’Hara, 
2005). Insight into which specific OSA symptomatology, such as sleep-related 
and mental health problems, are associated with impaired work functioning, may 
provide opportunities for preventive strategies for productivity-loss among work-
ers with OSA. Therefore, the present research and clinical practice should focus 
not only on the standard treatment of OSA, but also on ensuring that symptoms 
such as sleep-related problems or mental health impairment are managed. To do 
that, we first need to understand how these symptoms relate to functioning in OSA 
untreated patients. Thus, the aims of this study were 1) to examine whether OSA 
severity, sleep-related problems and anxiety are associated with work functioning 
in OSA patients, and 2) to investigate whether anxiety moderates the associations 
between sleep-related problems and work functioning. 
Materials and methods
Sample and procedure
This cross-sectional study was conducted at the Department of Pneumology and 
Phtiseology, L. Pasteur University Hospital and the Medical Faculty of PJ Safarik 
University in Kosice, Slovak Republic. All patients who visited the Department for 
one-night polysomnography (PSG) from July 2013 to April 2016 and underwent PSG 
were eligible for the study. Indication for PSG was based on a general practitioner 
referral form. OSA was diagnosed based on an overnight sleep examination. PSG 
was used to determine whether the diagnosis of OSA was present and to identify the 
severity of the disorder. PSG consists of a simultaneous recording of multiple physi-
ological parameters related to sleep and wakefulness, which directly monitor and 
quantify the number of respiratory events, related hypoxemia and arousals. PSG 
comprised the overnight recording of left and right electrooculograms, standard 
central and occipital electroencephalogram, submental electromyogram (EMG), 
bilateral tibialis EMG, nasal and oral airflow using a thermistor and thoracic and 
abdominal excursions using respiratory inductive plethysmography.
The study sample consisted of working patients with an Apnoea Hypopnoea 
Index (AHI; number of apnoeas + hypopnoeas per hour of sleep) score of 5 or 
more (American Academy of Sleep Medicine, 2005) who had not undergone any 
continuous positive airway pressure therapy or other OSA treatment, were Slovak-
speaking and had no major comorbidities. Patients with non-respiratory sleep-re-
lated complaints (e.g. circadian rhythm sleep disorder, insomnia) were routinely 
referred to another group of clinical specialists and were therefore not represented 
in our sample. Only OSA patients between 18 and 65 years of age were included due 
to possible functional changes, increased vulnerability and a decline in abilities and 
performance related to age.
Out of N=152 eligible OSA patients, a total of N=33 were excluded because of 
major comorbidities (a coexisting major sleep disorder such as insomnia, narcolep-
sy, or circadian rhythm sleep disorder; major cardiovascular diseases, primary pul-
monary hypertension, chronic obstructive pulmonary disease, diabetes, Pickwick 
syndrome, a history of cancer in the past twelve months, neurological deficit, a 
major psychiatric diagnosis in the medical record, and/or current usage of psychi-
atric medications which may affect cognitive functions (e.g. antipsychotics, benzo-
diazepines, or antidepressants), or drug abuse in the past six months) and regular 
shift work in the past six months. Screening for comorbidities was based on medical 
data and an initial clinical interview prior to data collection. The clinical diagno-
ses of the comorbidities were established according to the standard International 
Classification of Diseases, 10 Revision codes. Medical examinations of patients 
were conducted by a pulmonologist specialized in sleep-disordered breathing. 
Another N=14 patients refused to participate in the study (response rate 89%). A 
total of N=105 OSA patients (70% male; mean age 46.62±9.79 years) constituted 
the final study sample. 
The invitation letter, the informed consent and the self-reporting question-
naires were sent to participants by postal mail three weeks before the medical exam-
ination. One week before the medical examination, patients were reminded about 
the questionnaires by a phone call. Patients filled in the questionnaires at home. 
Each patient completed and signed an informed consent form prior to their partici-
pation in the study, which was fully voluntary and included no incentives for partici-
pation. The study was approved by the Ethics Committee of PJ Safarik University 
(approval no. 115/2011).
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Measures
Sociodemographic and clinical data 
Information on age, gender, and marital status was obtained from patient records. 
Patients were asked to identify the one industry that best characterized their cur-
rent employment (over the last 24 months) from a list of International Standard 
Classification of Occupations (1990). Patients were also asked to specify their oc-
cupation to reduce the obtaining of incorrect or inconsistent information. OSA 
patients in the following industries were classified as blue-collar workers: primary 
resource industry, construction industry, manufacturing industry, warehousing, 
trade, and transportation. Patients employed in public administration, armed forc-
es, government and the service sector (including tourism, business services, edu-
cation, healthcare, legislators, managerial occupations, professional, and utilities) 
were classified as white-collar workers. Body Mass Index (height and weight) was 
assessed by a physician. BMI was used to sort patients into categories: underweight 
(<18.5), normal (18.5-24.99), overweight (25.0-29.99), and obese (30+). The diag-
nosis of OSA was determined using PSG and was based on the Apnoea Hypopnoea 
Index (AHI; number of apnoeas + hypopnoeas per hour of sleep) starting with a 
score of 5 or more according to the standard criteria (American Academy of Sleep 
Medicine, 2005). According to this, OSA severity is mild (AHI≥5≤15), moderate 
(AHI>15≤30), or severe (AHI>30). An obstructive apnoea or hypopnoea can be 
defined as an event that lasts for ≥ 10 seconds and is characterized by an absence 
or a decrease from baseline in the amplitude of a valid measure of breathing during 
sleep that either reaches >50% with an oxygen desaturation of 3% or an arousal 
(alternatively a 30% reduction with 4% desaturation) (American Academy of Sleep 
Medicine, 2005).
Sleep-related problems 
Sleep-related problems concerned night-time sleep quality and daytime sleepiness. 
Night-time sleep quality was measured using the Pittsburgh Sleep Quality Index 
(PSQI) (Buysse et al., 1989). The PSQI is a self-rated questionnaire to assess sleep 
quality and disturbances over a one-month time interval. The PSQI consists of 19 
self-reported questions which cover seven domains: sleep latency, subjective sleep 
quality, sleep duration, sleep disturbances, habitual sleep efficiency, daytime dys-
function, and use of sleep medication. The score ranges from 0 to 21, with higher 
scores reflecting poor night-time sleep quality. A cut-off score of 5 separates good 
from poor sleepers (Buysse et al., 1989). The results of some previous studies sug-
gested that the seven PSQI domains are best represented by three latent factors 
(Cole et al., 2006; Casement et al., 2012). Empirical examination of the factor 
structure of the PSQI identified three distinct factors: perceived sleep quality, sleep 
efficiency, and daily disturbances. The PSQI subscales for subjective sleep quality, 
sleep medications and sleep latency were loaded onto the latent variable perceived 
sleep quality; the PSQI subscales for sleep duration and habitual sleep efficiency 
were loaded onto the latent variable sleep efficiency; and the PSQI subscales for 
sleep disturbances and daytime dysfunction were loaded onto the latent variable 
daily disturbances (Cole et al., 2006). Sleep efficiency is defined as closely related 
to sleep quantity (Casement et al., 2012), while the daily disturbances factor re-
flects sleep-related daytime impairment (i.e., trouble performing daytime activities) 
and interruptions in sleep due to physical or psychological symptoms (Casement et 
al., 2012). In our sample, Cronbach’s alpha was 0.85 for the total PSQI scale.
Daytime sleepiness was measured using the self-report Epworth Sleepiness 
Scale (ESS), an eight-item questionnaire assessing the tendency to fall asleep in 
various daytime scenarios (Miletin and Hanly, 2003). The score ranges from 0 to 
24, with higher scores indicating greater daytime sleepiness. An ESS total score 
greater than 10 indicates excessive daytime sleepiness (Miletin and Hanly, 2003). 
Cronbach’s alpha for ESS in our sample was 0.87. 
Anxiety
Anxiety was measured using the Beck Anxiety Inventory (BAI), which consists of 
21 items defining the most common anxiety symptoms (Beck and Steer, 1990). The 
BAI is a brief measure of anxiety with a focus on somatic symptoms and was devel-
oped as a measure adept at discriminating between anxiety and depression (Beck et 
al., 1988). Scores range from 0 to 63, with higher scores indicating a higher anxi-
ety level. The following categories were defined: no anxiety symptoms (score 0-9), 
mild anxiety (score 10-18), severe anxiety (score 19-29), and very severe anxiety 
(score 30-63) (Beck and Steer, 1990). Cronbach’s alpha in our sample was 0.90.
Work functioning
Work functioning was assessed with the Work Role Functioning Questionnaire 
(WRFQ 2.0) (Abma et al., 2013). The WRFQ measures the perceived difficulties in 
performing work demands among workers, given their emotional or physical health 
problems. The WRFQ consists of 27 items divided into subscales: work scheduling 
demands and output demands, physical demands, mental and social demands, and 
flexibility demands. In addition, a total score can be calculated. Items are answered 
on a five-point scale: 0= difficult all the time (100%), 1= difficult most of the time 
(75%), 2= difficult half of the time (50%), 3= difficult some of the time (25%), 4= 
difficult none of the time (0%). There is also a response option ‘Does not apply 
to my job’. The total score is calculated by adding all answers and dividing by the 
number of items and then multiplying by 25 to obtain percentages between 0 and 
100. Higher scores indicate better work functioning. The scores on ‘Does not ap-
ply to my job’ are transformed into missing values (Abma et al., 2013). To iden-
tify the prevalence of impaired work functioning, we used the cut-off value (<90) 
for patients with a chronic disease according Amick et al. (2004). In our sample, 
Cronbach’s alpha was 0.93 for the total scale, 0.97 for the work scheduling and 
output demands, 0.90 for the physical demands, 0.90 for the flexibility demands 
and 0.94 for the mental and social demands subscale.
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Statistical analyses
All analyses were performed using the Statistical Package for the Social Sciences 
(IBM SPSS 23) and Modgraph. We started with a description of the background 
characteristics of the sample and determined the prevalence of OSA severity, night-
time sleep quality (PSQI), daytime sleepiness (ESS), anxiety (BAI), and impaired 
work functioning (WRFQ). Descriptive analyses included frequencies and per-
centages for categorical variables and mean values and standard deviations (SD) 
for continuous variables. Next, we investigated the correlations between all vari-
ables. Then, we examined the associations between OSA severity, night-time sleep 
quality, daytime sleepiness, anxiety, and work functioning in crude and adjusted 
linear regression analyses, including interactions between sleep-related problems 
and anxiety. We applied the enter method in linear regression to identify the fac-
tors associated with summary scores of work functioning for the total scale and the 
subscales. For each factor, unstandardised beta coefficients represent the mean 
variation of work functioning. The first model of the variables included sociode-
mographic data (age, gender). The second model included a clinical variable (OSA 
severity - measured by AHI); the third model included the night-time sleep quality 
total scale. In addition, each of the three subscales of sleep quality was analysed 
separately. In the fourth model anxiety was included to assess the increase in the 
explained amount of total variance in work functioning. Multicollinearity was as-
sessed using the variance inflation factor (VIF<2.0). Finally, we used moderation 
analyses to examine whether the associations between night-time sleep quality total 
scale as well as the three subscales and work functioning were moderated by anxi-
ety. A p-value of <0.05 was considered to be statistically significant. Power analysis 
revealed that the statistical power for multivariate analysis exceed 86% with medium 
effect size at α=0.05. The statistical power for univariate analyses was 93% with 
medium effect size at α=0.05 (Faul et al., 2009). 
Results
Patient characteristics 
Most of the patients were male (70%) and had secondary education (60%). A total of 
55% were obese, with severe OSA (47%). Poor night-time sleep quality was present 
in 84% of the OSA patients, and the prevalence of daytime sleepiness was 59%. 
The majority (80%) of OSA patients were anxious and reported mild to very se-
vere anxiety. Impaired work functioning was present among 82% of OSA patients. 
Participants worked 39.5±7.8 hours and 5.3±1.1 days a week (Table 4.1). 
Table 4.1 Baseline characteristics of the OSA patients (AHI ≥5) 
Characteristics N=105
Age in years; mean, sd 46.62±9.79
Gender; N, % male 73 (70%)
Education; N, %
Elementary  4 (4%)
Secondary 63 (60%)
University 38 (36%)
Occupation type; N, % white-collar 51 (49%)
Marital status; N, % single 21 (20%)
Body Mass Index; N, % 31.27±7.04
Underweight (<18.5) 0   (0%)
Normal (18.5-24.99) 23 (22%)
Overweight (25.0-29.99) 24 (23%)
Obese (30+) 58 (55%)
Apnoea-hypopnoea index; mean, sd 37.03±22.75
OSA severity; N, %
Mild (AHI≥5≤15) 16 (15%)
Moderate (AHI>15≤30) 40 (38%)
Severe (AHI>30) 49 (47%)
Night-time sleep quality (PSQI); mean, sd (0-21) 10.31±4.31
Perceived sleep quality; mean, sd 4.78±2.36
Sleep efficiency; mean, sd 1.81±1.83
Daily disturbances; mean, sd 3.74±1.32
Prevalence of night-time sleep quality disturbance; N, % (cut-off score >5) 88 (85%)
Excessive daytime sleepiness (ESS); mean, sd (0-24) 11.09±5.29
Prevalence of increased daytime sleepiness; N, % (cut-off score >10) 62 (59%)
Anxiety (BAI); mean, sd (0-63) 32.99±13.03
Prevalence of anxiety; N, % (cut-off score >9) 84 (80%)
Prevalence of mild anxiety (10-18) 31 (30%)
Prevalence of severe anxiety (19-29) 35 (33%)
Prevalence of very severe anxiety (30-63) 18 (17%)
Work functioning (WRFQ) total scale; mean, sd (0-100%) 52.58±28.76
Work Scheduling and Output demands 49.19± 31.69
Physical demands 57.43± 30.57
Mental and Social demands 52.74± 31.15
Flexibility demands 56.25± 30.04
Impaired Work functioning; N, % (cut-off score <90) 82 (82%)
Workdays per week; mean, sd 5.32±1.10
Work hours per week; mean, sd 39.73±7.82
AHI – Apnoea-Hypopnoea Index; OSA – Obstructive Sleep Apnoea; PSQI – Pittsburgh Sleep Quality Index; ESS – Epworth Sleepiness Scale; 
BAI – Beck Anxiety Inventory; WRFQ – Work Role Functioning Questionnaire; Missing data: Occupation type: 1%; PSQI: 1%, WRFQ: 4%.  
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Correlations between OSA severity, sleep-related problems, anxiety and work 
functioning
Table 4.2 displays the correlations between the study variables. High OSA severity, 
poor overall night-time sleep quality, poor perceived sleep quality, poor sleep ef-
ficiency, high level of daily disturbances, and severe anxiety were significantly cor-
related with impaired work functioning. Daytime sleepiness was not correlated with 
work functioning.
Table 4.2 Correlation coefficients between OSA severity, night-time sleep quality the 















Night-time sleep quality 0.23*  - - - - - -
Perceived sleep quality 0.26* 0.68*** - - - - -
Sleep efficiency 0.14 0.65*** 0.43*** - - - -
Daily disturbances 0.33*** 0.62*** 0.62*** 0.20* - - -
Daytime sleepiness 0.34*** 0.20*  0.14 0.04 0.49*** - -
Anxiety 0.18 0.58***  0.34*** 0.32** 0.44*** 0.31** -
Work role functioning -0.20* -0.41***  -0.47*** -0.23* -0.36*** -0.09 -0.45***
OSA – Obstructive Sleep Apnoea; *p<0.05; **p<0.01; ***p<0.001
Associations between OSA severity, sleep-related problems, anxiety and work 
functioning (total scale)
A crude effect on work functioning was found for all variables, except for age (B: 
-0.22; 95%CI= -0.79; 0.36; p=0.46), type of occupation (B: -4.03; 95%CI= -15.40; 
7.34; p=0.49) and daytime sleepiness (B: -0.61; 95%CI= -1.70; 0.48; p=0.27) 
(Table 4.3). A weak association between OSA severity (B: -0.27; 95%CI= -0.53; 
-0.01; p<0.05) and poor work functioning was found in crude analyses but was no 
longer significant (B: -0.18; 95%CI= -0.45; 0.08; p=0.17) in the subsequent mul-
tivariate models (Model 2-Model 5). Poor night-time sleep quality total scale (B: 
-2.63; 95%CI= -3.85; -1.42; p<0.001) was significantly associated with impaired 
work functioning (Model 3). The association between poor night-time sleep qual-
ity total scale and work functioning attenuated (B: -1.64; 95%CI= -3.07; -0.23; 
p<0.05) when anxiety (B: -0.61; 95%CI= -1.10; -0.15; p<0.01) was added to the 
model (Model 4). After adding anxiety (Model 4), the explained variance in work 
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A crude effect on work functioning was found for all of the three night-time sleep 
quality subscales. Multivariate analyses of the three subscales revealed that per-
ceived sleep quality (B: -5.28; 95%CI= -7.48; -3.08; p<0.001) was more strongly 
associated with work functioning (Model 3, Supplementary Table S4.1, Supplement 
4.1) than sleep efficiency and daily disturbances (Model 3, Supplementary Table 
S4.2, Supplementary Table S4.3, Supplement 4.1). The associations between sleep 
efficiency (B: -3.31; 95%CI= -6.35; -0.27; p<0.05), daily disturbances (B: -6.45; 
95%CI= -10.92; -1.99; p<0.01) and work functioning (Model 3, Supplementary 
Table S4.2, Supplementary Table S4.3, Supplement 4.1) were no longer signifi-
cant when anxiety was added to the model (Model 4, Supplementary Table S4.2, 
Supplementary Table S4.3, Supplement 4.1). The explained amount of total vari-
ance in work functioning varied from 22% for models with sleep efficiency and daily 
disturbances included to 27% for the model with sleep efficiency included.
Associations between OSA severity, sleep-related problems, anxiety and work 
functioning by subscale
A crude effect on work functioning subscales was found for all variables, except for 
age, type of occupation and daytime sleepiness. OSA severity was associated with 
physical demands only. Overall night-time sleep quality and anxiety were signifi-
cantly associated with all work functioning subscales. Multivariate analyses showed 
that night-time sleep quality and anxiety were significantly associated with the work 
scheduling-output demands and physical demands in the final models (with an ex-
plained total variance of 26% for work scheduling and output demands, and 16% for 
physical demands) (Supplementary Table S4.4).  
Moderation analyses
To test the moderation effects, the interaction terms between anxiety and overall 
night-time sleep quality were added into the equation (Model 5). The interaction 
of overall night-time sleep quality and anxiety was statistically significant (B: 0.12; 
95%CI= 0.03; 0.22; p<0.05) (Table 4.3). Anxiety moderated the association be-
tween low and medium night-time sleep quality problems and work functioning. 
The impact of anxiety on the association between night-time sleep quality and work 
functioning was negligible in the case of high night-time sleep quality problems 
(Figure 4.1).
Figure 4.1 Anxiety as a moderator of the association between night-time sleep quality 
and work functioning
PSQI – Pittsburgh Sleep Quality Index; BAI – Beck Anxiety Inventory; WRFQ – Work Role Functioning Questionnaire; Higher 
WRFQ scores indicated better work functioning.
Separate analyses of the three night-time sleep quality subscales showed that the 
interactions of perceived sleep quality (B: 0.18; 95%CI= 0.10; 0.35; p<0.05) and 
daily disturbances (B: 0.56; 95%CI= 0.22; 0.90; p<0.01) with anxiety were statis-
tically significant (Model 5, Supplementary Table S4.1, Supplementary Table S4.3, 
Supplement 4.1). The interaction of sleep efficiency and anxiety was not significant 
(B: 0.09; 95%CI= -0.14; 0.32; p=0.45) (Model 5, Supplementary Table S4.2). The 
moderating effect of anxiety in the association between perceived sleep quality, daily 
disturbances and work functioning was especially profound in the case of low and 
medium perceived sleep quality problems and low and medium levels of daily distur-
bances (Figure 4.2, Figure 4.3).
Figure 4.2 Anxiety as a moderator of the association between perceived sleep quality 
and work functioning
PSQI – Pittsburgh Sleep Quality Index; BAI – Beck Anxiety Inventory; WRFQ – Work Role Functioning Questionnaire; Higher 
WRFQ scores indicated better work functioning.
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Figure 4.3 Anxiety as a moderator of the association between daily disturbances 
and work functioning
PSQI – Pittsburgh Sleep Quality Index; BAI – Beck Anxiety Inventory; WRFQ – Work Role Functioning Questionnaire; Higher 
WRFQ scores indicated better work functioning.
Discussion
The aims of this study were 1) to examine whether OSA severity, sleep-related 
problems, and anxiety are associated with work functioning in OSA patients when 
controlled for age, gender, and type of occupation, and 2) to investigate whether 
anxiety moderates the associations between sleep-related problems and work func-
tioning. Our results provided suggestive evidence that poor night-time sleep quality 
and increased anxiety were associated with impaired work functioning. Further, the 
moderating effect of anxiety on the association between night-time sleep quality and 
work functioning was especially profound in patients with better sleep quality, while 
the effect of anxiety on the association between work functioning and night-time 
sleep quality was negligible in the case of high night-time sleep quality problems. 
Separate analyses of the three night-time sleep quality subscales showed that 
perceived sleep quality was more strongly associated with work functioning than 
sleep efficiency and daily disturbances. The associations between sleep efficiency, 
daily disturbances and work functioning were weak and no longer significant when 
anxiety was added to the models. Additionally, the moderating effect of anxiety on 
the association between perceived sleep quality, daily disturbances and work func-
tioning was especially present in OSA patients with better-perceived sleep quality 
and a lower level of daily disturbances. No moderating role of anxiety in the associa-
tion between sleep efficiency and work functioning was found. 
We found a weak association between OSA severity and impaired work func-
tioning; only significant in crude analyses. In the study by Mulgrew et al. (2007), 
patients with the lowest apnoea-hypopnoea index (AHI) scores exhibited an even 
more significant level of work limitation, and this association was dependent on the 
type of occupation and particular subscale of the Work Limitation Questionnaire. 
In contrast, no association between the type of occupation and work functioning 
for the total scale, not even for subscales was found in our study. An explanation for 
the lack of clear association between OSA severity and work functioning could be 
the use of polysomnography (PSG) to determine the diagnosis of OSA. Although a 
one-night PSG is sufficient for a diagnosis of OSA (Scholle et al., 2003; Gouveris 
et al., 2010), current techniques to measure OSA are a matter of some controversy; 
i.e. PSG-based AHI has been discussed as being inadequate to detect OSA severity 
(Ryu et al., 2016; Lee at al., 2016). Our findings confirm the suggestion of Macey 
et al. (2010) that mechanisms other than the AHI may contribute to adverse health 
effects in OSA patients. 
Our study revealed an association between poor night-time sleep quality and im-
paired work functioning, whereas daytime sleepiness was not related to work func-
tioning. Contrary to this finding, previous studies in patients referred for OSA de-
scribed an association between excessive sleepiness (measured by ESS) and work 
limitation (Mulgrew et al., 2007; Ulfberg et al., 1996; Grunstein et al., 1995). There 
are a variety of potential explanations for the lack of clear association between day-
time sleepiness and work functioning. The study of Ulfberg et al. (1996) did not 
use PSG to diagnose OSA, and measures of work limitation and daytime sleepi-
ness were combined into a single questionnaire, making interpretation difficult. 
Similarly, Grunstein et al. (1995) did not use validated measures of work role per-
formance. Furthermore, the concepts used by Ulfberg et al.  (1996) and Omachi et 
al. (2009), such as recent work disability and longer-term work duty modification, 
do not fully capture the scope or nature of subjective work functioning impairment 
measured in our study. Another possible explanation for these discrepancies could 
be that daytime sleepiness, measured by ESS, is assessed predominantly in a setting 
of decreased activity level (e.g. watching TV, sitting, reading etc.) compared with 
the higher mental or physical activity level usually expected in the working envi-
ronment. The lack of association between daytime sleepiness and work functioning 
can be explained based on the hypothesized pathophysiology of insomnia; i.e. the 
symptoms of poor sleep quality and anxiety might be linked to each other by some 
form of underlying “hyperarousal” (Perlis et al., 2005). Anxiety in OSA patients 
may develop into a chronic state of hypervigilance (Krakow et al., 2015), which re-
fers to the predisposition to be on high alert much more than is considered normal. 
This arousal ultimately leads to a state of chronic anxiety and eventually sleepless-
ness. All these cases epitomize the related phenomenon of an anxiety process that 
may obliterate natural sleepiness (Perlis et al., 2005; Krakow et al., 2015). In line 
with the delineated hyperarousal theory, we found that anxiety was more strongly 
associated with poor overall night-time sleep quality and its three separate factors 
than with daytime sleepiness.
The fact that the association between night-time sleep quality and work func-
tioning was greatly attenuated after anxiety was added to the model is not surprising. 
Sleep disturbances are closely related to anxiety symptoms, as sleep disturbances 
are both a precursor and a symptom of anxiety (Shanahan et al., 2014). Moreover, 
we found a moderating effect of anxiety on the association between low and medium 
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night-time sleep quality problems and work functioning. Based on our results, it can 
be hypothesized that work functioning in OSA patients may be impacted by anxiety 
more significantly than by poor night-time sleep quality. However, the moderating 
role of anxiety in the association between work functioning and sleep quality was 
weakened in patients with the highest levels of sleep quality problems. Thus, high 
night-time sleep quality problems may become more significant in the association 
with poor work functioning than anxiety, while the moderating effect of anxiety on 
work functioning was especially profound in patients with better sleep quality. In 
line with the evidence that poor perceived sleep quality is more predictive of nega-
tive affectivity and impaired physical health than sleep efficiency, i.e. sleep quantity 
(Pilcher et al., 1997), we found that perceived sleep quality was more strongly as-
sociated with work functioning than sleep efficiency and daily disturbances. The 
association between sleep efficiency and work functioning was only weak and no 
longer significant when anxiety was added to the model. 
Regarding the role of sociodemographic variables, we identified a higher im-
pairment of work functioning in male when compared with female OSA patients. In 
contrast to our study, general functional status was found to be more impaired in 
female OSA patients when compared with males in some previous studies (Chervin 
2000; Quintana-Gallego et al., 2004; Silva et al., 2016). A potential explanation 
for these discrepancies can be that men more often than women work in jobs that 
are incompatible with increased sleep-related symptoms. Hence, male OSA pa-
tients may more often than females face demands in their jobs that cannot be dealt 
with when sleep-related problems are above a certain level (Bültmann et al., 2013). 
Furthermore, in our sample, 70% of OSA patients were men; thus, our results may 
be less generalizable to the female population of OSA patients. 
Although, it may be assumed that some OSA symptoms, such as sleep-related 
problems, may be more difficult to overcome due to the sedentary nature of work 
in the group of white-collar OSA patients, we found no significant difference re-
garding work functioning impairment in blue- and white-collar workers. However, 
the fact that white-collar workers in particular may have modified and more flex-
ible work options or benefits enabling those with more severe OSA symptoms to 
continue to work without significant impairment should be considered (Mulgrew 
et al., 2007). 
Strengths and limitations 
The strengths of this study are that we shed light on several novel aspects of work 
functioning among OSA patients. Patients in our study were diagnosed using PSG, 
which is an asset of the study. To our knowledge, this is the first time that the PSQI 
factor structure has been used in a sample of OSA patients. It is also the first study 
using the Work Role Functioning Questionnaire in an OSA population. Some 
limitations should also be noted. Due to the cross-sectional design of the study, 
causal inferences cannot be made. Next, work functioning has not been objectively 
evaluated. Nevertheless, the used instrument has been found to be appropriate to 
measure health-related work functioning in the occupational health care practice or 
in the rehabilitation process of disabled workers (Ramada et al., 2014). We can also 
assume that anxiety symptoms assessed in our study may be associated with panic 
disorder, rather than with anxiety in general. Although the Beck Anxiety Inventory 
(BAI) may be used as an indicator of anxiety in primary care patients with differ-
ent anxiety disorders (Wetherell and Gatz, 2005) it has been disputed for its focus 
on psychophysiological symptoms linked to panic disorder (Beck and Steer, 1991; 
Cox et al., 1996), such as a racing heart or dizziness (Julian, 2011). The associa-
tions identified in our study may also occur due to latent mental health problems 
or somatic disease; i.e. sleep disturbances have also been identified to be both a 
precursor and a consequence of depression (Ford and Cooper-Patric, 2001). 
Nevertheless, the measure of anxiety used in our study was found to be suitable 
to distinguish an overlap between anxiety and depressive symptoms (Beck et al., 
1988). Furthermore, considering that patients with any major somatic or mental 
health comorbidity in the medical record were excluded from our study, this bias 
is rather unlikely. Previous study showed that OSA patients had difficulties to com-
plete the work tasks and they subjectively felt a lack of trust from co-workers, which 
consequently caused subsequent embarrassment related to this (Reishtein et al., 
2006). Thus, it should be considered that increased anxiety may also be work (e.g. 
working environment, cutting down jobs) and not only OSA-related. 
Implications for practice and future research
This study shows that poor night-time sleep quality and anxiety were strongly as-
sociated with impaired work functioning in OSA patients. Thus, employee assess-
ment of their work functioning may be an important proxy for the economic burden 
of OSA (Mulgrew et al., 2007). Although patients with any major somatic or men-
tal health comorbidity in the medical record were excluded, we found that 80% of 
OSA patients experienced increased symptoms of anxiety, which varied from mild 
(30%) to severe (17%). Thus, the study suggests that early detection and treatment 
of OSA and anxiety should be one of the priorities on the stakeholders’ agenda. 
Furthermore, identifying patients with overlapping diagnoses of mental health 
problems and OSA in clinical care may help to improve their treatment outcomes 
through careful dosing of pharmacotherapy and use of continuous positive airway 
pressure treatment (Gupta and Simpson, 2015). Compared with sleep efficiency, 
perceived sleep quality was more strongly associated with work functioning. These 
results indicate that health care professionals, in their efforts to understand the role 
of sleep in the daily life of patients with OSA, should rather focus on sleep quality 
than on sleep quantity. In clinical and research settings, these qualitative aspects 
of sleep may be captured by clinical interviews and specific patient-reported out-
comes. There is a need for workplace strategies that encourage behaviours and 
practices that may be helpful in reducing OSA-related symptoms and improve work 
functioning in OSA patients. Employers can play a role in educating employees 
about effective management of sleep loss through a variety of proven strategies, in-
cluding better managed work demands, regular exercise, duty hour considerations, 
and instructing them on the basics of sleep hygiene (Jansson and Linton, 2006). 
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Some recent evidence shows that workplace flexibility (allowing more flexible work 
start and end times) may contribute to positive health-related behaviours and may 
play an important role in effective workplace health promotion programs (Moen 
et al., 2011). Previous studies have also shown that enabling “unwinding” time be-
tween work and home may improve sleep patterns; as reduced work-to-home inter-
ference has the potential to decrease the risk of poor night-time sleep quality (Nylen 
et al., 2007). 
As boundaries between work and private life become more blurry, there is a 
real need to examine the associations between work habits, sleep and other relat-
ed aspects, especially in common diseases such as OSA. Further research should 
identify risk groups of patients with impaired work functioning and increased anxi-
ety levels and tailor the counseling and interventions suitably for these patients. 
Although PSG is considered to be a gold standard for making a diagnosis of OSA, 
it is not easily applicable in large population-based studies due to its intrusiveness 
and high costs (Sivertsen et al., 2008). Therefore, screening instruments based on 
self-reported symptoms of OSA have been important in order to gain information 
on the prevalence, comorbid conditions of OSA or continuous positive airway pres-
sure treatment effectiveness, which would be difficult to obtain without using scale 
surveys (Sivertsen et al., 2008). As BAI does not assess other symptoms of anxiety, 
such cognitive aspects, futher research may be accompanied by additional anxiety 
measures to distinguish between panic symptoms and other anxiety disorders (e.g. 
generalized anxiety disorder). Moreover, the possibility that anxiety may mask the 
certain amount of daytime sleepiness in OSA patients (Krakow et al., 2015) should 
be examined in the future studies. Further prospective, longitudinal research is 
needed to elucidate the pathways from OSA, sleep-related problems, and anxiety 
to impaired work functioning. As perceived sleep quality and sleep efficiency are 
influenced by a range of factors related to age or health (Foley et al., 2004), there 
is a need for further studies examining the factor structure of the PSQI in OSA pa-
tients. Finally, we studied OSA patients without major comorbidities, as these are 
assumed to influence sleep and affective OSA symptoms (Macey et al., 2010). As a 
group with minimal comorbidities and recent diagnosis is not fully representative 
of the general OSA population, it may be assumed that work functioning and other 
health-related outcomes would be even more significantly impaired in a sample of 
OSA patients with comorbid diseases (Macey et al., 2010). 
Conclusion
Poor sleep quality and anxiety were significantly associated with impaired work 
functioning in OSA patients. We also found that perceived sleep quality was more 
strongly associated with work functioning than sleep efficiency; i.e. sleep quantity. 
Further, the moderating effect of anxiety on work functioning was especially strong 
in patients with better sleep quality. The role of anxiety in the association between 
sleep quality and work functioning was weakened in the case of poor night-time 
sleep quality. Impaired work functioning in OSA patients may represent a possible 
cause of disability, which may be improved by workplace strategies focused on de-
creasing poor sleep quality and anxiety when confirmed in longitudinal studies. As 
many people with OSA are undiagnosed, our results demonstrate to employers and 
health care professionals the need to encourage patients for OSA screening, es-
pecially in the situation of impaired work functioning, increased anxiety and poor 
sleep quality. 
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“I have such a desire 
to sleep and am so much 
behind my sleep. 
A good night, one good 
night and all this 
nonsense will be swept 
away.”
Jean Paul SARTRE
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Abstract 
B a c k g ro un d  a n d  a i m
So far, very little is known about the association between hostility, coping self-
efficacy and psychological distress in Obstructive Sleep Apnoea (OSA) patients. 
We aimed to assess whether hostility and coping self-efficacy are associated with 
psychological distress in OSA patients. Furthermore, we examined whether coping 
self-efficacy mediates the association between hostility and psychological distress. 
Me t h o d s
We included 150 OSA patients (Apnoea-Hypopnoea Index–AHI≥5; 68% male; 
mean age 48.9±9.5 years), diagnosed by a full-night polysomnography. Patients 
completed the General Health Questionnaire-28, the Coping Self-efficacy Scale, 
the Cook-Medley Hostility Scale, the Pittsburgh Sleep Quality Index and the 
Epworth Sleepiness Scale. Multiple linear regression and mediation analyses were 
used to analyse the data. 
R e su l t s
Regression models showed that hostility and poor coping self-efficacy were strong-
ly associated with psychological distress in OSA patients. All assessed coping self-
efficacy dimensions mediated the association between hostility and psychologi-
cal distress. Coping self-efficacy for stopping unpleasant emotions and thoughts 
showed the strongest association with a lower level of psychological distress. 
C o n c l u s i o n
This study has led us to conclude that the presence of psychological distress in OSA 
patients may not be solely due to the effect of OSA itself. Rather, hostility and the 
choice of coping strategies may play a key role in examining which OSA patients 
will experience higher level of psychological distress.
Introduction
Obstructive Sleep Apnoea (OSA) is considered one of the most prevalent sleep 
disorders (Manarino et al., 2012), affecting 2–10% of the adult population (Leger 
et al., 2012). OSA leaves patients exhausted due to sleep disruption (Tkacova and 
Dorkova, 2010; Manarino et al., 2012; Rezaeitalab et al., 2014). Besides physi-
cal symptoms, OSA patients may experience psychological distress (Kang et. al, 
2012; Rezaeitalab et al., 2014; Su et al., 2015), irritability and hostility (Yue et al., 
2003; Booth et al., 2006; Lau and Lee, 2014; Unal et al., 2017). Sleep-related OSA 
symptoms, such as poor night-time sleep quality and daytime sleepiness, have been 
shown to have a negative impact on patients’ psychological well-being and overall 
quality of life (Tsara et al., 2009; Antic et al., 2011). 
Hostility has previously been found to be associated with the presence of OSA, 
the degree of daytime sleepiness (Yue et al., 2003) and poor night-time sleep qual-
ity (Xiao et al., 2016, Freitag et al., 2017) but not with severity of the apnoea-hypo-
pnoea index (AHI) or oxygen desaturation (Yue et al., 2003). Hostility is concep-
tualized as a negative cynical attitude toward others, with a propensity for anger, 
aggression (Cook and Medley, 1954; Ireland and Culpin, 2006), distrust or cyni-
cism (Barefoot et al., 1989). Hostility may represent a risk factor for all-cause mor-
tality (Nabi et al., 2008) and impaired mental health outcomes, with evidence be-
ing especially strong in patients with cardiovascular diseases (Silarova et al., 2016). 
Furthermore, hostility may be linked to increased negative emotionality (Brissette 
and Cohen, 2002), depression (Heponiemi et al., 2006), suicidal ideation and at-
tempts (Brezo et al., 2006; Lemogne et al., 2011), sleep disruption (Brissette and 
Cohen, 2002) and poor sleep quality (Freitag et al., 2017). This symptomatic sleep 
disruption often causes serious decreases in blood oxygen levels, with potentially 
life-threatening cardiovascular consequences (Bardwell et al., 2001; Leger et al., 
2012), while these mechanisms may be even more strongly aggravated by hostil-
ity (Hall et al., 2004; Mezick et al., 2010). Several mechanisms explaining the link 
between hostility and health consequences have been proposed. For instance, 
hostile persons exhibit increased sympathetic reactivity in some situations, experi-
ence more interpersonal conflicts and and may display more unhealthy behaviours 
(Smith, 1992; Vandervoort, 2006). 
Effective coping strategies may be beneficial in handling chronic diseases, in-
cluding OSA (Bardwell et al., 2001; Gassara et al., 2017). Coping can be defined 
as an effort to manage a situation and involves various cognitive and behavioural 
strategies to overcome external or internal demands, which are appraised as either 
taxing or exceeding the person’s resources (Folkman et al., 1986). The terms cop-
ing and coping self-efficacy are closely linked (Park and Folkman, 1997; Bandura et 
al. 1999; Chesnay et al., 2006). The concept of coping self-efficacy is based on the 
integration of two well established theories within health research: the self-efficacy 
theory of Bandura (1999) and the coping theory of Lazarus and Folkman (1984). 
In the framework of these theories, coping-self efficacy addresses which coping 
strategy a person will apply based on the perceived self-efficacy, and thus, it rep-
resents an important prerequisite to coping behaviour (Park and Folkman, 1997). 
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The choice and level of coping self-efficacy in a particular circumstance reflects 
prior relevant experiences (Bandura et al., 1977). As such, greater levels of cop-
ing self-efficacy were found to be associated with more effective regulation of emo-
tional distress (Luberto et al., 2014). The ability to regulate emotions is crucial in 
diminishing psychological distress; however, healthy emotion-regulation may not 
merely be about using the “right” strategies (Haines et al. 2016). According to the 
strategy-situation-fit hypothesis, emotion-regulation strategies are able to dimin-
ish psychological distress only when used in appropriate contexts (Bonanno and 
Burton, 2013; Haines et al. 2016).
Previous research has focused on the effect of coping self-efficacy and coping 
behaviour on patients’ self-reported health outcomes in various diseases, such as 
heart failure (Graven and Grant, 2013), multiple sclerosis (Mikula et al., 2016) or 
chronic obstructive pulmonary disease (Tiemensma et al., 2016; Vaske et al., 2017). 
Previous studies have shown that a higher level of coping self-efficacy was associ-
ated with a better adjustment to various chronic diseases (Chesney et al., 2006; 
Benka et al., 2014; Mikula et al., 2016). Only a few studies have thus far addressed 
this concept, but these have shown an association between coping self-efficacy and 
psychological distress (Chesney et al. 2006; Benka et al., 2014) and better quality 
of life (Mikula et al., 2016) in the context of various chronic diseases. Overall, these 
results suggest that coping self-efficacy has direct effects on distress/well-being 
outcomes, beyond the impact of clinical and personality variables. Some studies 
indicate that problem-focused coping was the most beneficial in handling disease 
(Graven and Grant, 2013; Tiemensma et al., 2016), especially in the mental health 
domain (Scharloo et al., 2000). Nevertheless, in some studies, avoidance-oriented 
coping, such as coping self-efficacy for the ability to stop unpleasant emotions and 
thoughts, were defined as most effective in dealing with the disease (Mackay et al., 
2012; Harmell et al., 2011). Recent studies have concluded that the more active and 
less passive coping strategies reported by OSA patients, the lower the level of de-
pressive symptoms experienced by patients (Bardwell et al., 2001; Gassara et al., 
2017). Moreover, a mediating role of coping self-efficacy in the association between 
personality traits and psychological health was identified in patients with multiple 
sclerosis (Mikula et al., 2016). Coping strategies were found to play a mediating 
role in the relationship between hostility and self-rated health outcomes in a sample 
of healthy individuals (Vandervoort, 2006). Unfortunately, the nature of coping 
styles utilized by hostility-prone individuals has received scant empirical attention. 
So far, very little is known about the association between hostility, coping 
self-efficacy and psychological distress in OSA patients. To our knowledge, only 
two studies have directly focused on the association between coping and self-rated 
health outcomes, i.e. depression, in OSA patients (Bardwell et al., 2001; Gassara 
et al., 2017). Due to a lack of general consensus regarding the continous positive 
airway pressure treatment effect on self-reported (Weaver, 2013; Tippin et al., 
2016) and objective (Dimsdale et al., 2000) health outcomes, the present research 
and clinical practice should also focus on the identification of adequate internal 
resources which may diminish psychological distress in OSA patients. Thus, the 
aims of this study were 1) to assess whether hostility and coping self-efficacy are 
associated with psychological distress in OSA patients when controlled for sociode-
mographic, clinical and sleep-related variables, and 2) to examine whether coping 
self-efficacy mediates the association between hostility and psychological distress. 
Methods
Sample and procedure
This cross-sectional study was conducted at the Department of Pneumology and 
Phtiseology, L. Pasteur University Hospital and the Medical Faculty of PJ Safarik 
University in Kosice, Slovak Republic. All patients who visited the department for 
one-night polysomnography (PSG) from July 2013 to June 2016 were eligible for 
the study. The indication for PSG was based on a general practitioner referral form. 
OSA was diagnosed based on an overnight sleep examination. 
Only OSA patients between 18 and 65 years of age were included due to pos-
sible increased vulnerability, functional changes and a decline in abilities and/or 
performance related to age. The study sample consisted of patients with an Apnoea 
Hypopnoea Index (AHI; number of apnoeas + hypopnoeas per hour of sleep) score 
of 5 or more (American Academy of Sleep Medicine, 2005), who had not undergone 
any previous continuous positive airway pressure (CPAP) treatment or other OSA 
treatment, had no regular shift work in the past six months, were Slovak-speaking 
and had no major comorbidities. 
Out of N=263 patients, N=41 refused to participate in the study (response rate 
84.0%). Another N=72 patients were excluded because of major comorbidities. 
The reasons for exclusion were major comorbidities related to sleep (a coexisting 
sleep disorder such as insomnia, narcolepsy, or circadian rhythm sleep disorder), 
major cardiovascular diseases (e.g. angina pectoris, myocardial infarction, primary 
pulmonary hypertension), pulmonary conditions (e.g. Pickwick syndrome, chronic 
obstructive pulmonary disease) and a history of cancer in the past twelve months. 
Neurological and psychological comorbidities included a neurological condition 
(e.g. epilepsy, stroke), a major psychiatric diagnosis (e.g. major depression, psy-
chotic disorders) in the medical record and/or current usage of psychiatric medica-
tions which may affect cognitive functions (e.g. benzodiazepines, antidepressants 
or antipsychotics), drug abuse in the past six months, and regular shift work in 
the past six months. The clinical diagnoses of the comorbid diseases were estab-
lished according to the standard International Classification of Diseases 10 revision 
Codes. Screening for comorbidities was based on medical data and an initial clinical 
interview prior to data collection. Medical examinations of patients were conducted 
by a pulmonologist specialized in sleep-disordered breathing. Patients with non-
respiratory sleep-related complaints (e.g. narcolepsy, insomnia) were routinely 
referred to another group of clinical specialists.
The invitation letter, informed consent and questionnaires were sent to par-
ticipants by postal mail three weeks before the medical examination. One week be-
fore the medical examination, patients were reminded about the questionnaires by 
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telephone. Patients filled in self-report questionnaires at home. All patients’ signed 
the informed consent form prior to study participation. Participation in the study 
was fully voluntary, with no incentives offered to participate in the research. The 




Psychological distress was assessed using the General Health Questionnaire 
(GHQ-28) (Goldberg and Hillier, 1979). The GHQ-28 is a 28-item measure of psy-
chological distress in the general population and within community or non-psychi-
atric clinical settings, such as among primary care or general medical out-patients. 
The GHQ-28 was developed as a screening tool to detect those likely to be at risk of 
developing psychiatric disorders. The questionnaire is divided into four subscales: 
somatic symptoms (items 1–7); anxiety/insomnia (items 8–14); social dysfunction 
(items 15–21) and severe depression (items 22–28) (Goldberg and Hillier, 1979). 
Psychological distress was defined as a continuous variable (0-3), ranging from 0 to 
84. A total score of 23/24 represents the threshold for the presence of psychologi-
cal distress (Goldberg and Hillier, 1979). Psychological distress is understood as 
the opposite continuum to psychological well-being (Goldberg and Hillier, 1979; 
Spiteri et al., 2013). Higher scores indicated a higher level of psychological distress. 
In our sample the Cronbach’s alpha for the total GHQ-28 scale was 0.83. 
Hostility
Hostility was measured by the abbreviated 27-item version of the Cook-Medley 
Hostility Scale (CMHo) (Cook and Medley, 1954). The CMHo scale is a widely used 
self-report measure of trait hostility. The scale primarily assesses the cognitive aspects 
of hostility, cynicism and distrust. Cynicism items are defined as statements of belief; 
aggressive response items reflect behaviour and hostile affect items reflect emotional 
experiences. Each item is rated on a dichotomised scale (1=“true”, 0=“false”). The 
score ranges from 0 to 27, with a higher score indicating more hostility (Cook and 
Medley, 1954). Cronbach’s alpha for the total scale in our sample was 0.85. 
Coping self-efficacy 
Coping self-efficacy (CSE) was measured using the 26-item CSE Scale developed 
specifically for people suffering from chronic disease (Chesney et al., 2006). The 
CSE scale represents a measure of an individual’s confidence in performing cop-
ing behaviours when faced with life challenges. The term CSE relates to the ten-
dency to make certain attributions about control not in one context but in many 
(Lazarus and Folkman, 1984). The CSE scale advances our ability to explore the 
theoretical links between the secondary appraisal of stress, which asks ‘what can 
I do?’, and the major coping functions postulated by stress and coping theory – 
the regulation of distress and the management of underlying problems (Chesney et 
al., 2006). The term coping self-efficacy is understood as a prerequisite for using 
actual coping strategies, as people need to be sure that they can perform coping 
actions before they act upon them (Chesney et al., 2006). Patients were asked to 
respond to the following question: ‘When things are not going well for you, or when 
you are having problems, how confident or certain are you that you can do the fol-
lowing’: ‘sort out what can be changed, and what cannot be changed’, ‘break an 
upsetting problem down into smaller parts’, ‘look for something good in a nega-
tive situation’, and ‘get emotional support from friends and family’, or ‘take your 
mind off unpleasant thoughts’. The CSE consists of three subscales representing 
self-efficacy for the use of ‘problem-focused coping’ strategies (ranging from 0 to 
120), ‘ability to get support from friends and family’ (ranging from 0 to 50) and the 
‘ability to stop unpleasant emotions and thoughts’ (ranging from 0 to 90). Coping 
self-efficacy for the use of ‘problem-focused coping’ consists of items that measure 
an individual’s self-efficacy with respect to overcoming problems by analysing the 
nature of the problem and employing cognitive strategies to make the respondent’s 
perception of the problem less severe (e.g. ‘break an upsetting problem down into 
smaller parts’). Coping self-efficacy for the ‘ability to stop unpleasant emotions and 
thoughts’ measures a respondent’s self-efficacy with respect to trying not to dwell 
on negative feelings and altering the emotional response to an unsettling event or 
problem rather than addressing the characteristics of the problem itself (e.g. ‘take 
your mind off negative thoughts’). The ‘ability to get support from friends and fam-
ily’ represents a set of items that captures the social dimension by tapping the re-
spondent’s perception of their ability to seek help from friends and family to cope 
with problems (e.g. ‘get emotional support from friends and family’) (Chesney et 
al., 2006). The three factors in the CSE scale are consistent with the three major 
aspects of coping – problem-focused coping, emotion-focused coping and social 
support. Although the scales are moderately correlated, the results of the concur-
rent validity analyses indicate that the scales assess self-efficacy with respect to dif-
ferent types of coping and lend support to using the factors separately (Chesney et 
al., 2006). Respondents answered on an 11-point scale. A higher score indicates 
a higher ability to cope with a particular situation (Chesney et al., 2006). In our 
sample, the Cronbach’s alphas were 0.94 for self-efficacy for the use of problem-
focused coping, 0.86 for coping self-efficacy for the ability to get support, and 0.93 
for the ability to stop unpleasant emotions and thoughts, respectively. 
Sleep-related problems
Sleep-related problems concerned night-time sleep quality and daytime sleepiness. 
Night-time sleep quality was measured using the Pittsburgh Sleep Quality Index 
(PSQI) (Buysse et al., 1989). The PSQI is a self-rated questionnaire to assess sleep 
disturbances and sleep quality over a one-month time interval. The PSQI consists of 
19 self-report questions which cover seven domains: sleep duration, subjective sleep 
quality, sleep latency, habitual sleep efficiency, sleep disturbances, use of sleep med-
ication and daytime dysfunction. The score ranges from 0 to 21, with higher scores 
reflecting poor night-time sleep quality. A cut-off score of 5 separates good from 
poor sleepers (Buysse et al., 1989). Cronbach’s alpha in our sample was 0.85.
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Daytime sleepiness was measured using the self-report Epworth Sleepiness 
Scale (ESS), an eight-item questionnaire describing the tendency to fall asleep in 
various daytime scenarios (Miletin and Hanly, 2003). The score ranges from 0 to 
24, with higher scores indicating higher daytime sleepiness. An ESS total score 
greater than 10 indicates excessive daytime sleepiness (Miletin and Hanly, 2003). 
Cronbach’s alpha in our sample was 0.86. 
Sociodemographic and clinical data
Information on age, gender and marital status was obtained from patient records. 
Body Mass Index (BMI; height and weight) was assessed by a physician. BMI was 
categorized as: underweight (<18.5), normal (18.5-24.99), overweight (25.0-29.99) 
and obese (30+). Polysomnography (PSG) was used to determine whether the diag-
nosis of OSA was present and to identify the severity of the disorder. PSG consists of 
a simultaneous recording of multiple physiological parameters related to sleep and 
wakefulness which directly monitor and quantify the number of respiratory events, 
related hypoxemia and arousals. PSG included standard central and occipital elec-
troencephalogram, bilateral electrooculogram, submental electromyogram (EMG), 
oral and nasal airflow using a thermistor, thoracic and abdominal excursions using 
respiratory inductive plethysmography and bilateral tibialis EMG. OSA severity was 
determined based on an AHI score (American Academy of Sleep Medicine, 2005), 
with three categories: mild OSA (AHI ≥5 and ≤15), moderate OSA (AHI >15 and 
≤30) and severe OSA (AHI >30).
Statistical analyses
Firstly, we described the background characteristics of the sample and calculated 
means and standard deviations for hostility (CMHo), coping self-efficacy (CSE) 
and psychological distress (GHQ-28) and sleep-related problems. We calculated 
frequencies and percentage for sociodemographic and clinical variables. Secondly, 
we assessed the correlations between the variables under study. Thirdly, using re-
gression analyses we assessed the crude associations of hostility and coping self-
efficacy with psychological distress. Multicolinearity was assessed using the vari-
ance inflation factor (VIF<2.0). We applied the enter selection in multiple linear 
regression models to determine the factors associated with psychological distress. 
For each factor, beta coefficients represent the mean variation of the psychologi-
cal distress score. As the choice of coping strategies may be influenced by clinical 
and sleep-related variables, the associations between hostility, coping  self-efficacy 
and psychological distress were adjusted for OSA severity, night-time sleep quality 
and daytime sleepiness. The first model of the variables included sociodemograph-
ic data (age, gender). A second model included a clinical variable (OSA severity 
- measured by AHI), and a third model included night-time sleep quality and day-
time sleepiness. In the fourth and fifth model, hostility and all dimensions of coping 
self-efficacy were included separately (following Bardwell et al., 2001; Mikula et al., 
2016; Gassara et a., 2017) to assess the explained amount of the total variance of 
psychological distress. 
Finally, we performed mediation analyses to investigate whether the associa-
tions between hostility and psychological distress were mediated by the coping self-
efficacy. According to Baron and Kenny (1986), the following conditions must be 
met to establish mediation: the independent variable (hostility) must affect the de-
pendent variable (psychological distress); secondly, the independent variable (hos-
tility) must affect the mediator (separate coping self-efficacy dimensions); and last-
ly, the mediator (separate coping self-efficacy dimensions) must affect the depend-
ent variable (psychological distress). The proportion of the effect which is mediated 
was calculated as the indirect effect divided by the total effect and multiplied by 100, 
while the as-advised standardized total effect was at least ±0.2 (Kenny, 2016). Sobel 
z-tests were used to examine the mediating effects of the coping self-efficacy on the 
associations between hostility and psychological distress. Power analysis revealed 
that the statistical power for multivariate analysis exceed 95% at α=0.05. The statis-
tical power for univariate analysis was 0.99 at α=0.05 (Faul et al., 2009). A p-value 
of <0.05 was considered to be statistically significant. All analyses were performed 
using the Statistical Package for the Social Sciences (IBM SPSS 23) and MedGraph.
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Results
Sample characteristics
A total of N=150 OSA patients (68% male; mean age 48.9±9.5 years) were included 
in the study. The majority of patients had secondary education (57.3%). A total of 
44.7% were obese and 49.3% had severe OSA (Table 5.1).
Table 5.1 Baseline characteristics of the OSA patients (AHI≥5)
Characteristics N=150
Age in years; mean, sd 48.9±9.5
Gender; male, N (%) 102 (68.0%)





Body Mass Index; mean, sd 30.2±7.7
Body Mass Index; N (%)
Underweight (<18.50)   9 (6.0%)
Normal (18.50-24.99) 42 (28.0%)
Overweight (25.00-29.99) 32 (21.3%)
Obese (≥30.00) 67 (44.7%)
Apnoea-hypopnoea index (AHI) in events/h; mean, sd 36.1±22.3
OSA severity; N (%) 
Mild (AHI≥5≤15) 23 (15.3%)
Moderate (AHI>15≤30) 52 (34.7%)
Severe (AHI>30) 74 (49.3%)
Night-time sleep quality; mean, sd (PSQI; 0-21) 9.7±4.1
Excessive daytime sleepiness; mean, sd (ESS; 0-24) 11.0±5.3
Hostility (CMHo; 0-27) 15.1±5.6
Problem-focused coping self-efficacy (CSE; 0-120) 79.5±24.1
Get support from friends and family (CSE; 0-50) 32.9±10.0
Stopping unpleasant emotions and thoughts (CSE; 0-90) 56.1±19.6  
Psychological distress (GHQ-28; 0-84) 32.6± 18.4
Psychological distress  (GHQ-28 ≥24) 79 (56.0%)
AHI – Apnoea-Hypopnoea Index; OSA – Obstructive Sleep Apnoea; PSQI – Pittsburgh Sleep Quality Index; ESS – Epworth 
Sleepiness Scale; CMHo – Cook-Medley Hostility Scale; CSE – Coping Self-Efficacy Scale; GHQ-28 – General Health Questionnaire; 
Missing values: OSA severity (0.7%), age (1.0%), ESS (1.0%), PSQI (1.0%), CMHo (1.0%), GHQ-28 (6.0%), Problem-focused coping 
self-efficacy (6.0%), Get support from friends and family (2.0%), Stopping unpleasant emotions and thoughts (3.0%).
Correlations between hostility, coping self-efficacy and psychological distress
Table 5.2 shows the correlations between between hostility, coping self-efficacy 
and psychological distress. Small but significant correlations were found between 
hostility, self-efficacy for the use of problem-focused coping and coping self-effica-
cy for getting support from family and friends. A moderate correlation was found 
between hostility and ability to stop unpleasant emotions and thoughts. The cor-
relations between hostility, all dimensions of coping self-efficacy and psychological 
distress were high. 














Problem-focused coping self-efficacy -0.24* - - -
Get support from friends and family -0.23*  0.89*** - -
Stopping unpleasant emotions and thoughts -0.26**  0.90***  0.82*** -
Psychological distress  0.58*** -0.50*** -0.35*** -0.53***
*p<0.05; **p<0.01; ***p<0.001. Higher score indicates higher psychological distress. 
Associations between hostility, coping self-efficacy  and psychological distress
A crude effect on psychological distress was found for OSA severity, sleep-related 
problems, hostility and coping self-efficacy (Table 5.3). The associations between 
hostility, coping self-efficacy and psychological distress were adjusted for sociode-
mographic variables (age, gender), the clinical variables (OSA severity, BMI) and 
sleep-related variables (night-time sleep quality, daytime sleepiness). Model 4, with 
hostility added, explained 59% of the total variance of psychological distress. All 
coping self-efficacy dimensions were strongly associated with a lower level of psy-
chological distress. The regression models for coping self-efficacy for the ability 
to get support from family and friends, self-efficacy for the use of problem-focused 
coping and coping self-efficacy for the ability to stop unpleasant emotions and 
thoughts explained 63%, 67%, and 70% of the total variance of psychological dis-
tress (Model 5 A, B, C), respectively.






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Coping self-efficacy as a mediator between hostility and psychological distress
The mediation analyses showed that all three coping self-efficacy dimensions par-
tially mediated the associations between hostility and psychological distress in OSA 
patients. The indirect effects of all three coping self-efficacy dimensions were sig-
nificant. They accounted for 10.0% of coping self-efficacy for getting support from 
family and friends, 15.0% of self-efficacy for the use of problem-focused coping 
and 17.0% of coping self-efficacy for the ability to stop unpleasant emotions and 
thoughts (Table 5.4). Figure 5.1 shows the mediating effects of separate coping self-
efficacy dimensions on the association between hostility and psychological distress. 
Table 5.4 Mediating effect of coping self-efficacy on the association between hostility 
and psychological distress
Coping self-efficacy Psychological distress
Sobel z-value Direct effect Indirect effect
Problem-focused coping self-efficacy 2.60*** 0.49*** 15.0%
Get support 2.16* 0.53*** 10.0%
Stopping emotions and thoughts 2.85*** 0.48*** 17.0%
*p<0.05; *** p<0.001.








Stopping unpleasant  
emotions and thoughts
Mediating variable













Mediations were conducted separately for each particular coping-self-efficacy dimension *p<0.05; **p<0.01; *** p<0.001.
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Discussion
The aims of this study were 1) to assess whether hostility and coping self-efficacy are 
associated with psychological distress in Obstructive Sleep Apnoea (OSA) patients 
when controlled for sociodemographic, clinical and sleep-related variables, and 2) 
to examine whether coping self-efficacy mediates the association between hostility 
and psychological distress. We found that high levels of hostility and poor coping 
self-efficacy were strongly associated with psychological distress in OSA patients. 
Compared with self-efficacy for the use of problem-focused coping and coping 
self-efficacy for the ability to get support from friends and family, poor coping self-
efficacy for stopping unpleasant emotions and thoughts was more strongly associ-
ated with psychological distress. All coping self-efficacy dimensions mediated the 
association between hostility and psychological distress. Coping self-efficacy for 
stopping unpleasant emotions and thoughts was identified as the strongest media-
tor in the association between hostility and psychological distress.  
We found a strong association between high levels of hostility and psychologi-
cal distress in OSA patients, even after controlling for sociodemographic variables, 
disease severity, body-mass index and sleep-related problems. Earlier, it was shown 
that individuals with OSA demonstrated along with the presence of irritability, also 
frustration and increased engagement in conflict (Bardwell et al., 1999; Yue et al., 
2003, Unal et al. 2017). Hostility and anger were also found to be higher in OSA 
patients when compared to healthy controls in a Korean population (Lau and Lee, 
2014). Vandervoort et al. (2006) showed that individuals with a high level of hostil-
ity reported poorer mental health and used avoidant coping strategies more often 
than individuals with a low level of hostility (Vandervoort, 2006). 
As sleep-related symptoms in OSA may increase hostility, which may conse-
quently potentiate the negative health consequences of the disease, coping self-
efficacy may represent one of the key determinants in adaptation to sleep disorders. 
Our analyses showed that poor coping self-efficacy was strongly associated with psy-
chological distress in OSA patients. This results confirm previous findings on the 
association between coping self-efficacy and a lower level of psychological distress 
(Chesney et al. 2006; Benka et al., 2014) and a better quality of life (Mikula et al., 
2016) in the context of chronic diseases. Self-efficacy for the ability to stop unpleas-
ant emotions and thoughts in our sample explained the most variance of all the cop-
ing self-efficacy dimensions in the psychological distress. One possible explanation 
why stopping unpleasant emotions and thoughts might be the most adaptive cop-
ing self-efficacy dimension in OSA is that the patients have very little control (e.g. 
Cheng, 2001) over the symptoms of their disease. When patients do not have the 
ability to control the disease and have to learn how to live with it, this kind of cop-
ing self-efficacy can help them to reduce the stress that breathing and sleep-related 
symptoms bring and thus may diminish their psychological distress. In line with the 
strategy-situation-fit hypothesis, well-being may thus represent a function of the 
“goodness of fit” between emotion-regulation efforts and the contextual charac-
teristics  (Conway and Terry, 1992) of OSA. This interpretation is consistent with 
previous research on chronic conditions, which suggests that coping self-efficacy 
for stopping unpleasant emotions and thoughts is more adaptive when little control 
over disease is possible (De Ridder  and  Schreurs 2001; Mikula et al., 2014). In line 
with our findings, previous research also showed that individuals scoring higher 
on hostility were also more likely to employ escape-avoidance coping styles while 
handling psychological distress (Vandervoort, 2006) and were less likely to use 
problem-focused coping (Sasaki and Yamasaki, 2002).
Next, we found the ability to get support from friends and family to be the least 
adaptive coping self-efficacy domain in the association with psychological distress, 
including diminishing the negative effect of hostility on psychological well-being. 
This finding may be explained by the results of previous research, in which sleep-
related problems represented an important predictor of daytime functioning, in-
cluding engagement in social activities (Dew et al., 1994). Therefore, due to sleep-
related OSA symptoms, such as daytime sleepiness, the sources of social support 
may be less utilized and thus may be of less importance. As hostility was found to 
be associated with poor levels of social support (Smith, 1992), social dysfunction 
(Sasaki and Yamasaki, 2002) and involves an oppositional orientation toward oth-
ers and negative beliefs and feelings toward others (Houston and Vavak, 1991), it 
may be assumed that patients with OSA may be even less motivated to participate 
in social activities, when potentiated by the presence of hostility. Furthermore, 
hostility was found to lead to difficulty in extracting the needed social support 
(Vandervoort, 1999).  
In contrast, Bardwell et al. (2001) concluded that the more active and less pas-
sive coping strategies reported by OSA patients, the lower level of depressive symp-
toms they experienced. Depressive symptoms were associated with more emotional 
coping and with less problem-focused coping in the study by Gassara et al. (2017). 
Although our results differ from those of previous studies (Bardwell et al., 2001; 
Gassara et al., 2017), these discrepancies may be associated with the difference in 
OSA diagnosis criteria; e.g. patients in the study by Bardwell et al. (2001) were di-
agnosed using a Respiratory Disturbance Index of ≥ 15, while in our study OSA di-
agnosis was stated based on an Apnoea-Hypopnoea Index of ≥ 5. Another possible 
explanation for the inconsistency in the above studies could be caused by the use 
of univariate statistical procedures in the study by Gassara et al. (2017). Moreover, 
the discrepancies in the role of passive coping strategies could be influenced by the 
different assessment of psychological distress, with a focus on depression. These 
discrepancies may also concern the difference in theoretical perspective of the tools 
used to measure coping (e.g. Vaske et al., 2017). 
We also found that all coping self-efficacy dimensions mediated the association 
between hostility and psychological distress. Thus, active as well as passive coping 
may be adaptive when dealing with OSA. Moreover, coping self-efficacy may serve 
as a trigger or perpetuator for psychological distress in OSA patients. In line with 
our findings, efficient coping strategies were associated with a low levels of hos-
tility in previous research (Comijs et al., 1999). One of the first investigations on 
coping and hostility in people with a chronic condition found that efficient coping 
was associated with reacting to stress with a minimum of hostility either expressed 
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or suppressed (Schill et al., 1985). The transactional model of the relationship be-
tween hostility and disease suggests that personality, cognitive and behavioural fac-
tors operate in reciprocal interaction with the environment and lead to a variety 
of frequent physiological reactions and related pathophysiological consequences 
(Williams and Williams, 2001). 
Mediation analyses in our study revealed that coping self-efficacy for stop-
ping unpleasant emotions and thoughts was the most effective in diminishing the 
strengh of the association between hostility and psychological distress in OSA pa-
tients. In line with these findings, previous research also showed that escape-avoid-
ance-oriented coping strategies had a significant mediating role in the relationship 
between hostility and self-rated health outcomes in a sample of healthy individuals 
(Vandervoort, 2006). This finding is not surprising, as the affective component of 
hostility consists of the tendency to experience several negative emotions (Barefoot 
et al., 1989). 
Finally, we wanted to ensure that the choice of coping self-efficacy and its asso-
ciation with psychological distress was not simply a result of sociodemographic or 
clinical variables. Therefore, gender and age were employed as controlled variables, 
along with body mass index (BMI), AHI and sleep-related problems. We found no 
significant association between sociodemographic variables and psychological dis-
tress. Similarly, the association between clinical variables, measured as OSA sever-
ity and BMI, was no longer significant in complex models. Previous studies have 
shown that age (Ryff and Singer, 2013), overweight and obesity were found to be 
associated with poor levels of subjective health status, particularly in terms of physi-
cal well-being (Doll et al., 2000). Other studies, have not found any association be-
tween BMI and psychological disturbances or psychosocial functioning (Klesges et 
al., 1992). The missing associations between age, obesity and psychological distress 
may be a result of confounding by the presence of accompanying chronic illness 
(Doll et al., 2000). 
Strengths and limitations
Patients in our sample were diagnosed by polysomnography, which is an asset of 
the study. Moreover, this is the first study which examines the mechanism between 
hostility, coping self-efficacy and psychological distress using comprehensive 
measurements in a rarely studied population of OSA patients. It is plausible that 
a number of limitations could have influenced our findings. First, we used cross-
sectional data; thus, we can not make any causal inferences. Second, self-report 
hostility may be prone to providing socially acceptable answers (Davidson and Hall, 
1997); thus, replication with more objective measures would provide an important 
comparison. Finally, although emotional suppression may reduce the outward ex-
pression of emotion and possibly the subjective experience of emotion in the short 
term, it was found to be less effective in reducing emotion and physiological arousal 
over a long-term period (Gross and Thompson, 2007). Previous studies have also 
suggested that long-term suppression of negative thoughts may prevent habitua-
tion to emotional stimuli and as such may result in hypersensitivity to psychological 
distress and symptoms (Wenzlaff and Wegner, 2000). Thus, longitudinal studies 
are needed to assess the influence of coping self-efficacy for the ability to stop un-
pleasant emotions and thoughts on psychological distress. 
Implications for future research and practice
Psychological distress in OSA patients is clearly associated with hostility and poor 
coping self-efficacy and requires attention in both clinical care and research. We 
recommend that our study should be replicated with a larger sample and a longitu-
dinal design. Further, future research is needed to understand the causal mecha-
nisms between hostility, coping self-efficacy and psychological distress in OSA pa-
tients. It would also be interesting to examine the actual sleep disturbances among 
patients scoring high and low on the Cook-Medley hostility scale in the laboratory. 
Hostility levels are well known to fluctuate considerably over time, and thus a longi-
tudinal study including repeated measures is needed. Poor coping self-efficacy may 
represent a background factor partially underlying the adverse effect of hostility on 
psychological well-being. 
Psychological distress was found to have the capacity for interventions 
(Farrand et al., 2016; and various protective efforts, including self-efficacy and ef-
fective coping strategies (Hopman et al., 2009; Trojan et al., 2012; Mikula et al., 
2016). From a clinical perspective, knowing which coping strategies a patient uses 
and how much hostility they experience and express may be useful in OSA manage-
ment. Therefore, the assessment of hostility and particular coping self-efficacy di-
mension may help to identify those patients who might benefit most from the direct 
treatment of psychological symptoms, in addition to treatment of sleep-disordered 
breathing itself. Our findings suggest that it is necessary to monitor hostility in OSA 
patients during clinical care. Understanding these associations may be beneficial 
for therapy, as well. A person who believes in his/her ability to produce a desired 
effect can conduct a more active and self-determined health-behaviour (Schwarzer 
and Renner, 2000). Therefore, education about the role of coping self-efficacy can 
be included in shorter pragmatic programs (Goudsmith et al., 2009; Wersebe et 
al., 2018). As disease occurs in people having premorbidly varying coping self-effi-
cacy in general and illness-related stress in particular, personality and behavioural 
patterns may play a key role in determining which OSA patients will experience 
higher levels of psychological distress. Thus, rather than solely focusing on patients 
medical parameters and standard OSA treatment, patients should be encouraged 
to use adaptive coping strategies. When our findings are confirmed in longitudinal 
studies, screening for hostility and treatment focused on decreasing high levels of 
hostility, in addition to standard therapy of the disordered breathing, might help to 
handle psychological distress experienced by OSA patients. Feelings of hostility 
may be decreased by cognitive behavioural therapy (Seligman et al., 2005), con-
trolled interventions and behavioural modifications (Barefoot et al., 1989). 
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Conclusion
This study has led us to conclude that the presence of psychological distress in OSA 
patients may not be solely due to the effect of OSA itself. Rather, hostility and the 
choice of coping strategies may play a key role in examining which OSA patients 
will experience higher level of psychological distress. Thus, interventions focused 
on reducing hostility and enhancement of adaptive coping may help to optimize 
standard treatment in OSA patients and be paramount in diminishing psychological 
distress in OSA patients. Further longitudinal research is necessary to confirm the 
causality, however. 
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Abstract 
B a c k g ro un d  a n d  a i m
Recently, an increased level of Suicidal Ideation (SI) has been observed in 
Obstructive Sleep Apnoea (OSA) patients. Social support has been shown to have 
relevance in many chronic diseases and is supposed to decrease SI. However, evi-
dence is lacking on the association between sleep-related problems and social sup-
port with SI in OSA patients. Thus, we aimed to assess the prevalence of SI and to 
examine the relationships OSA severity, sleep-related problems, social support and 
SI in OSA patients. 
Me t h o d s 
We included 149 patients (68% male; mean age 48.99±9.57 years) with diagnosed 
OSA (Apnoea-Hypopnoea Index–AHI≥5) based on full-night polysomnography. 
All patients completed the General Health Questionnaire-28 subscale regard-
ing SI, the Pittsburgh Sleep Quality Index, the Epworth Sleepiness Scale, the 
Multidimensional Fatigue Inventory and the Multidimensional Scale of Perceived 
Social Support. Structural equation modelling (SEM) was used to analyze the data. 
R e su l t s 
The prevalence of SI among OSA patients was 20.1%. Structural equation mod-
elling showed that SI in OSA was strongly related to poor sleep quality and high 
fatigue levels. No relationship between social support and SI in OSA patients was 
found. 
C o n c l u s i o n
SI in OSA is strongly related to poor sleep quality and high fatigue levels. 
Understanding the pathways among these symptoms and SI in OSA patients is im-
portant, as it may contribute to better disease management. 
Introduction
Obstructive Sleep Apnoea (OSA) is an incapacitating chronic disease caused by 
pharyngeal collapse during sleep (Manarino et al., 2012), which is characterized by 
repeated breathing pauses. OSA, along with insomnia, is one of the most common 
sleep disorders in adults (Subramanian et al., 2011), with an estimated prevalence of 
2–10% (Leger et al., 2012). 
Recently an increased level of suicidal ideation (SI) has been observed in 
patients treated in medical sleep centres (Krakow et al., 2011), including among 
OSA patients (Choi et al., 2015). Suicide is an important cause of death worldwide. 
Globally more than 800,000 people take their own life every year, and there are 
many more suicide attempts (World Health Organization, 2016). Recent approach-
es have defined suicide as a health behaviour, in the sense that a person makes a de-
cision to take his/her own life, so an appreciation of the psychology of the suicidal 
mind is crucial to suicide prevention (O’Connor, 2017). The annual prevalence of 
SI in the general population according the World Mental Health Survey is around 
2% (Borges et al., 2010). The cross-national lifetime prevalence of SI in the general 
population is 9.2% (Nock et al., 2008), while 13% of participants treated in medical 
sleep centres reported SI, 4.5% of whom had clinically significant SI (Krakow et 
al., 2011). In 2015, Choi et al. (2015) reported an SI prevalence of 20.5% in a South 
Korean population of OSA patients, but information about the prevalence of SI in 
OSA patients in other countries is lacking. 
Sleep disturbances were not included in the recent suicide risk factor lists 
compiled by the World Health Organization (2012). Nonetheless, the potential 
association between sleep-related problems and suicide has been recognized. In 
a meta-analysis by Pigeon et al. (2012), sleep disturbances were identified as a risk 
factor for SI and suicidal behaviour beyond the effects of depression in various clini-
cal and healthy population groups. Poor sleep quality was found to be associated 
with an increased risk of committing suicide in one decade, even when adjusted 
for depressive symptomatology (Bernert et al., 2014). Krakow et al. (2011) found 
an association between sleep-related problems and SI in patients treated in medi-
cal sleep centres, which remained significant after controlling for depression. A 
Korean study on OSA patients found that they suffered from insomnia and SI, and 
that the concepts of SI, insomnia and depression showed overlap (Choi et al., 2015). 
Adequate social support may have a positive influence on SI and suicidal behav-
iour (Kleiman and Liu, 2013). In recent years, increasing attention has been paid to 
the protective effect of social support in many chronic diseases (Reblin and Uchino, 
2008). Lower social support was associated with worse health status (Bucholz et 
al., 2014) and more depressive symptoms (Bucholz et al., 2014; Lee et al., 2016a) in 
men and women with acute myocardial infarction (Bucholz et al., 2014) and chronic 
arthritis pain (Lee et al., 2016a). However, OSA patients may experience lower lev-
els of social support compared to other populations. Some previous studies have 
demonstrated for example that the partners of OSA patients were unable to engage 
in social activities due to poor energy levels (Luyster et al., 2016), and their overall 
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quality of life was adversely affected by OSA (McArdle et al., 2001; Luyster et al., 
2016). 
Another source of concern is that individuals with sleep problems suffering 
from psychological distress rarely seek formal mental health evaluation and treat-
ment (Weissman et al., 1997; Wojnar et al., 2009). Therefore, the idea of depend-
ing solely on the available psychological and psychiatric care to detect individuals at 
risk of SI may be insufficient for early suicide prevention efforts, especially for peo-
ple with chronic diseases such as OSA. However, in general little is known about 
the relationships between OSA severity, sleep-related problems, social support and 
SI in OSA patients. Understanding the pathways of and interrelationships between 
these constructs is of major importance, as better knowledge may contribute to bet-
ter disease management and may be useful in enhancing our ability to predict and 
prevent death by suicide. 
The aims of the present study were to: (a) assess the prevalence of SI, and (b) 
examine the relationships between OSA severity, sleep-related problems, social 
support and SI, in OSA patients. Based on previous findings in OSA populations, 
we hypothesized that OSA severity is related to poor night-time sleep quality, 
contributing to higher levels of fatigue and daytime sleepiness which may in turn 
contribute to a higher level of SI. Further, we hypothesized that OSA severity and 
sleep-related problems may be directly related to higher level of SI. Social support 
was expected to be associated with SI; i.e. poorer social support could contribute 
to a higher level of SI. 
Methods
Sample and procedure
This cross-sectional study was conducted at the Department of Pneumology and 
Phtiseology, L. Pasteur University Hospital and the Medical Faculty of PJ Safarik 
University in Kosice, Slovak Republic. All patients who visited the Department for 
one-night polysomnography (PSG) from July 2013 to June 2016 and underwent 
PSG were eligible for the study. Indication for PSG was based on a general prac-
titioner referral form. OSA was diagnosed based on an overnight sleep study. PSG 
was used to determine whether the diagnosis of OSA was present and to identify the 
severity of the disorder. 
Only patients between 18 and 65 years old were included due to possible func-
tional changes, increased vulnerability and a decline in abilities and performance 
related to age. The study sample consisted of patients with an Apnoea Hypopnoea 
Index (AHI; number of apnoeas + hypopnoeas per hour of sleep) score of 5 or more 
(American Academy of Sleep Medicine, 2005), who had no previous continuous 
positive airway pressure treatment or other OSA treatment, were Slovak-speaking 
and had no major comorbidities. Out of N=260 patients, N=39 refused to par-
ticipate in the study (response rate 85.0%). Another N=72 patients were excluded 
because of major comorbidities (a coexisting major sleep disorder such as insom-
nia, narcolepsy, or circadian rhythm sleep disorder; major cardiovascular diseases, 
primary pulmonary hypertension, chronic obstructive pulmonary disease, diabetes, 
Pickwick syndrome, a history of cancer in the past twelve months, neurological defi-
cit, a major psychiatric diagnosis in the medical record such as schizophrenia, bipo-
lar disorder or cognitive decline, and/or current usage of psychiatric medications 
such as sedative-hypnotics, or narcoleptics or drug abuse in the past six months) 
and regular shift work. Medical examinations were conducted by a pulmonologist 
specialized in sleep-disordered breathing. Clinical diagnoses were stated accord-
ing to the International Classification of Diseases-10 codes. Screening on comor-
bidities was based on medical data and an initial clinical interview prior to data col-
lection. The final sample consisted of N=149 OSA patients (68% male; mean age 
48.99±9.57 years). Patients received a self-reporting questionnaire. 
The study was approved by the Ethics Committee of PJ Safarik University in Kosice 
(approval no. 115/2011). All patients signed a written informed consent prior to 
study participation. Participation in the study was fully voluntary, with no incen-
tives for participation. 
Measures
Sociodemographic and clinical data
Information on age, gender and marital status was obtained from patient records. The 
Body Mass Index (BMI; height and weight) was assessed by a physician. BMI was used to 
sort patients into categories: underweight (<18.50), normal (18.50-24.99), overweight 
(25.00-29.99) and obese (≥30.00). OSA severity was determined using PSG and 
was based on the Apnoea Hypopnea Index (AHI; number of apnoeas + hypopneas 
per hour of sleep), starting with a score of 5 or more according to the standard crite-
ria (American Academy of Sleep Medicine, 2005). According to this, OSA severity 
is mild (AHI≥5≤15), moderate (AHI>15≤30) or severe (AHI>30).
Sleep-related problems
Sleep-related problems included night-time sleep quality, daytime sleepiness and fa-
tigue. Night-time sleep quality was measured using the Pittsburgh Sleep Quality Index 
(PSQI) (Buysse et al., 1989). The PSQI consists of 19 self-reported responses to 
questions covering seven domains: subjective sleep quality, sleep latency, sleep du-
ration, habitual sleep efficiency, sleep disturbances, use of sleep medication and 
daytime dysfunction. The total score with a maximum of 21 was used, with higher 
scores reflecting poor night-time sleep quality. A cut-off score of 5 points separates 
good sleepers from poor ones (Buysse et al., 1989). Cronbach’s alpha in our sample 
was 0.86. 
Daytime sleepiness was measured using the self-reporting Epworth Sleepiness 
Scale (ESS), an eight-item questionnaire assessing the tendency to fall asleep in 
various daytime scenarios (Miletin and Hanly, 2003). The score ranges from 0 to 
24, with higher scores indicating higher daytime sleepiness. An ESS total score 
greater than 10 indicates excessive daytime sleepiness (Miletin and Hanly, 2003). 
Cronbach’s alpha in our sample was 0.87. 
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Fatigue was measured using the Multidimensional Fatigue Inventory (MFI-20) 
(Smets et al., 1995). It consists of 20 individual items measuring five dimensions 
of fatigue: general fatigue, physical fatigue, reduced activity, reduced motivation 
and mental fatigue. Each dimension contains four items with a five-point response 
format; the total score in each dimension ranges from 4 (no fatigue) to 20 (high-
est possible fatigue). The values for Cronbach’s alphas were: general fatigue: 0.80; 
physical fatigue: 0.89; reduced activity: 0.75; reduced motivation: 0.81; and mental 
fatigue: 0.83.
Social support
Social support was measured using the Multidimensional Scale of Perceived Social 
Support (MSPSS), a 12-item measure of subjectively-assessed social support using a 
seven-point Likert-type scale with responses ranging from ‘very strongly disagree’ 
(score 1) to ‘very strongly agree’ (score 7). The total score ranges from 12 to 84, with 
higher scores indicating perceived higher social support (Zimet et al., 1988). The 
scale, with four items for each subscale, measures support provided by a significant 
other, family and friends. In our sample Cronbach´s alpha was 0.90 for each of the 
three items, and Cronbach´s alpha for the total scale was 0.94. 
Suicidal ideation
Suicidal ideation (SI) was assessed using the General Health Questionnaire (GHQ-
28) (Goldberg and Hillier, 1979). Four items directly dealing with SI were used: 
“Have you thought about the possibility of killing yourself?”, “Do you wish to be 
dead and far away from everything?”, “Do you have continual thoughts about end-
ing your life?”, and “Do you have the impression that life is not worth of living?” 
The validated four-item SI subscale of the GHQ-28 has been previously used to 
assess SI (Gili-Planas et al., 2001; Watson et al., 2001). In some previous stud-
ies the threshold of SI≥1 was used to assess the presence of SI (Gili-Planas et al., 
2001; Biddle et al., 2004). However, the GHQ threshold is partly determined by 
the prevalence of multiple diagnoses, with higher thresholds being associated with 
higher rates of both single and multiple diagnoses (Goldberg, et al. 1998). Thus, 
based on the presence of severe physical illness raising the best threshold to be 
adopted (Goldberg, et al. 1998), we determined the prevalence of SI with a cut off of 
SI≥2, in a binary manner, with the negative responses given a score of zero and the 
positive responses a score of one. The sum-score of the four items of SI therefore 
ranged from 0 to 4. SI was also used as a continuous variable (1-4) in SEM, with 
a range from 4 to 16. Higher scores indicated a higher level of SI. In our sample 
Cronbach´s alpha was 0.83. 
Statistical analyses
The analyses were performed using the Statistical Package for the Social Sciences 
(IBM SPSS 23). Structural equation modelling (SEM) was performed with Mplus 7.1 
(Muthén and Muthén, 2015). Firstly, we described the background characteristics 
of the sample, determined the SI prevalence and calculated the mean values of OSA 
severity, night-time sleep quality (PSQI), fatigue (MFI), daytime sleepiness (ESS) 
and social support (MSPSS) for the total sample and stratified by SI yes/no (SI≥2). 
Chi-square analyses were conducted on dichotomous variables. T-tests were con-
ducted to assess the differences between OSA patients with SI (yes/no). Secondly, 
we used correlation analysis to assess the association between social support and 
SI when controlled for age, gender and marital status. Thirdly we used SEM to ex-
amine the relationships between OSA severity, night-time sleep quality, fatigue, 
daytime sleepiness, social support and SI in OSA patients. The used model fit cri-
teria were: chi-square test, RMSEA (90% confidence interval, CI), Comparative Fit 
Index (CFI) and Tucker-Lewis Index (TLI). Swain’s corrections of the model fit cri-
teria were used because the sample size was small (Herzog and Boomsma, 2009). 
A p-value of <0.05 was considered statistically significant. 
Results
Sample characteristics 
The majority of the patients were male (68.0%), had secondary education (57.4%), 
had a partner (77.6%), 44.9% were obese, and 50.0% had severe OSA. Patients 
reporting SI scored significantly higher on sleep-related problems compared to 
non-SI patients. We observed no significant differences in the main clinical and so-
ciodemographic data, OSA severity and social support between OSA patients with 
and without SI. Based on the increased level of the threshold due to the presence 
of physical disorder, the prevalence of SI among OSA patients was stated at 20.1% 
(Table 6.1). 
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Table 6.1 Baseline characteristics of the OSA patients (AHI ≥ 5), total sample and 
stratified by SI yes/no (SI≥2)
OSA (N=149) OSA SI (N=30) OSA non-SI (N=119) p-value
Age in years, mean, sd 48.99±9.57 46.47±10.76 49.50±9.34 0.15
Gender, male, N (%) 101 (68.0%) 18 (60.0%) 83 (69.7%) 0.22
Education level, mean, sd 4.99±1.74 5.13±1.91 4.97±1.70 0.66
Education level, N (%) 0.07
     Elementary 8   (5.3%) 3   (10%) 5   (4.2%)
     Secondary school 86 (57.4%) 14 (46.6%) 72 (60.0%)
     University 55 (36.3%) 13 (43.3%) 42 (34.7%)
Employed, N (%) 127 (84.7%) 26 (86.6%) 101 (84.8%) 0.53
Marital status, single, N (%) 35 (23.4%)  3 (10.0%) 32 (26.8%) 0.52
Body Mass Index, mean, sd 30.24±7.66 32.15±7.70 29.80±7.61 0.13
Body Mass Index, N (%) 0.28
    Underweight (<18.5) 9   (6.0%) 0  (0%) 9   (7.5%)
    Normal (18.5-24.99) 41 (27.5%) 8  (26.6%) 33 (27.7%)
    Overweight (25.0-29.99) 32 (21.4%) 5 (16.6%) 27 (22.6%)
    Obese (≥30) 67 (44.9%) 17 (56.6%) 50 (42.0%)
Apnoea-hypopnoea index, mean, sd 35.64±22.30 40.37±18.16 34.66±23.12 0.21
OSA severity, N (%) 0.41
    Mild (AHI≥5≤15) 22 (15.0%) 0    (0%) 22 (18.5%)
    Moderate (AHI>15≤30) 52 (35.0%) 10  (33.3%) 41 (33.11%)
    Severe (AHI>30) 74 (50.0%) 20 (66.7%) 55 (48.3%)
Night-time sleep quality, mean, sd (PSQI; 0-21) 9.65±4.14 12.90±4.18 8.88±3.70 <0.001***
Daytime sleepiness, mean, sd (ESS; 0-24) 10.97±5.30 12.76±5.75 10.51±5.10   0.04*
Fatigue, mean, sd (MFI; 4-20)
   General fatigue 14.01±4.71 17.76±2.47 13.02±4.56   0.001**
   Physical fatigue 13.52±4.77 17.6±3.39 12.45±4.62 <0.001***
   Reduced activity 11.91±4.94 16.43±3.29 10.77±4.63 <0.001***
   Reduced motivation 9.13±3.63 12.26±3.52 8.34±3.28 <0.001***
   Mental fatigue 11.97±4.82 16.93±2.79 10.71±4.39 <0.001***
Social support, mean, sd (MSPSS; 12-84) 63.11±13.48 58.86±14.68 64.18±12.99   0.05
SI, mean, sd (GHQ; 4-16) 6.67±3.30 12.03±2.14 5.31±1.75 <0.001***
Prevalence of SI, N (%) (GHQ-28 SI≥1) 54 (36.2 %) -
Prevalence of SI, N (%) (GHQ-28 SI≥2) 30 (20.1%) -
Prevalence of SI, N (%) (GHQ-28 SI≥3) 19 (12.8%) -
Prevalence of SI, N (%) (GHQ-28 SI=4) 13 (8.8%) -
OSA – Obstructive Sleep Apnoea; SI – Suicidal Ideation; PSQI – Pittsburgh Sleep Quality Index; ESS – Epworth Sleepiness Scale; 
MFI – Multidimensional Fatigue Inventory; MSPSS – Multidimensional Scale of Perceived Social support; GHQ-28 – General 
Health Questionnaire; *p<0.05; **p<0.01; ***p<0.001. Missing values: OSA severity: (0.7%); age, PSQI, MFI, ESS (1.0%); MSPSS: 
(2.0%).  
Relationships between OSA severity, night-time sleep quality, daytime sleepi-
ness, fatigue, social support and SI
Daytime sleepiness and social support were not significantly related to night-time 
sleep quality and SI in the hypothesized model (Figure S6.1, Supplement 6.1). As 
our hypothesis was not confirmed, we tested an alternative, modified model without 
sleepiness and social support (Figure 6.1, Table 6.2). The model fit criteria of the 
modified model were chi-square test = 29.909 (p value 0.04) and RMSEA = 0.066 
(90%CI = 0.016, 0.107). The CFI was 0.984; TLI was 0.975. Swain’s correction 
factor was 0.972. Swain’s corrected chi-square statistic was 29.063 (p-value: 0.05). 
Swain’s corrected RMSEA was 0.064 (90%CI = 0.007, 0.106), Swain’s corrected 
TLI was 0.971 and Swain’s corrected CFI was 0.991. 
Sleep quality (β = 0.28, p<0.001) and fatigue (β = 0.49; p<0.001) were strong-
ly related to SI. Sleep quality mediated the effect of OSA severity on SI (β = 0.06, 
p<0.05), OSA severity was associated with poor sleep quality (β = 0.21; p<0.01) 
while fatigue was associated with poor sleep quality (β = 0.60; p<0.001). Social 
support was not significantly associated with SI using complex modelling, and ad-
justment for sociodemographic variables as potential confounders (age, gender and 
marital status) did not change the association between social support and SI either.
Figure 6.1 Modified model of the relationships among OSA severity, night-time sleep 
quality, fatigue and SI: beta (standard error)
Night-time sleep quality
OSA severity (AHI)




F A T I G U E
1. general fatigue 0.84 (0.03)
2. physical fatigue 0.84 (0.03)
3. reduced activity 0.94 (0.02)
4. reduced motivation 0.72 (0.04)
5. mental fatigue 0.85 (0.03)
0.32*** (0.09)
AHI – Apnoea-Hypopnoea Index; OSA – Obstructive Sleep Apnoea; **p<0.01; ***p<0.001.
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Table 6.2 Relationships between OSA severity, night-time sleep quality, fatigue and SI
Standardized coefficients (S.E.)
Direc t  paths
OSA severity – Night-time sleep quality 0.21** (0.08)
Night-time sleep quality – Fatigue 0.60*** (0.06)
Night-time sleep quality – Suicidal ideation 0.28***(0.08)
Fatigue – Suicidal ideation 0.49*** (0.07)
Ind i rec t  paths
OSA severity – Night-time sleep quality – Suicidal ideation 0.06* (0.03)
OSA severity – Night-time sleep quality – Fatigue – Suicidal ideation 0.06* (0.03)
OSA – Obstructive Sleep Apnoea; S.E. – Standard Error; *p<0.05; **p<0.01; ***p<0.001.
Discussion
This study shows a 20.1% prevalence of Suicidal ideation (SI) in people with 
Obstructive sleep apnoea (OSA). Patients reporting SI scored higher on sleep-
related problems compared to non-SI patients. Poor night-time sleep quality and 
fatigue were directly related to SI. Night-time sleep quality mediated the effect of 
OSA severity on SI. We found no relationship between social support and SI in 
OSA patients. 
Based on the presence of OSA, which represents severe physical illness con-
sistently raising the best threshold to be adopted (Goldberg et al., 1998), we can 
assume that 20.1% of OSA patients in our study reported SI. This finding is in line 
with Choi et al. (2015), who found an SI prevalence of 20.5% in a Korean popula-
tion of OSA patients. This SI prevalence of 20.1% among OSA patients is alarming, 
especially when compared to the cross-national lifetime prevalence of SI (9.2%) in 
the general population (Borges et al., 2010) and the annual prevalence (2.0% to 
2.1%) of SI in the general population (Borges et al., 2010). 
OSA severity was not directly related to SI in our study. Choi et al. (2015) also 
found no correlation between OSA severity and SI in OSA patients. However, night-
time sleep quality mediated the effect of OSA severity on SI in our study. Although 
one-night polysomnography (PSG) is sufficient for diagnosis of OSA (Scholle et al., 
2003; Gouveris et al., 2010), significant variability in the apnoea-hypopnoea index-
es (AHI) taken from two nights was revealed in people with OSA (Gouveris et al., 
2010). Thus, the missing direct relationship between OSA severity and SI may be 
related, according to Choi et al. (2015), to individuals’ adaptation to the combina-
tion of the hospital environment and the recording equipment. However, some pre-
vious studies suggest that AHI based on numbers of all apnoeas and hypopnoeas, 
but not severity of apnoeic events, may not be the most appropriate measure of OSA 
severity when considering the clinical impact of OSA on subjective quality of life 
assessment (Weaver et al., 2005; Lee at al., 2016b). 
Our findings demonstrate that disturbed night-time sleep quality was directly 
related to SI. This finding aligns with Bernert et al. (2014), who showed that poor 
night-time sleep quality in an older population was associated with increased risk 
of committing suicide, even after adjustment for depressive symptomatology. 
Therefore, SI may not only represent a symptom of major depression but has also 
been found to be driven by neurobiological processes (Fried and Nesse, 2015; Du 
et al., 2017). Another recent meta-analysis revealed that psychiatric patients with 
sleep disturbances, including sleep-related breathing disorders, are about twice 
as likely to report suicidal behaviours compared to patients without sleep related-
problems (Malik et al., 2014). Similarly, Choi et al. (2015) found that higher insom-
nia levels correlated with higher level of SI in OSA patients.
We found that fatigue was most strongly related to SI. Patients reporting SI 
scored significantly higher on daytime sleepiness, but the association was weak and 
no relationship between daytime sleepiness and sleep quality or SI was observed 
using complex modelling. Within a medical framework, excessive daytime sleepi-
ness and fatigue are generally considered a result of sleep deprivation or poor sleep 
quality (Nicassio et al., 2002; Fava, 2004). However, according to Chervin (2000), 
some OSA patients report fatigue more often than daytime sleepiness, and there-
fore treatment of fatigue complaints in the absence of clear daytime sleepiness war-
rants more attention in OSA treatment. Nevertheless, the possibility that daytime 
sleepiness in OSA patients may simply be masked by the presence of psychologi-
cal distress associated with a chronic state of hypervigilance (Krakow et al., 2015) 
should also be considered.   
Unexpectedly, the relationship between social support and SI was not signifi-
cant. Some previous analyses have revealed that social support had a greater im-
pact on well-being (Antonucci and Akiyama, 1987; Walen and Lachman, 2000) and 
health (Walen and Lachman, 2000) in female compared with male populations. 
However, we found no significant impact of gender on the association between so-
cial support and SI when controlled for sociodemographic variables. 
Given the evidence that sleep disturbances may represent an important predic-
tor of daytime functioning, including engagement in social activities (Dew et al., 
1994), it may also be hypothesized that in the case of extreme fatigue or daytime 
sleepiness, the sources of social support may not be adequately utilized and thus 
may be of less importance. On the other hand, it is also plausible that the reverse 
pathway is true; i.e. sleep disturbances may lead to a more negative perception of 
the social environment (Troxel et al., 2010). Furthermore, social interactions may 
represent stressful situations for patients with OSA; e.g. OSA patients subjec-
tively felt a lack of trust from co-workers which caused them subsequent embar-
rassment (Reishtein et al., 2006). In line with these assumptions, OSA symptoms 
were also found to be associated with reduced social participation (Liu et al., 2016). 
Nevertheless, Choi et al. (2015) identified significant correlation between social 
support and SI in OSA patients with comorbid insomnia. In line with their findings, 
most subjects in our study had a partner, were employed and had relatively high 
education. However, the patients in our study were observed to have higher mean 
scores for social support (63.11±13.48) compared to the mean score of 44.38±7.81 
found by Choi et al. (2015) using the Multidimensional Scale of Perceived Social 
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Support. Another possible explanation may be that discrepancies in the results 
were caused by the different statistical methods used. 
Strengths and limitations 
To our knowledge, this is one of the first studies examining OSA severity, sleep-
related problems, social support and SI in a rarely studied population of OSA 
patients using structural equation modelling (SEM). Another strength is that the 
patients in our sample were diagnosed by means of polysomnography, which is 
considered the criterion standard for diagnosing OSA and determining the sever-
ity of the disease. However, in interpreting our data one has to consider certain 
limitations. Firstly, the diagnosis of OSA was stated based on a single sleepover. 
Secondly, no formal psychiatric diagnosis of SI was established, but on the other 
hand the GHQ-28 items are frequently used to assess the presence of SI in vari-
ous populations (Hamilton and Schweitzer 2000; Gili‐Planas et al., 2001; Watson 
et al., 2001; Romeo et al., 2013; Kawabe et al., 2016). Furthermore, it should be 
noted that the four-item GHQ-28 SI subscale has shown good concurrent valid-
ity with Beck’s Suicide Intent Scale (Watson et al., 2001). Different cut-off values 
of the GHQ-28 SI subscale were used in some previous studies (Gili-Planas et al., 
2001; Biddle et al., 2004). In our study we set the cut-off value of SI≥2, considering 
this threshold to be a good representation of the clinical picture (Goldberg, et al. 
1998). Another limitation to be mentioned is gender bias. In our sample 68% of the 
OSA patients were men; thus, our results may be less generalizable to the female 
population. However, the number of participants in our study is consistent with the 
man-to-woman ratio in OSA (3:1). Finally, the cross-sectional nature of this study 
does not allow firm conclusions about causality in the relationships between the 
variables. Nevertheless, it has been argued that SEM methods may offer the poten-
tial for tentative causal effects to be drawn when used with specified and controlled 
designs (Bullock et al., 1994). 
Implications for practice and future research
This study shows that disturbed night-time sleep quality and fatigue are directly 
related to SI. Our findings, if confirmed in longitudinal studies, may highlight the 
necessity of monitoring SI in OSA patients during clinical care. Intervention stud-
ies may be helpful in determining whether the continuous positive airway pressure 
(CPAP) treatment is effective in reducing the level of SI via reduction of fatigue, 
although the results of previous research are less encouraging, indicating that OSA 
patients suffering from psychological distress have poor compliance with CPAP 
treatment (Kjelsberg et al. 2005; Hussain et al., 2014), which means that the role 
of compliance bias should additionally be considered. Next, in research and clinical 
practice, symptoms common to OSA and depressive symptomatology such as day-
time sleepiness and fatigue represent obstacles in determining the presence, cau-
sality and severity of one condition in the presence of the other (Harris et al., 2009). 
As such, severe fatigue can contribute to longer and more severe depression, or 
vice versa, fatigue may be aggravated by depressive symptomatology (Carney et al., 
2014), and therefore the presence of reverse causality should be examined in OSA 
patients. However, the latter pattern may be more applicable to the general popu-
lation than to OSA patients, as previous longitudinal studies defined OSA and its 
symptoms as risk factors for psychological distress. In particular, sleep fragmen-
tation was identified as a primary cause of daytime sleepiness and fatigue in OSA 
patients, which is assumed to result in depressive symptomatology (Schröder and 
O’Hara, 2005). 
Due to a lack of general consensus regarding the CPAP treatment effects on 
self-reported health outcomes such as functional status or quality of life in peo-
ple with OSA (e.g. Weaver, 2013), current research and clinical practice should 
focus not just on treating OSA, but also on ensuring that the symptoms such as 
poor night-time sleep quality, fatigue or daytime sleepiness as well as depression 
and anxiety are managed. Based on the strong relationship between poor sleep 
quality, fatigue and SI, clinicians should consider investigating SI in people with 
sleep-related disorders. Furthermore, SI may suddenly lead to suicidal behaviour 
(Simon, 2014; Du et al., 2017), while across all countries, 60% of transitions from 
ideation to plan and attempt occur within the first year after ideation onset (Nock 
et al., 2008). This may be dangerous, especially for people with undiagnosed and 
untreated OSA. SI may be largely preventable (Stanley and Brown, 2012; Simon, 
2014) through early detection. However, sleep disorders including OSA are very 
rarely assessed on a regular basis in patients suffering from psychological distress. 
This is of particular importance, as adjunct treatment for symptoms of depression 
such as sedative-hypnotics may exacerbate OSA (Pagel and Parnes, 2001). Another 
source of concern is that OSA patients with depressive symptomatology and/or fa-
tigue may suffer from reduced activity and consequently may have poor motivation 
to visit hospital, get a diagnosis and receive appropriate OSA treatment. Thus, it 
may be beneficial to detect undiagnosed OSA in psychological and psychiatric care 
with simple and economical screening tools. Disturbed night-time sleep quality is 
largely modifiable through medication or behavioural interventions. The education 
of people with OSA on basic sleep hygiene may improve the quality of sleep and 
decrease fatigue. With a larger sample and a longitudinal design, the relationships 
should be further unveiled.  
Conclusion
The prevalence of SI in OSA patients was found to be 20.1%. Poor night-time sleep 
quality and fatigue were strongly related to SI. Social support was not significantly 
related to SI. Our findings emphasize the necessity of monitoring SI in OSA pa-
tients during clinical care. Longitudinal research is needed as a source of better 
understanding of the pathways between OSA severity, sleep-related problems so-
cial support and SI in OSA patients, as this may contribute to better disease man-
agement. 
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“No one in my family, not one of 
my friends ..realized that 
I was going through life asleep...
My body had no more feeling 
than a drowned corpse. My very 
existence, my life in the world, 
seemed like a hallucination. 
A strong wind would make me think 
my body was about to be blown 
to the end of the earth, to some 
land I had never seen or heard 
of, where my mind and body would 
separate forever. 'Hold tight,' 
I would tell myself, but there was 
nothing for me to hold on to.”
Haruki MURAKAMI
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Abstract 
B a c k g ro un d  a n d  a i m
Social support and mastery are important aspects in the treatment of chronic dis-
eases, however their role in connection with Obstructive Sleep Apnoea (OSA) re-
mains unclear. The purpose of this study was to examine the associations between 
social support, mastery, sleep-related problems and functional status in untreated 
patients with OSA and to assess the mediating role of social support and mastery 
in the association between sleep-related problems and functional status in patients 
with OSA. 
Me t h o d s
All patients completed the Multidimensional Scale of Perceived Social Support, the 
Pearlin Mastery Scale, the Pittsburgh Sleep Quality Index, the Epworth Sleepiness 
Scale and the Functional Outcomes of Sleep Questionnaire. Multiple linear regres-
sion and mediation analyses were used to analyse the data. 
R e su l t s
Participants were 150 newly diagnosed OSA patients (Apnoea-Hypopnoea Index–
AHI≥5; 68% male; mean age 48.9±9.5 years). Compared with social support, 
mastery was more strongly associated with functional status. Moreover, mastery 
mediated the association between sleep-related problems and functional status. 
The direct effects of sleep-related problems on functional status varied between 
76.7% and 82.3%, whereas the indirect effects via mastery varied between 17.7% 
and 23.3%.  
C o n c l u s i o n s
Supporting OSA patients’ sense of mastery over one’s life and circumstances may 
significantly contribute to better disease management. 
Introduction
Obstructive Sleep Apnoea (OSA) is an incapacitating chronic disease caused by 
pharyngeal collapse during sleep (Manarino et al., 2012). OSA, along with insom-
nia, is considered to be one of the most common sleep disorders in adults, with 
an estimated prevalence of 2–10% (Leger et al., 2012), and is related to higher all-
cause mortality (Marshall et al., 2008). OSA has been shown to be associated with 
night-time sleep disturbance (Krakow et al., 2015; Tippin et al., 2016) and daytime 
sleepiness (Antic et al., 2011). These disabling symptoms pose multiple challenges 
for functional status in patients with OSA (Weaver et al., 2007), with a larger ef-
fect in females (Chervin, 2000; Quintana-Gallego et al., 2004; Silva et al., 2016; 
Boccabella and Malouf, 2017). Recent studies have also emphasized the importance 
of studying patients’ functional status in sleep medicine research, because of its 
ability to provide insights which may go beyond the pathophysiology of commonly 
investigated OSA-related symptoms (Boccabella and Malouf, 2017).
Despite the acceptance of continuous positive airway pressure (CPAP) as a 
standard OSA treatment, there is a lack of consensus regarding the CPAP treatment 
effect on functional status in patients with OSA. Several studies have concluded that 
patients with OSA, even with a good CPAP treatment adherence, do not achieve 
normal functional status (Weaver et al., 2007; Reishtein et al., 2010; Weaver, 2013; 
Tippin et al., 2016) when compared to the general population. This suggests that 
other key factors may play a role (Reishtein et al., 2010). Moreover, personalization 
of the OSA treatment (Hesselbacher et al., 2014), which includes overall evaluation 
of functional status and the psychosocial aspects of disease, becomes more impor-
tant in current clinical practice (Boccabella and Malouf, 2017). 
Social support may be one of the essential, though under-investigated, protec-
tive factors associated with healthier sleep and better functional status in people 
with OSA (Günbey and Karabulut, 2014). There are several plausible pathways 
which may link social support with sleep, including protecting against social isola-
tion, attenuating stress responses, encouraging healthy sleep behaviours, and en-
training circadian rhythms (Troxel et al., 2010). Patients with OSA may experience 
lower levels of social support compared to other populations with chronic diseases. 
A study by Glenn et al. (2015) revealed an association between a low level of social 
support and the presence of sleep disordered breathing symptoms. Poor social sup-
port was also found to be independently associated with short sleep duration when 
controlled for sociodemographic variables (Glenn et al., 2015). Moreover, partners 
of patients with OSA also described their relationship as adversely affected by their 
partners’ OSA symptomatology (Luyster et al., 2016). Lack of social support has 
a significant impact on health-related behaviour and risk of illness (Reblin and 
Uchino, 2008; Alemi et al., 2003). Moreover, lack of social support was associated 
with poorer self-rated health in patients with acute myocardial infarction (Bucholz 
et al., 2014) chronic arthritis pain (Lee et al., 2016), multiple sclerosis (Krokavcova 
et al., 2008a) and depression (Liu et al., 2016). Social support also had a posi-
tive influence on sleep in people with insomnia (Troxel et al., 2010). Although it 
has been posited that social support may be a key indicator of how patients with 
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OSA manage their disease (Günbey and Karabulut, 2014), to date only one study 
(Choi et al., 2015) has been performed regarding social support in the association 
with health outcomes in patients with OSA. Social support was also found to have 
a positive effect on CPAP treatment adherence (Luyster et al., 2016). Insufficient 
emotional (e.g., encouragement) and instrumental (e.g. help with putting on mask, 
verbal reminders) support from partners of OSA patients was identified as a barrier 
for adherence with CPAP treatment (Luyster et al., 2016).
As patients with OSA have very little control over the symptoms of their disease 
and have to learn how to live with it, mastery may help them to reduce the stress 
that breathing, and sleep-related symptoms bring about, and may thus improve 
their functional status (De Ridder and Schreurs, 2001). According to Pearlin and 
Schooler (1978), mastery is defined as a general sense of control over one’s life and 
circumstances. In line with this, a diminished sense of mastery was associated with a 
decrease in overall functional ability (Kempen et al., 2006), physical, mental and so-
cial functioning (Krokavcova et al., 2008b; Sloan et al., 2009), and with increased 
mortality rates (Surtees et al., 2006) in patients with various chronic conditions 
or the general population (Tang, 2009). In older people a greater sense of mas-
tery was found to be associated with seeking treatment at an early stage of disease 
and more efficient use of healthcare services (Menec and Chipperfield, 1997). In 
OSA patients with comorbid insomnia, the positive associations between mastery 
and both physical and mental quality of life remained significant even after adjust-
ment for age, obesity, chronic diseases, erectile dysfunction, sleepiness, mood and 
financial strain (Lang et al., 2016). It has also been suggested that the relationship 
between social support and mastery may be reciprocal, and that higher levels of 
mastery may help to facilitate needed social support, while greater perceived social 
support may lead to greater feeling of mastery over one’s life and circumstances 
(Green and Rodgers, 2001).
Sleep-related problems are associated with functional status in patients with 
chronic conditions (Kim et al., 2015), including OSA (Boccabella and Malouf, 
2017). Previous studies have shown that sleep disruption (Mermigkis et al., 2009) 
poor sleep quality and daytime sleepiness (Lau et al., 2013) were associated with im-
paired functional status in patients with idiopathic pulmonary fibrosis (Mermigkis 
et al., 2009) and OSA (Lau et al., 2013). Research and clinical practice should 
therefore focus not only on treating OSA, but also on ensuring that all OSA-related 
symptoms, including sleep related problems, are managed adequately. To achieve 
this, we first need to understand how these symptoms and constructs relate to func-
tioning in untreated patients with OSA.
Patients with OSA are known to have a high level of sleep-related problems; 
in contrast, the role of social support and mastery in the association between poor 
sleep quality, daytime sleepiness and functional status is less clear. Therefore, the 
purpose of this study was to examine the associations between social support, mas-
tery, sleep-related problems and functional status in untreated patients with OSA, 
and to assess the mediating role of social support and mastery in the association 
between sleep-related problems and functional status in patients with OSA. 
Methods
Sample and procedure
This cross-sectional study was conducted at the Department of the Department 
of Pneumology and Phtiseology, L. Pasteur University Hospital and the Medical 
Faculty of PJ Safarik University in Kosice, Slovak Republic. All patients who visited 
the Department for one-night polysomnography (PSG) between July 2013 and June 
2016 and underwent PSG were eligible for the study. Indication for PSG was based 
on a general practitioner referral form. OSA was diagnosed based on an overnight 
sleep examination. Only patients with OSA between 18 and 65 years of age were 
included due to possible functional changes, increased vulnerability and decline in 
abilities and performance related to age. The study sample comprised patients with 
an Apnoea Hypopnoea Index (AHI; number of apnoeas+ hypopnoeas per hour of 
sleep) score of 5 or more (American Academy of Sleep Medicine, 2005) who had no 
previous continuous positive airway pressure (CPAP) therapy or other OSA treat-
ment, were Slovak-speaking and had no major comorbidities. Out of 263 eligible 
patients, 41 patients who underwent PSG refused to participate in the study, yield-
ing a total response of 84.0%. Another 72 were excluded because of major comor-
bidities. The reasons for exclusion were major comorbidities related to sleep (co-
existing sleep disorder such as insomnia, narcolepsy, or circadian rhythm sleep dis-
order); major cardiovascular diseases (e.g. myocardial infarction, angina pectoris; 
primary pulmonary hypertension); pulmonary conditions (e.g. chronic obstructive 
pulmonary disease; Pickwick syndrome); and a history of cancer in the past twelve 
months. Neurological and psychological comorbidities included neurological con-
dition (e.g. stroke, epilepsy); major psychiatric diagnosis (e.g. psychotic disorders, 
major depression) in the medical record, and/or current usage of psychiatric medi-
cations which may affect cognitive functions (e.g. benzodiazepine, antipsychotics 
or antidepressants); drug abuse in the past six months, and regular shift work in the 
past six months. Due to assessment of health outcomes related to sexual function-
ing, we excluded patients with diabetes and those using hypotensive medication, 
which may affect sexual functioning (following Hoekema et al., 2007). Screening 
for comorbidities was based on medical data and an initial clinical interview prior to 
data collection. The clinical diagnoses were established according to the standard 
International Classification of Diseases-10 revision Codes. Medical examinations 
of patients were conducted by a pulmonologist specialized in sleep-disordered 
breathing. Patients with non-respiratory sleep-related complaints (e.g. narcolepsy, 
insomnia) were routinely referred to another group of clinical specialists. The invi-
tation letter, the informed consent and the questionnaires were sent to participants 
by postal mail three weeks before the medical examination. One week before the 
medical examination, patients were reminded about the questionnaires by phone 
call. Patients filled in self-report questionnaires at home.
To maintain ethical principles with regard to the participants, we explained 
the purpose of the study and guaranteed confidentiality. We also explained that the 
collected data would only be used for the purposes of this research. Each patient 
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completed and signed an informed consent form prior to their participation in the 
study, which was fully voluntary and included no incentives for participation. The 
study was approved by the Ethics Committee of PJ Safarik University in Kosice (ap-
proval no. 115/2011). 
Measures
Functional status
Functional status was assessed using the Functional Outcomes of Sleep 
Questionnaire (FOSQ). (Weaver et al., 1997). The FOSQ is a 30-item self-report, 
disease-specific measure designed to assess the impact of sleep disorders or exces-
sive daytime sleepiness on multiple activities of daily living. The FOSQ has five sub-
scales: activity level, vigilance, intimacy and sexual relationships, general produc-
tivity, and social outcomes. Responses are averaged (excluding missing responses) 
to create a subscale score of 1 to 4, and then subscale scores are summed for the 
total score (5-20), with higher scores indicating less effect of sleepiness on daily life 
(Billings et al., 2014). In our sample, Cronbach’s alpha was 0.90 for the total scale, 
0.90 for the activity level, 0.84 for vigilance, 0.95 for intimacy and sexual relation-
ships, 0.90 for the general productivity subscale and 0.82 for the social outcomes 
subscale.
Social support
The Multidimensional Scale of Perceived Social Support (MSPSS) is a 12-item self-
report measure of social support (Zimet et al., 1988). It uses a seven-point Likert-
type scale, with scores ranging from ‘very strongly disagree’ (1) to ‘very strongly 
agree’ (7), so the total score ranges from 12 to 84, with higher scores indicating 
greater social support (Zimet et al., 1988). The MSPSS has three subscales: signifi-
cant others, family and friends. In our sample, Cronbach´s alpha was 0.90 for all 
three separate subscales. Cronbach’s alpha of the total scale was 0.94.  
Mastery
Mastery was measured using the Pearlin Mastery Scale (PMS) (Perlin and Schooler, 
1978). The PMS measures an individual’s level of mastery, a psychological resource 
that has been defined as “the extent to which one regards one’s life-chances as be-
ing under one’s own control in contrast to being fatalistically ruled” (Perlin and 
Schooler, 1978).  The scale includes 7 items (five negatively-worded items and two 
positively-worded items), e.g. “You have little control over the things that happen 
to you”, and “What happens to you in the future mostly depends upon you”. The 
negatively-worded items require reverse coding prior to scoring, resulting in a 
score range of 7 to 35, with higher scores indicating higher levels of mastery (Perlin 
and Schooler, 1978). Cronbach’s alpha of the total scale was 0.85. 
Sleep-related problems
Sleep-related problems concerned night-time sleep quality and daytime sleepiness. 
Night-time sleep quality was measured using the Pittsburgh Sleep Quality Index 
(PSQI) (Buysse et al., 1989). The PSQI is a self-rated questionnaire to assess sleep 
quality and disturbances over a one-month time interval. The PSQI consists of 19 
self-report questions which cover seven domains: subjective sleep quality, sleep 
latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep 
medication and daytime dysfunction. The score ranges from 0 to 21, with higher 
scores reflecting poor night-time sleep quality. A cut-off score of 5 separates good 
from poor sleepers (Buysse et al., 1989). Cronbach’s alpha in our sample was 0.85.
Daytime sleepiness was measured using the self-report Epworth Sleepiness 
Scale (ESS), an eight-item questionnaire assessing the tendency to fall asleep in 
various daytime scenarios (Miletin and Hanly, 2003). The score ranges from 0 to 
24, with higher scores indicating greater daytime sleepiness. An ESS total score 
greater than 10 indicates excessive daytime sleepiness (Miletin and Hanly, 2003). 
Cronbach’s alpha in our sample was 0.86. 
Sociodemographic and clinical data 
Information on age, gender and marital status was obtained from patient records. 
The Body Mass Index (BMI; height and weight) was assessed by a physician. BMI 
was used to sort patients into categories: underweight (<18.50), normal (18.50-
24.99), overweight (25.00-29.99) and obese (≥30.00). PSG was used to determine 
whether the diagnosis of OSA was present and to identify the severity of the disor-
der. PSG consists of a simultaneous recording of multiple physiological parameters 
related to sleep and wakefulness, which directly monitor and quantify the number 
of respiratory events, related hypoxemia and arousals. PSG consisted of the over-
night recording of left and right electrooculograms, standard central and occipital 
electroencephalogram, submental electromyogram (EMG), bilateral tibialis EMG, 
nasal and oral airflow using a thermistor and thoracic, and abdominal excursions 
using respiratory inductive plethysmography. OSA severity was determined using 
PSG and was based on an AHI (number of apnoeas + hypopnoeas per hour of sleep) 
score of 5 or more, according to standard criteria (American Academy of Sleep 
Medicine, 2005). According to this, OSA severity is mild (AHI≥5≤15), moderate 
(AHI>15≤30) or severe (AHI>30).
Statistical analyses
All analyses were performed using the Statistical Package for the Social Sciences 
(IBM SPSS 23) and MedGraph. Firstly, we described the background characteris-
tics of the sample and calculated means and standard deviations for functional status 
(FOSQ), social support (MSPSS), mastery (PMS), night-time sleep quality (PSQI), 
daytime sleepiness (ESS) and OSA severity (AHI) for the total sample and stratified 
by gender. T-tests were conducted to assess gender differences in the continuous 
variables. Differences in the categorical variables were analysed using Chi-square 
tests. Secondly, we investigated the bivariate correlations between all variables. 
Thirdly, multiple linear regressions were used to examine the associations between 
social support, mastery, sleep-related problems and functional status for the total 
scale and by subscales, controlled for sociodemographic and clinical variables. 
170 CHAPTER 7 171
Using regression analyses we firstly assessed the crude effects (i.e. associations 
unadjusted for the number of predictors) of each variable separately on functional 
status, and then we continued with multiple regression analyses. Multicollinearity 
was assessed using the variance inflation factor (VIF<2.0). We applied the enter 
method in linear regression to identify the factors associated with summary score of 
functional status in the total scale and in the subscales. For each factor, beta coef-
ficients represent the mean variation of functional status for the total scale and by 
subscales. The first model of the variables included sociodemographic data (age, 
gender, marital status). A second model included a clinical variable (OSA severity - 
measured by AHI), and a third model included night-time sleep quality and daytime 
sleepiness. Finally, in the fourth and fifth models, social support and mastery were 
included separately to assess the increase in the explained amount of total variance 
in functional status. 
Mediation analyses were used to assess the role of social support and mastery 
in the association between sleep-related problems and functional status. According 
to Baron and Kenny (1986), the following conditions must be met to establish me-
diation: the independent variable must affect the dependent variable; secondly, the 
independent variable must affect the mediator; and lastly, the mediator must affect 
the dependent variable. The proportion of the effect which is mediated was calcu-
lated as the indirect effect divided by the total effect and multiplied by 100, while the 
as-advised standardized total effect was at least ±0.2. The Sobel z-test was used to 
examine the mediating effects of social support and mastery on the association be-
tween sleep-related problems and functional status in patients with OSA. We used 
partial correlation analyses to assess the association between variables under study 
when controlled for age, gender, marital status and OSA severity. 
A p-value of <0.05 was considered statistically significant. Missing data were 
expressed as percentage of total number of patients for each variable. Power analy-
sis revealed that the statistical power for multivariate analyses exceeded 93%, with 
medium effect size at α=0.05. The statistical power for univariate analysis was 98%, 
with medium effect size at α=0.05 (Faul et al., 2009). 
Results
Sample characteristics 
The final sample consisted of 150 patients with OSA (AHI≥5). The mean age of par-
ticipants was 48.9±9.5 years. The majority of patients were male (68.0%), had sec-
ondary education (57.3%) and had a partner (76.0%). A total of 47.7% were obese 
and 49.3% had severe OSA. The mean score for functional status was 13.68±4.04. 
Female patients with OSA reported a significantly poorer level of perceived social 
support, greater sleep-related problems and poorer functional status compared 
with male patients with OSA (Table 7.1). 
Table 7.1 Baseline characteristics of the patients with OSA with AHI ≥ 5





Age in years; mean, sd 48.9±9.5 47.9±9.5 51.4±9.3 0.04*
Gender; male, N (%) 102 (68.0%) 102 (68.0%) 48 (32.0%) 
Education; N (%) 0.27
    Elementary 8 (5.3%) 4 (3.9%) 4 (8.3%)
    Secondary 86 (57.3%) 56 (54.9%) 30 (62.5%)
    University 56 (37.3%) 42 (41.2%) 14 (29.2%)
Marital status; single, N (%) 36 (24.0%) 26 (25.5%) 10 (20.8%) 0.53
Body Mass Index; mean, sd 30.2±7.7 30.1±7.4 30.6±8.2 0.73
Body Mass Index; N (%) 0.28
    Underweight (<18.50)   9 (6.0%) 4 (3.9%) 5 (10.4%)
    Normal (18.50-24.99) 42 (28.0%) 32 (31.4%) 10 (20.8%)
    Overweight (25.00-29.99) 32 (21.3%) 23 (22.5%)  9 (18.8%)
    Obese (>30.00) 67 (44.7%) 43 (42.2%) 24 (50.0%)
Apnoea Hypopnoea index; mean, sd 36.1±22.3 33.9±21.0 39.4±24.6 0.16
OSA severity; N (%) 0.41
     Mild (AHI≥5≤15) 23 (15.3%) 16 (15.7%) 7 (14.6%)
     Moderate (AHI>15≤30) 52 (34.7%) 38 (37.2%) 14 (29.2%)
     Severe (AHI>30) 74 (49.3%) 47 (46.1%) 27 (56.2%)
Night-time sleep quality; mean, sd (PSQI; 0-21) 9.7±4.1   9.2±4.0 10.7±4.1 0.03*
Excessive daytime sleepiness; mean, sd (ESS; 0-24) 11.0±5.3 10.2±4.9 12.5±5.8 0.01*
Perceived social support; mean, sd (MSPSS; 12-84) 62.9±13.5 63.6±12.6 62.0±15.3 0.50
     Perceived social support; family; mean, sd 21.2±5.4 21.4±5.2 20.8±5.8 0.50
     Perceived social support; friends; mean, sd 19.9±4.9 19.9±4.3 19.8±5.5 0.92
     Perceived social support; signif. other; mean, sd 22.0±5.1 22.3±4.7 21.4±5.4 0.31
Mastery; mean, sd (PMS; 7-35) 20.4±4.3 20.9±4.5 19.4±3.6 0.05
Functional status; mean, sd (FOSQ; 5-20) 13.7±4.0 14.5±3.9 11.8±4.2 0.001**
    Activity level  2.8±0.8   2.9±0.9   2.5±0.8 0.01*
    Vigilance  2.11±0.8   2.3±0.8   1.7±0.7 p<0.001***
    Intimacy and sexual relationships  2.6±1.3   2.8±1.1   2.1±1.4 p<0.001***
    General productivity  3.0±0.8   3.2±0.8   2.7±0.9 p<0.001***
    Social outcome  3.2±1.0   3.3±0.9   2.9±1.3  0.001**
OSA – Obstructive Sleep Apnoea; PSQI – Pittsburgh Sleep Quality Index; ESS – Epworth Sleepiness Scale; MSPSS – 
Multidimensional Scale of Perceived Social Support; SS – Social Support; PMS – Pearlin Mastery Scale; FOSQ – Functional 
Outcomes of Sleep Questionnaire; *p<0.05; **p<0.01; ***p<0.001. Missing values: OSA severity: (0.7%); age: (1%); ESS, PSQI (1%); 
MSPSS: (2.0%). 
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Correlations between the study variables 
Table 7.2 shows the correlations between the study variables. Poor social support, 
low level of mastery, poor night-time sleep quality and daytime sleepiness were sig-
nificantly correlated with functional status impairment in patients with OSA. 
Table 7.2 Correlations between age, gender, marital status, OSA severity, social sup-
port, mastery, night-time sleep quality and daytime sleepiness












Marital status -0.13 -
OSA severity 0.13 0.11 0.13 -
Social support 0.06 -0.07 -0.12 0.07 -
Mastery 0.07 -0.17* 0.08 -0.12 0.20** -
Night-time sleep quality 0.05 0.17* -0.09 0.19* -0.16* -0.28** -
Daytime sleepiness -0.00 0.21** 0.10 0.24** -0.14 -0.29*** 0.15* -
Functional status -0.05 -0.34*** -0.05 -0.35*** 0.26** 0.57*** -0.43*** -0.56***
Associations between social support, mastery, sleep-related problems and 
functional status (total scale)
Significant crude associations on functional status were found for gender (B: -2.68; 
95%CI= -4.07;-1.30; p<0.001), OSA severity (B: -0.06; 95%CI= -0.09; -0.03; 
p<0.001), sleep quality (B: -0.43; 95%CI= -0.58; -0.28; p<0.001), daytime sleepi-
ness (B: -0.43; 95%CI= -0.53; -0.33; p<0.001), social support (B: 0.08; 95%CI= 
0.03; 0.13; p<0.01), and mastery (B: 0.54; 95%CI= 0.42; 0.67; p<0.001) (Table 
7.3). In the subsequent multivariate models, the effects of gender, OSA severity and 
sleep-related problems on functional status were statistically significant (Model 1 - 
Model 3). The association between social support (B: 0.04; 95%CI= 0.01; 0.08; 
p<0.05) and functional status (Model 4) was no longer statistically significant (B: 
0.03; 95%CI= -0.00; 0.06; p=0.06) when mastery was added to the model (Model 
5). The association between mastery and functional status was strong (B: 0.33; 
95%CI= 0.22; 0.43; p<0.001), and the final model (Model 5) explained 62% of the 
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Associations between social support, mastery, sleep-related problems and 
functional status by subscale
Significant crude effects on all functional status subscales were found for social sup-
port, mastery, sleep quality and daytime sleepiness. Social support was significantly 
associated with intimacy-sexual relationships only, while mastery was associated 
with all functional status subscales in the final models (with an explained total vari-
ance of 38% for activity level, 48% for vigilance, 45% for intimacy-sexual relation-
ships, 63% for general productivity and 38% for social outcome). Sleep-related 
problems were associated with all functional status subscales in the final models, ex-
cept for the association between night-time sleep quality and vigilance (Table S7.4). 
Mediating effect of social support on the association between sleep-related 
problems and functional status 
No mediating role of social support was observed in the association between night-
time sleep quality and functional status (Sobel z-value=-1.55, p=0.12). 
Mediating effect of mastery on the association between sleep-related problems 
and functional status 
A significant partial mediating effect of mastery on the association between night-
time sleep quality (Sobel z-value= -3.202; p<0.001), daytime sleepiness (Sobel z-
value=-3.302; p<0.001) and functional status was found. Standardized coefficients 
showed that 17.7% of the total effect of night-time sleep quality (PSQI) on functional 
status was mediated by mastery (-0.08), and 82.3% of the total effect was direct 
(-0.35) (Figure 7.1). 
Figure 7.1 The mediating role of mastery in the association between night-time sleep 












Nighttime sleep quality (PSQI)
Outcome variable
Functional status (FOSQ)
PSQI – Night-time sleep quality; PMS – Pearlin Mastery Scale; FOSQ – Functional Outcomes of Sleep Questionnaire; **p<0.01; 
***p<0.001.
Further, standardized coefficients showed that 23.3% of the total effect of daytime 
sleepiness (ESS) on functional status was mediated by mastery (-0.13), and 76.7% of 
the total effect was direct (-0.43) (Figure 7.2).
Figure 7.2 The mediating role of mastery in the association between daytime sleepi-















ESS – Epworth Sleepiness Scale; PMS – Pearlin Mastery Scale; FOSQ – Functional Outcomes of Sleep Questionnaire; ***p<0.001.
Discussion 
Our results provide evidence that suggests that poor social support, low levels of 
mastery, poor night-time sleep quality and daytime sleepiness were associated with 
impaired functional status in patients with OSA. The association between social 
support and functional status was weak, and no longer significant when mastery 
was added to the model. Mastery was strongly associated with functional status. 
Furthermore, mastery mediated the association between sleep-related problems 
and functional status. 
We found a small but significant association between social support and func-
tional status in patients with OSA. Given the evidence that sleep disturbances may 
represent an important predictor of daytime functioning, including engagement in 
social activities (Dew et al., 1994), it may be hypothesized that in cases of extreme 
daytime sleepiness, the sources of social support may not be adequately utilized and 
thus may be of less importance. Furthermore, it is also plausible recent studies have 
suggested that sleep disturbances may lead to more negative perceptions of the so-
cial environment (Troxel et al., 2010). Previous research has shown that disturbed 
sleep in people with OSA and their partners was associated with mood swings and 
aggression which affected relationships in a negative way. Patients with OSA also 
had difficulties initiating new intimate relationships or friendships (Broström et al., 
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2007). In line with these assumptions, OSA symptoms were also associated with 
reduced social participation (Liu et al., 2016). Nevertheless, the subscale analyses 
in our study showed that social support was significantly associated only with one 
functional status subscale, i.e. intimacy-sexual relationships, while mastery was 
strongly associated with all functional status subscales. Thus, it may be assumed 
that mastery, together with social support, may improve intimate and sexual func-
tioning in patients with OSA. This may be crucial as better relationship quality was 
identified as being the most important need expressed by untreated patients with 
OSA (Broström et al., 2007).
Mastery was strongly associated with overall functional status and explained an 
additional 10% of the variance in functional status beyond the variance explained by 
sociodemographic, clinical, sleep-related variables and social support. Moreover, 
the association between social support and functional status was attenuated and 
no longer significant when mastery was added to the model. These results are in 
line with findings from studies of other incapacitating diseases (Krokavcova et al., 
2008b; Sloan et al., 2009; Raaijkmakers et al., 2014), including one preliminary 
study involving OSA patients with comorbid insomnia (Lang et al., 2016), where 
higher levels of mastery were associated with better self-rated health and quality 
of life.  As expected, our study identified a significant association between poor 
sleep quality, daytime sleepiness and consequent functional impairment in patients 
with OSA. Furthermore, mastery mediated the association between sleep-related 
problems and functional status. The associations between mastery, sleep-related 
problems, and functional status were statistically significant after controlling for 
sociodemographic variables and OSA severity. 
Our results suggest that adequate mastery may have the potential to dimin-
ish the negative effects of sleep-related problems on functional status. As patients 
with OSA were found to have reduced energy and activity levels (measured with 
the Functional Outcomes of Sleep Questionnaire-FOSQ) even after treatment with 
continuous positive airway pressure treatment (CPAP) (Lau et al., 2013), mastery 
may help in diminishing the negative effects of sleep-related symptoms on function-
al status. The establishment of new strategies for functional status improvement 
may be crucial in patients with OSA, as reduced general productivity, poor energy 
and impaired vigilance lead to work-related and vehicle accidents (Karimi et al., 
2013; Allen et al., 2016) and impaired work functioning in these patients (Mulgrew 
et al., 2007). Thus, greater levels of mastery may contribute to better functional 
status and better OSA management and treatment. 
Since OSA is diagnosed according to a cut-off score in the Apnoea-Hypopnoea 
Index (AHI), a logical assumption is that higher AHI indicates higher sleep-related 
problems. Previous research has shown that AHI does not correlate well with the 
presence or degree of daytime sleepiness (Bixler et al., 2005; Roure et al., 2008; 
Macey et al., 2010; Dündar et al., 2015), poor sleep quality (Kezirian et al., 2009; 
Macey et al., 2010), psychological symptomatology (Macey et al., 2010; Lau et al., 
2013; Rezaeitalab et al., 2014) or female sexuality (Hoekema et al., 2007). Moreover, 
contrary to the common belief, sleepy patients showed longer sleep duration and 
increased slow-wave sleep compared to non-sleepy patients with OSA (Roure at al., 
2008). In contrast, we found significant associations between AHI, sleep-related 
problems and functional status both in univariate as well as multivariate analyses. 
This profound role of OSA severity revealed in our study may occur due to lack of 
major comorbidities which are expected to influence sleep and affective symptoms 
(Macey et al., 2010). Also, unlike previous research, participants with regular shift 
works in the past six months were excluded from our study, which may strengthen 
the role of AHI. 
Additionally, our results reveal possible gender differences in the impact of 
OSA on functional status. We found that despite the absence of a significant differ-
ence in age, marital status, body mass index and AHI, newly-diagnosed female pa-
tients with OSA reported significantly greater sleep-related problems and function-
al status impairment when compared with male OSA patients. In previous studies, 
functional status and sleep quality were also more impaired in female OSA patients 
compared with male patients (Chervin, 2000; Quintana-Gallego et al., 2004; Ye 
et al., 2009; Silva et al., 2016) despite similarity in sociodemographic and clinical 
variables (Ye et al., 2009). This larger impact of OSA severity on health outcomes 
cannot be explained only by female gender per se (Chervin, 2000; Quintana-
Gallego et al., 2004); there are other attendant factors, for instance that women 
may be more often underdiagnosed regarding OSA when compared with men due 
to circumstances related to family lifestyle, sociocultural factors and different OSA 
clinical expressions (Chervin, 2000; Quintana-Gallego et al., 2004).
Strengths and limitations 
The strength of our study lies in the objective assessment of OSA using PSG. To 
our knowledge, this is the first study examining the ways in which social support 
and mastery are associated with functional status in patients with OSA. Some limi-
tations should be noted, however. Due to the cross-sectional design of our study, 
causal relationships cannot be established. In addition, in our sample 68% of the 
patients with OSA were men; thus, our results may be less generalizable to female 
patients with OSA. However, the number of participants in our study is consist-
ent with the man-to-woman ratio in OSA (3:1). Another limitation is the length of 
the questionnaires used, which may influence the data quality, especially in patients 
with sleep-related problems. This limitation was mitigated by our sending the ques-
tionnaires to the patients three weeks in advance by postal mail, so they had enough 
time to fill them in.
Implications for practice and future research
This study shows that social support, mastery and sleep-related problems are as-
sociated with functional status in patients with OSA, and that mastery may contrib-
ute to functional status improvement. As elimination of OSA symptoms with CPAP 
does not lead to complete restoration of daytime energy, subjective and objective 
sleepiness (Pack et al., 2001; Lau et al., 2013), and overall functional status (Weaver 
et al., 2007; Weaver, 2013; Tippin et al., 2016) in many adherent patients, present 
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research and clinical practice should focus not just on standard treatment of OSA, 
but also on functional status in these patients. In line with this, health care profes-
sionals should be aware of the possibility that interventions focusing on mastery 
enhancement may help improve functional status in patients with OSA. Mastery 
as a part of patient empowerment (Aujoulat et al., 2008) was also found to be as-
sociated with individuals’ capacity to make decisions about their health behaviour 
and to have or to take control over aspects of their lives that are related to health 
(McAllister et al., 2012). Moreover, as psychological resources associated with con-
trol over one’s life, such as self-efficacy (Baron et al., 2011) or internality (Wild et 
al., 2004), were found to contribute to CPAP treatment adherence, the role of mas-
tery may have a similar effect. 
As mastery is not considered as a fixed personality trait but as an adaptive self-
concept born of pivotal experience (Pearlin et al., 2007), education of patients with 
OSA, provided by psychologists or trained nurses focusing on personal empower-
ment for maintaining an adequate level of mastery in people affected by OSA, may 
be important. Mastery may also be improved by relaxation techniques (O’Brien et 
al., 2012), or by chronic disease management programmes which have been found 
to be effective in patients with pulmonary disease (Rea et al., 2004). Thus, health 
practitioners’ education about the role of mastery and counselling supporting mas-
tery for patients with OSA may be one of the important components of effective pa-
tient management. Additionally, we found that these interventions should be aimed 
especially at the group of female patients with a severe condition, who have higher 
probability of experiencing significant impairment in functional status. 
Research advancing our knowledge of protective factors to enhance functional 
status in patients with OSA may help to develop comprehensive multidiscipli-
nary strategies designed to improve self-management skills in patients with OSA. 
Further research should identify risk groups of patients with low mastery levels, so 
that counselling and interventions can be tailored to these patients. Future longi-
tudinal intervention studies targeting patients with OSA should be designed to cast 
more light on the causality in the associations between social support, mastery and 
functional status. We recommend that our study should be replicated with a larger 
sample and in a longitudinal setting. As mastery may reflect components of negative 
affectivity or neuroticism (Surtees et al., 2006), future studies should examine the 
associations between mastery and psychological symptomatology. Finally, future 
studies may verify the association between mastery and CPAP treatment adherence. 
General CPAP treatment adherence has been found to be poor (Aloia et al., 2004; 
Haniffa et al., 2004; Weaver and Grunstein, 2008) due to various reasons includ-
ing discomfort and feelings of claustrophobia due to the mask (Aloia et al., 2004), 
as well as other unspecified reasons (Haniffa et al., 2004). However, interventions 
to increase patients’ autonomous motivation (e.g self-efficacy) have demonstrated 
increased nightly use (Richards et al., 2007). Similarly, mastery is likely to increase 
patients’ autonomous motivation to manage their condition (Raaijmakers et al., 
2014), so it may be useful for improvement of CPAP treatment adherence.
Conclusion
While poor social support was weakly associated with impaired functional status in 
patients with OSA, we found a strong association between low mastery and impaired 
functional status. Mediation analysis showed that mastery may have the potential to di-
minish the negative effect of sleep-related problems on functional status. As support-
ing mastery of patients with OSA may play an important role in management of the 
condition, patients and health care professionals should learn more about the concept 
of mastery in connection with sleep-related problems and functional status. 
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"I've always loathed the 
necessity of sleep. 
Like death, it puts even 
the most powerful men on 
their backs." 
Frank UNDERWOOD
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Obstructive sleep apnoea (OSA) has been linked with the exacerbation of physi-
ological and psychological disturbances that not only contribute to decreased qual-
ity of life (QoL) (Bishop et al., 2018), and poor daytime functioning (Sharkey et al., 
2013; Aaronson et al., 2016), but also may be associated with increased suicide risk 
(Bishop, et al., 2018; Gupta and Jarosz, 2018). Therefore, OSA is recommended 
to be approached as a chronic disease requiring multidisciplinary managerial and 
treatment implications, including behavioural treatments (Epstein et al., 2009). The 
burden of this long-term chronic condition poses a challenge for health-care profes-
sionals, and for a successful management of OSA, bio-psycho-social factors need to 
be taken into consideration (Weaver, 2013; Vaske et al., 2017; Hilbert and Yaggi, 
2018). This thesis seeks to address the psycho-social factors that have been identified 
as key determinants in the adaptation to various chronic diseases but are less known 
in OSA yet. The thesis further aims to contribute to the understanding of the associa-
tions between biomedical factors and self-reported health outcomes in OSA patients 
that have been identified as ambivalent in previous research.  Section 8.1 summarizes 
the main findings of Chapters 3-7. The next section 8.2 provides a general overview 
and discussion of the main findings. The methodological considerations of the study 
are addressed in section 8.3. Finally, implications of the study for practice along with 
opportunities for future research are discussed in section 8.4. 
8.1   Main findings
Research question 1 (Chapter 3)
Has continuous positive airway pressure (CPAP) treatment a positive effect on 
quality of life (QoL) in OSA patients when compared to sham CPAP, placebo pills, 
and conservative treatment? 
Meta-analysis of 13 randomised controlled trials showed no significant differences 
in overall (0.18; 95%CI = 0.10, 0.26) and psychological QoL (0.25; 95%CI = -0.23, 
0.72) comparing values of CPAP treated patients with controls; however, physical 
QoL improved (0.20; 95%CI = 0.04, 0.35). Subgroup analyses and sensitivity anal-
yses showed that CPAP significantly affected the overall QoL in studies with controls 
receiving sham CPAP, parallel design, low risk of bias, and mild OSA patients.
Research question 2a (Chapter 4)
Are OSA severity, sleep-related problems, and anxiety associated with work func-
tioning in OSA patients when controlled for age, gender, and type of occupation? 
Impaired work functioning was reported by 82% of the OSA patients. A weak as-
sociation between OSA severity and impaired work functioning was found in the 
crude model that was no longer significant in the adjusted models. Multivariate 
analyses revealed that poor perceived sleep quality was more strongly associated 
with impaired work functioning than sleep efficiency and daily disturbances. We 
found no significant association between daytime sleepiness and work functioning. 
Anxiety was strongly associated with impaired work functioning (-0.61; 95%CI = 
-1.10, -0.15). After adding anxiety to age, gender, OSA severity, and night-time sleep 
quality, the explained variance of work functioning increased from 20% to 25%. 
Research question 2b (Chapter 4)
Does anxiety moderate the associations between sleep-related problems and work 
functioning? 
The moderating effect of anxiety on the association between overall night-time 
sleep quality and work functioning was especially strong in patients with better 
sleep quality, while the effect of anxiety on the association between overall night-
time sleep quality and work functioning was negligible in case of high sleep quality 
problems. Separate analyses of the three night-time sleep quality factors showed 
that anxiety moderated the associations between low and medium levels of per-
ceived sleep quality problems, daily disturbances and work functioning. No mod-
erating effect of anxiety on the association of sleep efficiency with work functioning 
was found.  
Research question 3a (Chapter 5)
Are hostility and coping self-efficacy associated with psychological distress in OSA 
patients when controlled for sociodemographic, clinical, and sleep-related vari-
ables? 
A high level of hostility and poor coping self-efficacy were strongly associated with 
psychological distress in OSA patients. In the regression models, hostility and the 
three coping self-efficacy dimensions, a) the ability to get support from family and 
friends, b) problem-focused coping self-efficacy, and c) coping self-efficacy for 
stopping unpleasant emotions and thoughts explained 5%, 4%, 8%, and 11% of the 
variance of psychological distress, respectively. 
Research question 3b (Chapter 5)
Does coping self-efficacy mediate the association between hostility and psychologi-
cal distress? 
All coping self-efficacy dimensions mediated the associations between hostility and 
psychological distress. The indirect effects of all three coping self-efficacy dimen-
sions were significant. They accounted for 10% of coping self-efficacy for getting 
support from family and friends, 15% of problem-focused coping self-efficacy, and 
17% of coping self-efficacy for stopping unpleasant emotions and thoughts.
Research question 4 (Chapter 6)
What is the prevalence of suicidal ideation in OSA patients? Are OSA severity, sleep-
related problems, and social support related to suicidal ideation in OSA patients? 
The prevalence of suicidal ideation in OSA patients was 20.1%. Patients reporting 
suicidal ideation scored higher on sleep-related problems compared to non-suicidal 
ideation patients. OSA severity was not directly related to suicidal ideation but the 
association was mediated by night-time sleep quality. Poor night-time sleep quality 
and fatigue were directly related to suicidal ideation; with fatigue most strongly re-
lated to suicidal ideation. Unexpectedly, the relationships between daytime sleepi-
ness, social support and suicidal ideation were not significant. Adjustment for age, 
gender, and marital status did not change the associations between social support, 
daytime sleepiness and suicidal ideation. 
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Research question 5a (Chapter 7)
Is there an association between social support, mastery, sleep-related problems and 
functional status in OSA patients when controlled for sociodemographic and clini-
cal variables?  
Social support was weakly associated with functional status in OSA patients and 
this association was no longer significant when mastery was added to the model. 
Mastery was strongly associated with functional status in OSA patients. We also 
identified significant associations between poor night-time sleep quality, daytime 
sleepiness and functional impairment. 
Research question 5b (Chapter 7)
Do social support and mastery mediate the association between sleep-related prob-
lems and functional status? 
No mediating role of social support was observed in the association between sleep-
related problems and functional status. Mastery, however, mediated the association 
between sleep-related problems and functional status. The direct effects of sleep-
related problems on functional status varied between 76.7% and 82.3%, whereas 
the indirect effects via mastery varied between 17.7% and 23.3%.  
8.2   Discussion of the main findings
This thesis focuses on the associations between bio-psycho-social factors and se-
lected aspects of self-reported health outcomes in OSA patients, i.e. quality of life, 
functional status, work functioning, and overall psychological distress — with par-
ticular interest in suicidal ideation. Our health model, the choice of examined con-
structs, and related measures were partially inspired by Wilson and Cleary (1995) 
and the bio-psycho-social approach as proposed by Engel (1978). The chosen 
health model stresses the presence of interactive, causal, and complex relationships 
between symptoms of the disease, functional status, general health perceptions, 
and overall QoL, as experienced by individuals (Wilson and Cleary 1995; Krabbe, 
2017). More detailed information about the used health model can be found in 
Chapter 1. 
Figure 8.1. Conceptual model of the associations between constructs examined in the thesis 
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8 . 2 .1   B i o m e d i c a l  a n d  p s y c h o l o g i c a l  f a c to r s  a n d  t h e i r  as s o -
c ia t i o n  w i t h  s e l f - re p o r te d  h ea l t h  o u tc o m e s  i n  o b s t r u c t i v e 
s l e e p  a p n o ea  p a t i e n t s
The examined OSA-related biomedical factors in this thesis concerned CPAP treat-
ment, OSA severity, and sleep-related problems – measured as night-time sleep 
quality, daytime sleepiness, and fatigue. Psychological factors in this thesis were 
operationalized as anxiety and hostility. Other important intra-individual psycho-
logical resources, considered as major features within the process of coping with 
chronic disease (Kempen et al., 1997), were defined as coping self-efficacy and 
sense of mastery over one’s life and circumstances.
Continuous positive airway pressure treatment and quality of life  
We identified no CPAP treatment effect on overall QoL in studies with a crossover 
design compared to a small but significant effect found in studies with a parallel 
design. This finding supports the results of prior research, as parallel-group trials 
were found to be more efficient at capturing the persistence of benefits from CPAP 
treatment (Richens, 2001; Jing et al., 2008). Subgroup analyses further showed 
that CPAP led to a small but significant improvement in overall QoL in studies 
with controls undergoing sham CPAP treatment, compared to negligible overall 
QoL improvement revealed in controls receiving placebo pills. This result is un-
expected, as sham CPAP treatment is supposed to worsen both sleep quality and 
gas exchange (Engleman et al., 1999; Sanner et al., 2000). A possible explanation 
may be that most studies that used placebo pills as control condition also had very 
small study samples. Moreover, all studies with placebo pills as control condition 
had a crossover design – identified as less sensitive in capturing the effect of CPAP 
treatment due to short wash-out periods which are not able to eliminate the effects 
of the first treatment (Richens, 2001). We also found significant QoL improvement 
in studies with mild OSA patients and low risk of bias. Thus, disease severity and 
level of low risk of bias may also be relevant when measuring the effect of CPAP 
treatment on QoL in OSA patients. 
In line with previous meta-analyses by Jing et al. (2008), we have further 
confirmed that CPAP treatment may help to improve physical symptoms of OSA, 
whereas impaired psychological QoL still cannot be alleviated. The suboptimal 
effect of CPAP treatment on psychological QoL may be explained by irreversible 
OSA-related brain injuries, confirmed by recent histopathological investigations of 
brain tissue autopsy in OSA patients (Owen et al., 2018). These neural alterations 
in OSA patients may contribute to the development of psychological symptomatol-
ogy (Huang et al., 2019), including mood (Peiffer et al., 2001), anxiety disorders 
(Milad 2007), and disturbed social functioning (Jack and Pelphrey, 2015). Owen 
and colleagues (2018) further suggest that myelin in OSA patients is impacted 
and not protected by CPAP treatment. Moreover, poor neuropsychological func-
tion and psychological symptoms may diminish adherence with CPAP treatment 
(Kushida, 2007; Hussain et al., 2014; Jackson et al., 2018). Thus, if the hypothesis 
on irreversible brain injuries and their contribution to psychological impairment in 
OSA patients can be confirmed, the next step is to better understand OSA-related 
psychological symptoms and to adopt appropriate psycho-social interventions in 
disease management. Another possible explanation for the lack of a CPAP treat-
ment effect on QoL is that there is no “perfect placebo” for CPAP and each ap-
proach has limitations and difficulties in blinding. For example, even a patient on 
sham CPAP treatment may be made aware of persisting snoring or observed ap-
noeas by a bed partner (Kushida et al., 2007). 
Finally, the results of our meta-analyses may also be explained by the relatively 
low CPAP compliance level (with the highest value of 5.0 hours per night) in the 
included studies. It is well known that CPAP adherence is often suboptimal and re-
mains persistently low over twenty years of reported data (Rotenberg et al., 2016b). 
Due to problematic adherence, the real effectiveness of CPAP may be poor, with a 
large proportion of users abandoning the machine within one year of prescription 
(Rotenberg et al., 2016a). These low rates of adherence consequently call into ques-
tion the status of CPAP as first line treatment for OSA (Rotenberg et al., 2016b). 
Moreover, the question of what level of CPAP yields optimal health outcomes and 
defines adherence has not yet been clearly established and varies between 4 and 7.5 
hours per night (Zimmerman et al., 2006; Weaver et al., 2007; Masa and Corral-
Peñafiel, 2014), while some patients are not able to achieve normal daily function-
ing or remain excessively sleepy despite optimal CPAP treatment (Weaver et al., 
2007; Antic et al., 2011; Jackson et al., 2018). The aforementioned findings may 
serve as a reminder that a “one size fits all” approach may not be appropriate in OSA 
and that decisions concerning the effectiveness of evaluation of CPAP treatment 
and its management need to be more individualized (Hilbert and Yaggi, 2018).   
OSA severity and self-reported health outcomes
Mostly weak and inconsistent associations between OSA severity and self-reported 
health outcomes were found. The missing association between OSA severity and 
subjective health outcomes may be related to the lack of adaptation to the hospital 
environment and the recording equipment during the first night of polysomnog-
raphy (PSG) assessment (Choi et al., 2015). We may further assume that this lack 
of adaptation may be especially significant in patients experiencing psychological 
distress. Therefore, issues such as abbreviated PSG monitoring, night-to-night 
variability, or the ‘‘first-night effect’’ of the PSG may partly explain the variability of 
OSA severity across different studies and outcomes (Punjabi, 2008). Furthermore, 
the Apnoea-Hypopnoea Index (AHI) does not capture the range of physiological 
variability related to adverse health outcomes of OSA, such as sleep fragmentation, 
degree of hypoxemia, or arousal threshold (Butler et al., 2019). All in all, consid-
ering the aforementioned problems, we believe that many controversies in the 
field of OSA may be caused due to the inability of AHI to measure the exact sever-
ity of the disease in a reliable and valid way (e.g. Asghari et al., 2012; Asghari and 
Mohammadi; 2013; Ryu et al., 2016). 
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Daytime sleepiness and work functioning
No significant association between daytime sleepiness and work functioning was 
found. We assume that the perception of subjective daytime sleepiness may be con-
founded by the patients´ habituation to the increased sleep fragmentation that may 
occur with the long duration of the untreated disease. Perhaps, daytime napping 
could also be a confounding factor in the expression of the symptoms of sleepiness, 
e.g. people with more flexible working hours may have more nap opportunities, 
when compared to people with fixed working hours. Sleepiness, further, represents 
an interaction of physiological systems that increase sleep tendency and other sys-
tems opposing sleep drive. These complemantary factors provide a dynamic equi-
librium that oscilates over the course of a day depending on homeostatis between 
sleep debt and circadian phase. Thus, it may be difficult to objectively assess the 
level of daytime sleepiness as it may inevitably vary during the day (Kushida, 2007; 
Hurdiel et al., 2018). Moreover, the levels of daytime sleepiness were found to be 
significantly influenced by a deterioration of the circadian rhythm, especially in 
OSA patients with poor sleep quality (Burioka et al., 2008; More et al., 2019). 
Other observations indicate that the Epworth Sleepiness Scale may be an unre-
liable screening tool for OSA (Al Houqani and Arora, 2019). Sleepiness is a subjec-
tive, physiological, and behavioural construct and this may lead to a certain amount 
of confusion in the discussion of its prevalence, mechanisms, and societal implica-
tions (Cappuccio et al., 2010). The subjective evaluation of daytime sleepiness is 
often complicated by the fact that patients may complain about a lack of energy, ex-
haustion, and tiredness, rather than sleepiness itself (Chervin, 2000; Sharkey et al., 
2013). Therefore, if OSA patients underestimate these symptoms, we recommend 
health care professionals to accompany self-reported measures of daytime sleepi-
ness by clinical judgement and objective assessment – using technological devices 
to monitor sleepiness and alertness with documented validity (e.g. Cappuccio et al., 
2010; Kaplan et al., 2018). 
Finally, the lack of an association between daytime sleepiness and work func-
tioning may be attributed to the hyperarousal theory, which links the symptoms of 
poor sleep quality and anxiety (Perlis et al., 2005). More specifically, both sleep-
disordered breathing and anxiety may be associated with waking or sleeping hy-
perarousal activity (Krakow, 2015). Thus, anxiety in OSA patients may develop into 
a chronic state of hypervigilance, which refers to being on high alert much more 
than normal. This arousal may ultimately lead to a state of chronic anxiety and may 
eventually obliterate the natural daytime sleepiness or cause sleeplessness (Perlis et 
al., 2005; Krakow, 2015). 
Night-time sleep quality and work functioning: the moderating role of anxiety 
One of the most interesting findings of the moderation analysis was that the role of 
anxiety in the association between sleep quality and work functioning was weak-
est in OSA patients with the highest levels of sleep quality problems. Moderation 
analyses revealed that high sleep quality problems may become more significant 
in the association with poor work functioning than anxiety, while the moderating 
effect of anxiety on work functioning may be especially profound in patients with 
better sleep quality. Thus, it can be assumed that in case of very poor night-time 
sleep quality, anxiety symptoms in OSA patients may become less dominant. An 
explanation may be that very poor sleep quality may cause fatigue, which may de-
crease the levels of (work-related) anxiety. Due to fatigue, OSA patients may have a 
lack of energy and may thus avoid work-related social interactions (e.g. Haack and 
Mullington, 2005), which are perceived by OSA-patients as stressful (Reishtein et 
al., 2006). Prior research showed that OSA patients may have difficulties to com-
plete work tasks and that they perceived a lack of trust from coworkers which led 
to embarrassment (Reishtein et al., 2006). Thus, it should be considered that an 
increased prevalence of anxiety as identified in our study may also be social or work-
related (e.g. adverse work environment, poor relationships at work) and not solely 
OSA-related. 
Although the Beck Anxiety Inventory (BAI) represents a reliable indicator of 
anxiety in primary care (Wetherell and Gatz, 2005; Muntingh et al., 2011), its focus 
on psychophysiological symptoms linked to panic disorder such as a racing heart or 
dizziness (Julian, 2011), should be considered when interpreting our results (Beck 
and Steer, 1991; Cox et al., 1996), including the relatively high prevalence of anxiety 
identified in our study. It seems that the mechanism of the association between sleep 
and anxiety in OSA is complicated, e.g. a previous study reported a higher anxiety 
dream incidence in OSA patients (Carrasco et al., 2006) and OSA-related snoring 
when compared to controls (de Groen et al., 1993). OSA also appears to confer a 
higher risk for future development of nocturnal panic attacks due to breathing-relat-
ed OSA symptoms (Edlund et al., 1991; Su et al., 2015), as well as somatic symptoms 
of anxiety such as excessive sweating, or nightmares (Wiersema et al., 2018). In light 
of these findings, it can be assumed that anxiety as measured in our study may be 
associated with psychophysiological symptomatology related to panic attacks, rather 
than with anxiety in general. As the BAI does not assess other aspects of anxiety, 
such as cognitive symptomatology, further research should include additional anxi-
ety measures to distinguish between symptoms linked to panic disorder and other 
anxiety disorders (e.g. generalized anxiety disorder) in OSA patients. 
Sleep-related problems and suicidal ideation 
We found that disturbed night-time sleep quality and fatigue were directly related 
to suicidal ideation. There is a large body of evidence showing that disrupted night-
time sleep quality may directly affect mental functioning in several ways including 
increased impulsivity, decreased executive functioning, and emotional exhaustion 
(Krakow et al., 2000; Weaver and George, 2011; Bernert et al., 2014) all of which 
may consequently diminish the capacity to inhibit suicidal ideation or behaviour 
(e.g. Malik et al., 2014). Notable is also the recent study by Bishop et al. (2018) 
which described that self-reported OSA was significantly associated with suicidal 
ideation and suicide planning, after controlling for key covariates such as depres-
sion, substance use disorders, and comorbid physical diseases. Nonetheless, sleep 
disturbances were not included in the recent suicide risk factor lists compiled by 
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the World Health Organization (2012). Therefore, the associations between dis-
turbed night-time sleep quality, fatigue, and suicidal ideation revealed in our study 
may provide an additional support for the importance of sleep-related problems in 
the course and development of suicidal ideation in OSA patients beyond major de-
pression (Krakow et al., 2011; Bishop et al., 2018), when confirmed in longitudinal 
studies. 
Several mechanisms may explain our findings. First, it seems that repeated 
OSA-related arousal during sleep may exacerbate suicidality through the effects on 
night-time sleep quality (e.g. Krakow et al., 2000; Tseng et al., 2018). Second, the 
theory of entrapment may apply. Entrapment represents a core component of the 
psychological mechanisms underlying suicidal ideation. The term entrapment is 
derived from the concept of ‘‘arrested flight,’’ whereby a powerful motivation to es-
cape from a situation, driven by threat-related psychobiological systems, is blocked 
(Gilbert and Allan, 1998). As poor sleep quality was found to alter the association 
between pre-sleep entrapment and awakening suicidal ideation (Littlewood et al., 
2019), OSA patients may represent a group endangerd by suicide. Moreover, OSA 
may lead to a low perception of control over the disease and its symptoms, which 
may potentiate the feeling of entrapment. Sleep may further be seen as an alterna-
tive way to escape these perceptions of entrapment. The potential downside to this 
occurs when people start ‘escaping’ via daytime napping, because this can disrupt 
night-time sleep. Subsequently, this behaviour may reinforce the disturbed sleep 
patterns, which in turn contribute to increased suicidal ideation and behaviours 
(Littlewood et al., 2016). Furthermore, if the hypothesis on the ‘escaping’ via sleep 
in the daytime is valid, it may be used as a possible explanation for the lack of the 
significant association between daytime sleepiness and suicidal ideation. Finally, 
the lack of an association between daytime sleepiness and suicidal ideation can be 
explained by the conceptual difference between fatigue and sleepiness. More spe-
cifically, daytime sleepiness can be defined as drive for sleep while fatigue can be 
described as drive for rest. Fatigue was also found to be strongly associated with 
psychological symptoms (Harvey et al., 2009) and involves neurastenic qualities 
(Kushida, 2007) and thus may better reflect the presence of psychological distress, 
including SI, when compared to daytime sleepiness. 
Hostility and psychological distress: the mediating effect of coping self-efficacy
All assessed coping self-efficacy dimensions mediated the association between hos-
tility and psychological distress. The coping self-efficacy for stopping unpleasant 
emotions and thoughts was the most adaptive strategy in attenuating the association 
between hostility and psychological distress. An explanation why coping self-effica-
cy for stopping unpleasant emotions and thoughts may be most adaptive in OSA pa-
tients is that they have very little control over the symptoms of their disease. When 
patients lack the ability to control disease-related symptoms and need to learn how 
to manage them, the avoidance-oriented coping strategies may help them to dimin-
ish the level of psychological distress (e.g. De Ridder and Schreurs 2001; Mikula et 
al., 2014). Furthermore, our results corroborate with previous studies showing that 
hostile individuals were more likely to employ escape-avoidance coping styles to 
handle psychological distress (Vandervoort, 2006). All in all, our findings support 
the hypothesis that healthy emotion-regulation may not merely be about using the 
“right” problem focused strategies (Haines et al. 2016) and that coping can dimin-
ish psychological distress only when used in appropriate contexts (Bonanno and 
Burton, 2013; Haines et al. 2016). 
However, our findings coincide with previous research among OSA patients. 
Two former studies (Bardwell et al., 2001; Gassara et al., 2017) concluded that the 
more active coping strategies reported by OSA patients, the lower the level of de-
pressive symptoms they experienced. A possible explanation for the inconsistency 
with our findings may be the difference in OSA diagnosis criteria (Bardwell et al., 
2001) and different measurements of coping and psychological symptomatology 
(Bardwell et al., 2001; Gassara et al., 2017). Recent studies also identified active 
coping processes as potential behavioural intervention targets to promote CPAP 
use (Dieltjens et al., 2013; Saconi et al., 2018), while passive coping was signifi-
cantly associated with poor adherence with treatment. Thus, it may be assumed that 
during the solution-oriented CPAP treatment process, active coping strategies may 
become more useful when compared with passive-oriented coping. Therefore, an 
important issue to resolve in future research is the role of the different coping self-
efficacy dimensions in the management of CPAP treatment. 
Sleep-related problems and functional status: the mediating role of mastery 
Mastery over one’s life and circumstances was significantly associated with all func-
tional status subscales in terms of activity level, vigilance, general productivity, so-
cial outcomes, and intimate and sexual relationships. Our findings are in line with 
previous studies showing that mastery was found to facilitate QoL, psychological 
well-being, and adaptation under stressful situations, including medical events 
(Kempen et al., 1997; Lang et al., 2016).  Furthermore, when looking at the me-
diating effect of mastery on the association between sleep-related problems and 
functional status, we found that mastery mediated the association between night-
time sleep quality, daytime sleepiness and functional status. As OSA patients were 
found to experience reduced energy and activity levels even after treatment with 
CPAP (Lau et al. 2013; Weaver, 2013) with optimal compliance (Antic et al., 2011; 
Jackson et al., 2018), adequate mastery may help in diminishing the negative ef-
fects of sleep-related symptoms on functional status. As mastery is not considered 
a stable element of personality but is understood as a personal resource that may 
evolve and change over the lifespan in response to circumstances and interventions 
(Pearlin et al., 2007; Zautra et al., 2012), the development of new strategies for the 
improvement of mastery may be beneficial. 
8 . 2 . 2   S o c ia l  f a c to r s  a n d  s e l f - re p o r te d  h ea l t h  o u tc o m e s 
It is now generally accepted that health and illness are not only the result of an inter-
action between biological and psychological factors, but also social factors (Haslam 
et al., 2018). The impact of OSA is significant and the disease does not only affect 
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physical and psychological health but the whole person in the context of his or her 
social life. OSA itself may cause changes in the social envinronment which may in-
evitably affect health outcomes of the individual. In this thesis, we were particularly 
interested in the associations between social support (measured as perceived social 
support) and health-related outcomes (assessed as functional status and suicidal 
ideation).  
Social support and functional status 
We identified only a weak association between social support and overall functional 
status in OSA patients. Still, we found that social support was strongly associated 
with one functional status subscale, i.e. intimacy-sexual relationships. Beyond the 
increasing interest in the associations between sleep disorders and a couple’s inti-
mate relationships, some specific consequences of OSA such as the high incidence 
of erectile dysfunction (Schulz et al., 2019), or experienced sexual dysfunction in 
female OSA patients (Yilmaz et al., 2017) make the investigation of intimate re-
lationships worthwhile. The role of social support in couples may be significant, 
since relationship satisfaction represents a relevant variable in enhancing the QoL 
and helps to diminish psychological distress in OSA patients (Baron et al., 2009). 
Moreover, improving intimate relationships may be crucial as better relationship 
quality was identified as being the most important need expressed by untreated 
OSA patients (Broström et al., 2007). 
Social support and suicidal ideation 
The importance of social support was consistently described across multiple 
theories of suicidal behaviour. The sociological theory of suicide (Durkheim and 
Simpson, 1951), the psychache theory of suicide (Shneidman, 1993), the arrested 
flight model (Williams, 2001), and the interpersonal-psychological theory of sui-
cide (Joiner, 2007; Mars et al., 2019) suggest that inadequate social support, lack of 
strong interpersonal relationships, and perception of low belonginess may increase 
the risk for suicidal ideation and suicidal attempts. Perception of social support was 
found to represent a protective factor for suicidal ideation and behaviours (Rowe et 
al., 2006). Surprisingly, we found only a weak, non-significant association between 
perceived social support and suicidal ideation in OSA patients. The lack of the asso-
ciation between social support and suicidal ideation in our study may be explained 
by the presence of severe sleep-related problems in OSA patients. In line with this 
hypothesis, individuals with severe sleep deprivation report being less sociable 
(Haack and Mullington, 2005). Previous research also showed that the association 
between perceived and received social support may be reciprocal and people who 
reported giving less social support also reported getting less support (Piferi et al., 
2006). Families of OSA patients also described their relationships and their overall 
QoL as negatively affected by OSA of their relatives or partners (Parish and Lyng 
2003; Brown, 2005; Luyster et al., 2016; Bergeron et al., 2017). Moreover, people 
may be less willing to interact with an extremely sleep-deprived person (Sundelin et 
al., 2017). Thus, it should be considered that in case of extreme sleep-related OSA 
symptoms, the sources of social support may be of less importance  as well as of less 
adequacy, which may reduce resilience and increase the risk of suicidal behaviour 
when difficulties are encountered. 
8 . 2 . 3   To wa rd s  a  b i o - p s y c h o - s o c ia l  a p p ro a c h  f o r  O S A 
“Macbeth does murder sleep, the innocent sleep,
Sleep that knits up the ravell’d sleeve of care,
The death of each day’ s life, sore labour’s bath,
Balm of hurt minds, great nature’s second course,
Chief nourisher in life’s feast”
William Shakespeare, Macbeth
The aforementioned findings of the lack of the CPAP treatment effect on overall and 
psychological QoL call into question the identification of factors that may help to 
improve impaired health outcomes in OSA patients. All in all, the studies presented 
in this thesis revealed that sleep-related problems, including night-time sleep qual-
ity, dayime sleepiness, and fatigue explained more variance in health outcomes, 
when compared to psychological or social factors. Thus, the treatment of sleep-
related problems should be recommended as a main practical tool for promoting 
mental health and daily functioning in OSA patients. 
This thesis also revealed that factors related to external resources such as self-
perceived social support and coping self-efficacy for the ability to get support from 
family and friends explained less variance in health outcomes when compared to in-
tra-individual psychological resources such as mastery and coping-self-efficacy for 
the ability to stop unpleasant emotions and thoughts and problem-focused coping. 
A possible explanation may be that sleep-related problems hamper social inter-
actions (Haack and Mullington, 2005; Cappuccio et al., 2010). Moreover, because 
of the tendency to disengage from stressful situations (e.g. Reishtein et al., 2006; 
Kang et al, 2018), interpersonal sensitivity (Kang et al, 2018), or negative feedback 
provided from patients´ relatives, partners (Parish and Lyng 2003; Brown, 2005; 
Schwarzer, 2014; Luyster et al., 2016; Bergeron et al., 2017; Sundelin et al., 2017), 
or co-workers (Reishtein et al., 2006), OSA patients may do little to improve their 
social interactions. Another reason why the social support may be insufficient is that 
the person is not able to cope in an adaptive manner. Paradoxically, those individu-
als who have valuable personal resources such as competence, high self-esteem, in-
ternal locus of control, and optimism were found to elicit a stronger tendency in 
others to provide social support. The expression of too much distress strains the 
social network, evokes negative reactions, and turns away those who would have 
been supportive (Schwarzer, 2014).
Negative feedback from others may further booster social inhibition and serve as 
precursor to social isolation and loneliness. Neuroimaging techniques also showed 
that loneliness may consequently lead to an increased level of hypervigilance to hostile 
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cues and a negative attitude towards others (Cacioppo et al., 2016). Moreover, higher 
levels of anxiety or hostility identified in OSA patients (Lau et al., 2014; Unal et al., 
2017; Wiersema et al., 2018) may be associated with a lack of ability to communicate 
with others (Perfect et al., 2013), social inhibition, social dysfunction (Sasaki and 
Yamasaki, 2002), and oppositional orientation towards others (Houston and Vavak, 
1991). Thus, it may be assumed that patients with OSA, identified as hostility-prone, 
may have even poorer motivation to participate in social activities. 
Nevertheless, we should also consider the ways in which the bio-psycho-social 
factors have the capacity to influence and restructure each other over time (Jull, 
2017; Haslam et al., 2018). Moreover, if the hypothesis based on the hyperarousal 
theory and the theory of entrapment can be confirmed, then the next step is to re-
veal whether a decrease in psychological distress with adequate treatment induces 
daytime sleepiness in OSA patients (Krakow et al., 2015).
We may also ask: “Are sleep problems only symptoms or also causes and con-
sequences of other OSA-related problems?” Shakespeare says it rather well: it may 
be all three. First, lack of sleep is a cause of distress and ill health. If we miss sleep, 
we miss the balm of hurt minds. Second, Macbeth’s distress murders sleep. Sleep 
disturbance is a consequence of the circumstances of people´s life. Third, Lady 
Macbeth’s heart is sorely charged and her sleep is disturbed. Sleep disturbance is a 
symptom of psychological distress or perhaps other disease. Moreover, these three 
domains – causes, consequences, and symptoms, can all interact. Sleep-related 
problems can not only be a result of disorder, but can in turn, cause other problems 
(Marmot, 2010). 
The abovementioned examples illustrate that the possibility of interaction be-
tween causes, consequences, and symptoms in the bio-psycho-social model must 
always be considered, as it is important to sort out which of the three is dominant, 
as interventions might differ (Marmot, 2010). All in all, failure to recognise the ‘flu-
idity’ in the bio-psycho-social model lessens the appreciation of the variety within, 
as well as the associations between its domains, and the relative importance of each 
factor in the individual patient at initial and progressive time points could have neg-
ative impact on disease management. Thus, the graphical presentation of the bio-
psycho-social factors as three mainly symmetrical areas can cause misleading infor-
mation or errors in the clinical reasoning (Haslam et al., 2018). Therefore, when 
interpreting our results, we need to consider the relative and variable contributions 
of each domain of the bio-psycho-social model to individual patients’ presentations 
over time (Jull, 2017; Haslam et al., 2018). 
Although the bio-psycho-social model has been successfully applied to obtain 
a better theoretical understanding of the causes of the disease and its processes, or 
for public health purposes (Alonso, 2004), unfortunately, it has not yet been in-
cluded in a model of medical practice (Wade and Halligan, 2017; Hadi et al., 2017). 
Nevertheless, as Engel (1978) pointed out, even though both patient and doctor may 
culturally adhere to the biomedical model, the patient’s needs and ultimate criteria 
for defining disease are always psycho-social, even when the health complaints are 
physical. Thus, despite many drawbacks related to greater knowledge, personnel, 
and time investment, which will probably continue to relegate the bio-psycho-so-
cial model to a secondary position in clinical practice (Wade and Halligan, 2017), 
the broadening of the health-care professionals’ knowledge of the importance of 
psychological and social aspects may be beneficial for the patient (Alonso, 2004). 
Moreover, if the findings of OSA-related biological mechanisms involved in the 
spread of brain injuries resistent to CPAP treatment (Owen et al., 2018) and their 
consequent contribution to psychological symptomatology in OSA patients (Huang 
et al., 2019) can be confirmed, the next step should definitely include the adoption 
of appropriate psycho-social interventions in disease management. 
8.3   Methodological considerations 
The strenghts and limitations of the studies are described in more detail in the sepa-
rate chapters of this thesis. A short synopsis of the main methodological considera-
tions is presented below. First, the quality of the study sample will be discussed. 
Second, the quality of the measuring instruments will be described. Finally, causal-
ity and confounding will be considered. 
8 . 3 .1   Q u a l i t y  o f  t h e  s a m p l e
A strength of the study is that it was based on a sample with a wide age range (25-65 
years) and a man-to-woman ratio of 3:1. Next, patients were diagnosed using PSG, 
which is considered the criterion standard for diagnosing OSA and determining 
disease severity. The indication for PSG was based on a general practitioner refer-
ral form while OSA was diagnosed based on an overnight sleep study carried out 
at a clinical laboratory. Medical examinations were carried out by a pulmonologist 
specialized in sleep-disordered breathing. To ensure that health outcomes were 
not influenced by major comorbidities such as stroke, comorbid sleep-disorders 
or diseases associated with the use of sedatives or hypnotics, we studied recently-
diagnosed, mild to severe OSA patients with minimal comorbidities, who had not 
started treatment. Only OSA patients between 18 and 65 years of age were included 
due to possible increased vulnerability, functional changes and a decline in abilities 
and/or performance related to age. We also excluded participants in shift work, 
due to the negative impact of shift work on QoL (Kaliterna et al., 2004), well-being 
(Nezamodini et al., 2014), mood, alertness (Cori et al., 2018), and quality of sleep 
(Nezamodini et al., 2014). Thus, the findings are not generalizable to the general 
working population including shift workers, only to workers with regular working 
time arrangements. It may be assumed that the results may be even worse when 
shift workers are included. It should further be noted, that our sample with minimal 
co-morbidities and recent diagnosis may be not fully representative of the general 
OSA population. Another major limitation concerns the small sample size. Finally, 
in our sample, the majority of OSA patients was male. Thus, the results may be less 
generalizable to female OSA patients. 
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8 . 3 . 2   Q u a l i t y  o f  t h e  m easur i n g  i n s t r um e n t s
Patients’ reported outcome measures (PROMS) increasingly accompany the tradi-
tional clinical way of measuring health and the effect of treatment in various chronic 
diseases (Weldring and Smith, 2013; Appleby et al., 2016), including OSA (Tam 
et al., 2014). A clear strenght of this thesis is that it aimed to get more insight into 
less known factors underlying adaptive functioning of OSA patients. To our best 
knowledge, this is the first time that the Work Role Functioning Questionnaire has 
been used in a sample of OSA patients. It is also the first study using the Pittsburgh 
Sleep Quality Inventory factor structure in an OSA population. Although we used 
valid and reliable measures of the relevant constructs, some limitations should be 
noted. A major limitation concerns that we used self-reported measures and no for-
mal psychiatric diagnosis of suicidal ideation or anxiety was established. Another 
limitation is that the OSA diagnosis was based on a single sleepover. Although a 
one-night PSG is sufficient for the diagnosis of OSA (Scholle et al., 2003; Gouveris 
et al., 2010), significant variability in the AHIs taken from two nights was revealed 
in OSA patients (Gouveris et al., 2010). Many studies have further shown that AHI 
may not be able to quantify the disease severity (e.g. Ryu et al., 2016) and complica-
tions such as clinical impact of OSA on self-reported health outcomes, including 
QoL (Moyer et al., 2001), or psychological distress (Asghari et al., 2012). Another 
source of concern may be the length of the used questionnaires, which may have 
influenced the data quality, especially in patients with sleep-related problems. To 
overcome this methodological limitation, the questionnaires were sent to the pa-
tients three weeks before the PSG examination by postal mail, so they had enough 
time to fill them in at home. 
8 . 3 . 3   C au s a l i t y  a n d  c o n f o un d i n g
Due to the cross-sectional design of the study, causal inferences cannot be made. 
Although we adjusted for key covariates that have consistently been associated with 
health outcomes in OSA patients, including sociodemographic and clinical vari-
ables; we did not adjust for all possible confounders. Thus, we cannot rule out the 
possibility of residual confounding that may account for the associations between 
the examined variables.
8.4   Implications 
In clinical sleep medicine, the focus has shifted from OSA diagnosis to OSA man-
agement, with the emergence of new, integrated models of care (Heatley et al., 
2013). Multidisciplinary OSA treatment can help to minimize fragmentation of care 
(Shelgikar et al., 2014), to improve the risk assessment for the consequences of un-
treated OSA, and can lead to better treatment strategies (Kapur, 2018). Results of 
this study may be helpful in identifying bio-psycho-social factors associated with 
poor health outcomes that can be modified by health care professionals and by the 
patients themselves.  
8 .4 .1   Im p l i c a t i o n s  f o r  c l i n i c a l  p ra c t i c e 
We found that medical treatment of OSA may help to improve physical symptoms 
of the disease, whereas existing psychological impairment still cannot be success-
fully alleviated. Therefore, the current research and clinical practice should focus 
not only on the standard treatment of OSA, but also on ensuring that psychological 
symptoms are efficiently managed. 
As impaired work functioning was reported by 82% of the OSA patients, em-
ployee assessment of their work functioning may be an important proxy for the 
health burden of OSA. There is also a need for workplace strategies that encourage 
behaviours and practices that may be helpful in reducing OSA-related symptoms 
and improve work functioning in OSA patients. Occupational health professionals 
may together with OSA patients find ways to address the specific work demands 
that are difficult to conduct. Management of unsatisfactory sleep through a variety 
of proven strategies, including naps, better management of work demands, regular 
exercise, duty hour considerations, and instruction on the basics of sleep hygiene 
including stimulating activities prior to bedtime, ingestions, and bedtime rituals 
(Jansson and Linton, 2006; Kushida, 2007) may be helpful. 
Further, our findings may enhance health care professionals’ understanding of 
the mental health problems in OSA patients. Health care professionals should keep 
in mind that OSA may not be immediately apparent but might present in an atypi-
cal fashion. The presence of some atypical psychological OSA-related symptoms 
revealed in this study, was also identified in previous research (Krakow et al., 2015; 
Choi et al., 2015; Unal et al., 2017) and may include anxiety, hostility, or suicidal 
ideation. A lack of knowledge regarding the heterogeneity of OSA‘s clinical pres-
entation may pose critical challenges to its clinical recognition, resulting in missed 
or delayed diagnosis. Moreover, the lag time between initial OSA symptoms and 
OSA diagnosis can vary widely, with the average duration from seven to ten years 
(Guilleminault et al., 1995; Rahaghi and Basner, 1999). People with atypical or less 
known OSA symptomatology may have had a longer lag time, leading to a longer 
duration of exposure to untreated OSA and, thus, a higher probability of develop-
ing comorbidities. All in all, primary care providers represent the key to successful 
case finding. Therefore, it is essential to promote an understanding of the signs and 
symptoms of OSA. Simple questions about key OSA symptoms such as snoring, 
witnessed nocturnal apnoeas, and sleep-related problems, together with questions 
about atypical psychological symptoms should become a routine component of the 
medical interview.
Health care professionals also have to be informed about the alarming preva-
lence’s of overall psychological distress (56.0%) and suicidal ideation (20.1%) 
in OSA patients. As suicidal ideation and behaviour may be largely preventable 
(Stanley and Brown, 2012; Simon, 2014) by early detection, preventive education 
of caregivers and relatives about the high prevalence of suicidal ideation in OSA 
patients may be important. Based on the strong relationship between poor sleep 
quality, fatigue and suicidal ideation, we recommend health care professionals to 
204 CHAPTER 8 205
consider investigating and monitoring suicidal ideation in people with sleep-re-
lated disorders. Sleep problems are a modifiable risk factor for suicidal thoughts 
and behaviours (Littlewood et al., 2019). Thus, the education of OSA patients on 
basic sleep hygiene may improve the quality of sleep and decrease fatigue. OSA pa-
tients with psychological symptoms and/or sleep-related problems may suffer from 
decreased activity and reduced social participation (e.g. Haack and Mullington, 
2005), and consequently may have poor motivation to seek health care. Therefore, 
an OSA diagnosis may represent an early opportunity for health care providers to 
discuss mental health with their patients. Health care professionals’ communica-
tion skills, particularly related to a frank and clear discussion of suicidality, should 
be developed through training courses. Because assessing suicidality in medical 
settings may be challenging, the use of self-administered screening questionnaires 
that identify patients at risk of suicidality could be a promising strategy (Kye and 
Park, 2017). Our results further indicated that anxiety was strongly associated with 
poor-nighttime sleep quality and impaired work functioning. Anxiety, especially 
at severe and panic levels, has a major impact on night-time sleep and breathing, 
which may in turn exacerbate OSA symptoms and contribute to difficulties with 
CPAP adaptation (Shapiro, 2014). Therefore, screening for anxiety at the time of 
OSA diagnosis with a simple, cost-effective self-rating tool may improve reporting 
of anxiety symptoms among OSA patients, and in turn, may help to improve assess-
ment of OSA in primary care settings. 
Another source of concern is that sleep disorders along with OSA are rarely 
assessed on a regular basis by mental health professionals in patients suffering from 
psychological distress. The presence of the sleep-wake complaints in a patient’s 
profile, and the onset of those complaints prior to the development of the psycho-
logical symptomatology, should draw the mental health professional’s attention 
to a potential concurrent or underlying OSA. Screening for symptoms associated 
with OSA can easily be integrated in symptom screening in a psychiatric interview 
(Braitman, 2018). Additionally, it is important for mental health professionals to 
understand that the routinely prescribed psychiatric medications may affect OSA. 
Thus, identifying patients with overlapping diagnoses of mental disorders and 
OSA may help to improve their treatment outcomes through more careful dosing 
of pharmacotherapy and CPAP treatment. Especially, sedation medications should 
be used with caution, as they were found to exacerbate OSA (Weatherspoon et al., 
2016). Notably benzodiazepines are considered to be inappropriate due to poten-
tial adverse effects, such as increased risk for adverse respiratory events, decrease 
in wakefulness and airway muscle tone, as well as weak response to hypoxemia 
(Hanly and Powles, 1993; Kushida, 2007; Zhang, et al., 2014; Kao et al., 2018). 
Benzodiazepines have the potential to cause next-day hangover and may contribute 
to fatigue and cognitive impairment already experienced by individuals with OSA 
(Kushida, 2007). Furthermore, patients with coexisting OSA and mental disorders 
may respond less well to antipsychotic medications than psychiatric patients with-
out OSA (Gupta and Simpson, 2015).
Targeted psychological interventions, such as psychotherapy which starts early 
in the OSA disease trajectory, may help to prevent serious problems later on. Our 
study revealed that both high hostility and poor coping self-efficacy may result in a 
higher level of psychological distress in OSA patients. Considering our findings, 
we may conclude that the use of adaptive coping self-efficacy may be used as a gate-
way to improve overall psychological well-being and to diminish the negative effect 
of hostility on psychological well-being in OSA patients. Although hostility is a rela-
tively stable personality trait, coping self-efficacy can be actively modified, e.g. by 
cognitive behavioural therapy. Given that sense of mastery was found to represent a 
skill of importance to daily functioning, interventions focused on mastery enhance-
ment may be a part of an integrated OSA care model. Specifically, brief interven-
tions may be applied for the improvement of the functional status, as mastery seems 
to be responsive to short-term psychological treatment (Zautra et al., 2012). 
8 .4 . 2   Im p l i c a t i o n s  f o r  f u ture  re s ea rc h
Clearly, more high-quality studies with larger study populations and with longer 
treatment duration are needed to better understand the effect of CPAP treatment 
on QoL in OSA patients. Yet, further longitudinal research is required to reveal 
how and to what extent social and psychological resources are relevant and effective 
in ameliorating the impact of OSA-related symptomatology and whether they can 
be of use in targeting interventions. The lack of widely acknowledged, tested and 
proven explanatory models of the pathophysiological mechanisms to understand 
the relationships between anxiety, suicidal ideation, sleep-related problems and 
OSA may be a barrier for understanding the clinical relevance of these conditions. 
Therefore, examining these factors over time may help to properly address the re-
vealed associations in a more comprehensive way. Next, since major comorbidities 
may influence sleep and affective symptoms, a detailed assessment of OSA patients 
with various categories of major comorbidities will further extend our knowledge. 
Another key challenge of future research is our limited knowledge of the fac-
tors that determine suicidal behaviour, i.e., which individual with suicidal ideation 
will act on this ideation (O’Connor, 2017). Thus, it is important to examine the 
inter-relationships between sleep disturbances, suicidal ideation, and other symp-
toms of OSA, which will provide novel insights into the specific pathways by which 
sleep-related symptoms contribute to the occurrence of suicidal ideation. Future 
research should include both objective and subjective assessments of key sleep 
parameters to ascertain suicide risk among OSA patients. Because suicidality can 
reflect a wide range of factors that can have various effects in different sociocultural 
contexts, more research is needed to explore the long-term effects of OSA on suici-
dality, while considering comprehensive psycho-social factors. 
Our findings indicate that coping self-efficacy for the ability to stop unpleas-
ant emotions and thoughts may be the most closely associated with diminishing of 
psychological distress in OSA out of the three studied coping strategies. Previous 
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research demonstrated that emotional suppression may be less adaptive in reduc-
ing psychological distress and symptoms over a longer time span (Wenzlaff and 
Wegner, 2000; Gross and Thompson, 2007). Thus, longitudinal studies are need-
ed to verify the role of coping self-efficacy for the ability to stop unpleasant emo-
tions and thoughts in diminishing the negative effect of OSA-related symptoms on 
psychological well-being in OSA patients. Finally, as social support was strongly 
associated with one functional status subscale, i.e. intimacy-sexual relationships, 
another area that merits further attention is the patient-partner dyad. With respect 
to the clinical importance of our study, the revealed significance of sources of social 
support in intimate relationships should be addressed as previous research identi-
fied poor health-related outcomes not only in OSA patients, but also in their bed-
partners (Parish and Lyng 2003; Luyster et al., 2016). 
Conclusion
The results of this thesis confirmed the previous findings of a very small improve-
ment in self-reported health outcomes with CPAP treatment in OSA patients. Based 
on the results of our meta-analysis, we may assume that medical treatment of OSA 
may help to improve physical symptoms of OSA, whereas existing psychological im-
pairment still cannot be successfully alleviated. We further found that psychological 
factors, together with some biological and social factors, are associated with health-
related outcomes in OSA patients. As we found strong associations between sleep-
related problems and self-reported health outcomes, we recommend health care 
professionals to intervene on sleep to reduce psychological distress and impaired 
daytime functioning in OSA patients. Our findings indicate that factors related to 
external resources such as social support and coping self-efficacy for the ability to 
get support from family and friends, may be of less importance in influencing health 
outcomes when compared with patients’ intra-individual psychological factors such 
as coping self-efficacy for stopping unpleasant emotions and thoughts, problem 
focused coping, and mastery. Based on these results we may further assume that 
helping OSA patients to strengthen their intra-individual psychological resources 
may be an important strategy to attenuate the negative impact of OSA-related symp-
toms.  However, longitudinal research is needed to confirm our results. 
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“Unlike stories, real life, when 




This thesis studied patients with obstructive sleep apnoea (OSA) who face the burden 
of this chronic disease in their everyday lives. OSA represents one of the most wide-
spread sleep disorders that requires lifetime care. It has serious consequences, not only 
for patients and their families, but also for society as a whole. Thus, regarding clinical 
care, one of the main goals is to improve patients’ daily functioning and well-being. 
While medical treatment of OSA may help to improve physical symptoms of the dis-
ease, existing psychological impairment still cannot be successfully cured. Therefore, 
in clinical sleep medicine, the main focus has shifted from OSA diagnosis to OSA 
management, with the emergence of new, integrated models of care. Thus, this thesis 
seeks to address the psycho-social factors that have been identified as one of the key 
factors in the adaptation to various chronic diseases, but less are known in OSA yet. 
This thesis further aims to contribute to the understanding of the associations between 
biomedical factors and self-reported health outcomes in OSA patients that have been 
identified as ambivalent in previous research.
Chapter 1 provides a general introduction of OSA. It further describes the key 
theoretical constructs of the thesis: continous positive airway pressure (CPAP) treat-
ment, sleep-related problems, anxiety, hostility, coping self-efficacy, mastery over one’s 
life and circumstances, and social support. Health-related outcomes were identified as 
quality of life (QoL), functional status, work functioning, and psychological distress, 
including suicidal ideation. This chapter also introduces the conceptual model of the 
associations between constructs examined in the thesis. 
Chapter 2 presents information about the study design. It describes the sample 
and procedure of the data collection, and settings used in the thesis. It also provides a 
description of the measures and used statistical analyses. 
Chapter 3 examines the effect of CPAP treatment on QoL, when compared to 
placebo pills, sham CPAP, and conservative treatment. We found no significant differ-
ences in overall and psychological QoL between CPAP treated patients and controls. 
However, physical QoL improved in CPAP treated patients compared with control 
treatments. Furthermore, subgroup analyses and sensitivity analyses showed that the 
type of control group, the study design, OSA severity, and risk of bias may be relevant 
in capturing the effect of CPAP on QoL. However, high-quality trials with low risk of 
bias and more participants are needed for further investigation of the effect of CPAP 
treatment on QoL improvement.  
Chapter 4 examines whether OSA-severity, sleep-related problems, and anxiety 
are associated with work functioning in OSA patients when controlled for age, gen-
der, and type of occupation. It also investigates whether anxiety moderates the as-
sociations between sleep-related problems and work functioning. We found that the 
majority of working OSA patients was anxious and had impaired work functioning. 
The results of our study further showed that poor night-time sleep quality and anxiety 
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were associated with impaired work functioning. The moderating effect of anxiety on 
the association between night-time sleep quality and work functioning was especially 
strong in patients with better sleep quality, while the effect of anxiety on the associa-
tion between night-time sleep quality and work functioning was negligible in case of 
worse sleep quality. 
Chapter 5 examines the associations between hostility, coping self-efficacy and 
psychological distress in OSA patients when controlled for sociodemographic, clini-
cal, and sleep-related variables. It further explores whether coping self-efficacy dimen-
sions mediate the association between hostility and psychological distress. Our study 
revealed that hostility and poor coping self-efficacy were strongly associated with 
psychological distress in OSA patients. We also found that all coping self-efficacy di-
mensions mediated the association between hostility and psychological distress. Our 
sudy further provided the evidence that coping self-efficacy for stopping unpleasant 
emotions and thoughts was found to be the most adaptive strategy in OSA patients. 
Chapter 6 describes the prevalence of suicidal ideation in patients with OSA. It 
also examines the associations between OSA severity, sleep-related problems, social 
support and suicidal ideation in OSA patients. Our findings suggest that suicidal idea-
tion is highly prevalent among OSA patients (20.1%). Poor night-time sleep quality 
and fatigue were directly related to suicidal ideation, however OSA severity and social 
support were not. The adjustment for sociodemographic variables did not change the 
association between social support and suicidal ideation either. Sleep quality mediated 
the effect of OSA severity on suicidal ideation. 
Chapter 7 examines the associations between social support, mastery, sleep-re-
lated problems and functional status in patients with OSA when controlled for soci-
odemographic and clinical variables. It also investigates the mediating role of social 
support and mastery in the association between sleep-related problems and functional 
status. Our results provided suggestive evidence that low level of social support, poor 
mastery, disturbed night-time sleep quality, and daytime sleepiness were associated 
with an impairment in functional status in OSA patients. While social support was 
weakly associated with functional status, we found a strong association between mas-
tery and overall functional status in OSA patients. The subscale analyses showed that 
social support was strongly associated with one functional status subscale, i.e. intima-
cy-sexual relationships, while mastery was associated with all functional status sub-
scales in the final models. We found that mastery mediated the association between 
sleep-related problems and functional status. However, no mediating role of social 
support in the association between sleep-related problems and functional status was 
observed.  
Finally, in Chapter 8 we summarise the key findings as presented in the Chapters 
3-7, discussed them in the context of contemporary scientific research and provided 
implications. In line with previous studies, the results of our meta-analysis confirmed 
that CPAP treatment may help to improve physical symptoms of OSA, whereas exist-
ing psychological impairment still cannot be successfully cured. Therefore, the cur-
rent research and clinical practice should focus not only on the standard treatment 
of OSA, but also on ensuring that psychological symptoms are efficiently managed. 
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Our findings may also enhance health care professionals’ understanding of the mental 
health problems in OSA patients. Next, our study provided evidence for high preva-
lence of overall psychological distress in OSA patients including suicidal ideation and 
anxiety. Thus, the necessity of monitoring psychological symptoms in OSA patients 
during clinical care should be highlighted. The education of people with OSA on basic 
sleep hygiene and application of behavioural interventions may improve the quality 
of sleep and decrease fatigue strongly associated with self-reported health outcomes. 
Health care professionals may also directly recommend targeted psychological care, 
which starts early in the OSA trajectory and may help to prevent serious problems 
later on. Moreover, identifying patients with overlapping symptoms of mental disor-
ders and OSA may help to improve the diagnostic process and treatment outcomes 
through careful dosing of pharmacotherapy and use of CPAP treatment. 
Another interesting observation to emerge from our study was that the external 
resources related to social support explained less variance in health outcomes when 
compared to intra-individual psychological resources such as mastery and coping-
self-efficacy focused on stopping unpleasant emotions and thoughts or problem fo-
cused coping self-efficacy. Based on these results we may conclude that helping OSA 
patients to strengthen their intra-individual resources may be one of the important 
protective strategies, attenuating the negative impact of OSA-related symptoms. 
Therefore, encouraging mastery over ones’ life and circumstances, and dispelling cop-
ing self-efficacy may be paramount in improving functional status and handling the 
psychological distress in OSA patients. Still, we found that social support was strongly 
associated with one functional status subscale, i.e. intimacy-sexual relationships. Thus, 
the revealed significance of sources of social support in intimate relationships should 
be addressed as previous studies identified poor health-related outcomes not only in 
OSA patients, but also in their bed-partners. 
Chapter 8 also addresses the methodological considerations and future research 
implications of the study. Strengths of this study include OSA diagnosis stated using 
polysomnography. Results of our study may be helpful in identifying bio-psycho-so-
cial risk factors of poor health outcomes that can be modified by health care profes-
sionals or by the patients themselves. Multidisciplinary OSA care can help to reduce 
effort duplication, minimize fragmentation of care, control costs, improve risk assess-
ment for the consequences of untreated OSA, and lead to better treatment strategies. 
All in all, our study has led us to conclude that impairment of health outcomes in OSA 
patients may not be solely due to biomedical factors or the effect of OSA itself. Rather, 
psychological factors such as anxiety, hostility, the choice of coping strategies, or mas-
tery, may play a key role in determining the experience of poor health. However,  fur-
ther longitudinal confirmation of our results is needed.  
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Sammenvattig
Dit proefschrift bestudeert patiënten met obstructieve slaapapneu (OSA) die in hun 
dagelijks leven geconfronteerd worden met de last van deze chronische ziekte. OSA is 
een van de meest voorkomende slaapstoornissen waarvoor levenslang zorg nodig is. 
Het heeft ernstige gevolgen, niet alleen voor patiënten en hun families, maar ook voor 
de samenleving als geheel. Wat klinische zorg betreft, is één van de hoofddoelen het 
verbeteren van het dagelijks functioneren en welzijn van patiënten. Hoewel medische 
behandeling van OSA kan helpen de fysieke symptomen van de ziekte te verbeteren, 
kunnen bestaande psychische klachten nog steeds niet met succes worden genezen. 
In de klinische slaapgeneeskunde is met de opkomst van nieuwe, geïntegreerde zorg-
modellen de nadruk verschoven van de OSA-diagnose naar het omgaan met OSA. 
Dit proefschrift zal ingaan op de psychosociale factoren die zijn geïdentificeerd als 
sleutelfactoren bij de aanpassing aan verschillende chronische ziekten, maar bij OSA 
zijn er minder zulke factoren bekend. Dit proefschrift beoogt verder bij te dragen 
aan het begrip van de associaties tussen biomedische factoren en zelfgerapporteerde 
gezondheid bij OSA-patiënten die in eerder onderzoek als niet-doorslaggevend zijn 
geïdentificeerd.
In Hoofdstuk 1 wordt een algemene introductie van OSA gegeven. De belangrijk-
ste theoretische constructen van het proefschrift worden beschreven: continue posi-
tieve luchtweg-druk (CPAP), slaapgerelateerde problemen, angst, vijandigheid, zel-
fredzaamheid, eigen effecitiviteit,   beheersing van iemands leven en omstandigheden, 
en sociale steun. De gezondheidsgerelateerde uitkomstmaten die zijn gebruikt zijn 
kwaliteit van leven (KvL), functionele status, functioneren in het werk en psychische 
klachten, inclusief zelfmoordgedachten. Dit hoofdstuk introduceert ook het concep-
tuele model van de verbanden tussen de constructen die in het proefschrift zijn onder-
zocht.
Hoofdstuk 2 geeft informatie over de onderzoeksopzet. Het beschrijft de steekproef 
en de procedure van de gegevensverzameling die in het proefschrift zijn gebruikt. Het 
geeft ook een beschrijving van de meetinstrumenten en gebruikte statistische analyses.
In Hoofdstuk 3 wordt het effect van CPAP-behandeling op KvL onderzocht, in 
vergelijking met placebo-pillen, schijn-CPAP en conservatieve behandeling. We 
vonden geen significante verschillen in de totale en psychologische KvL tussen met 
CPAP behandelde patiënten en controles. De fysieke KvL verbeterde echter bij met 
CPAP behandelde patiënten in vergelijking met de controlebehandelingen. Verder 
toonden subgroepanalyses en sensitiviteitsanalyses aan dat het type controlegroep, de 
onderzoeksopzet, de ernst van OSA en het risico op bias relevant kunnen zijn bij het 
bepalen van het effect van CPAP op de KvL. Kwalitatief hoogwaardige onderzoeken 
met een laag risico op bias en meer deelnemers zijn nodig voor verder onderzoek naar 
het effect van CPAP-behandeling op KvL verbetering.
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In Hoofdstuk 4 wordt onderzocht of de ernst van OSA, slaapgerelateerde proble-
men en angst geassocieerd zijn met het functioneren in het werk bij OSA-patiënten als 
gecontroleerd wordt voor leeftijd, geslacht en type beroep. Ook wordt onderzocht of 
angst de verbanden tussen slaapgerelateerde problemen en functioneren in het werk 
beinvloedt. We vonden dat de meerderheid van de werkende OSA-patiënten angstig 
was en dat het functioneren in het werk belemmerd was. De resultaten van onze studie 
toonden verder aan dat slechte nachtelijke slaapkwaliteit en angst geassocieerd waren 
met een verminderd functioneren in het werk. Het modererende effect van angst op 
het verband tussen nachtelijke slaapkwaliteit en functioneren in het werk was vooral 
sterk bij patiënten met een betere slaapkwaliteit, terwijl het effect van angst op het 
verband tussen nachtelijke slaapkwaliteit en functioneren in het werk te verwaarlozen 
was in het geval van slechte slaapkwaliteit. 
In Hoofdstuk 5 worden de verbanden onderzocht tussen vijandigheid, eigen ef-
fectiviteit en psychische klachten bij OSA-patiënten als deze gecontroleerd worden 
voor sociodemografische, klinische en slaapgerelateerde variabelen. Verder wordt 
onderzocht of dimensies van eigen effectiviteit het verband tussen vijandigheid en 
psychische klachten mediëren. Onze studie toonde aan dat vijandigheid en lage eigen 
effectiviteit sterk geassocieerd waren met psychische klachten bij OSA-patiënten. We 
ontdekten ook dat alle dimensies van eigen effectiviteit het verband mediëerden tussen 
vijandigheid en psychische klachten. Ons onderzoek leverde verder op dat eigen ef-
fectiviteit in de zin van het stoppen van onaangename emoties en gedachten de meest 
adaptieve strategie bleek te zijn bij OSA-patiënten.
In Hoofdstuk 6 wordt de prevalentie beschreven van suïcidale gedachten bij 
patiënten met OSA. Ook worden de verbanden onderzocht tussen de ernst van OSA, 
de slaapgerelateerde problemen, de sociale steun en de suïcidale ideeën bij OSA-
patiënten. Onze bevindingen suggereren dat suïcidale ideeën zeer gangbaar zijn bij 
OSA-patiënten (20,1%). Slechte nachtelijke slaapkwaliteit en vermoeidheid waren di-
rect gerelateerd aan suïcidale ideeën, maar de ernst van OSA en sociale steun waren 
dat niet. De controle voor sociodemografische variabelen veranderde ook het verband 
tussen sociale steun en suïcidale ideeën niet. Slaapkwaliteit mediëerde het effect van 
OSA-ernst op suïcidale gedachten. 
In Hoofdstuk 7 worden de verbanden onderzocht tussen sociale steun, beheers-
ing, slaapgerelateerde problemen en functionele status bij patiënten met OSA die ge-
controleerd werden voor sociodemografische en klinische variabelen. Ook wordt de 
mediërende rol van sociale steun en beheersing in het verband tussen slaapgerela-
teerde problemen en functionele status onderzocht. Onze resultaten leverden sugges-
tief bewijs op dat een laag niveau van sociale steun, een slechte beheersing, verstoorde 
nachtelijke slaapkwaliteit en slaperigheid overdag een verband hebben met een ver-
slechtering van de functionele status bij OSA-patiënten. Hoewel er tussen sociale ste-
un en functionele status een zwak verband was, vonden we een sterk verband tussen 
beheersing en functionele status bij OSA-patiënten. De subschaalanalyses toonden 
aan dat sociale steun sterk geassocieerd was met één subschaal van functionele sta-
tus, te weten die van intimiteit-seksuele relaties, terwijl beheersing geassocieerd was 
met alle subschalen van functionele status in de uiteindelijke modellen. We ontdekten 
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dat beheersing het verband tussen slaapgerelateerde problemen en functionele status 
mediëerde. Zo een mediërende rol werd niet van sociale steun waargenomen met be-
trekking tot het verband tussen slaapgerelateerde problemen en functionele status.
Tenslotte vatten we in hoofdstuk 8 de belangrijkste bevindingen samen zoals 
gepresenteerd in de hoofdstukken 3-7, we bespreken de bevindingen in de context 
van het hedendaags wetenschappelijk onderzoek en geven implicaties aan. In over-
eenstemming met eerdere studies, bevestigden de resultaten van onze meta-analyse 
dat CPAP-behandeling kan helpen om fysieke symptomen van OSA te verbeteren, 
terwijl bestaande psychische klachten nog steeds niet met succes kunnen worden 
behandeld. Daarom moet het huidige onderzoek en de klinische praktijk niet alleen 
gericht zijn op de standaardbehandeling van OSA, maar ook op het waarborgen van 
een efficiënte behandeling van psychische problemen. Onze bevindingen kunnen ook 
de kennis van zorgverleners over psychische problemen bij OSA-patiënten verbeteren. 
Vervolgens liet ons onderzoek een hoge prevalentie van algemene psychische klachten 
bij OSA-patiënten zien, inclusief zelfmoordgedachten en angst. Daarom is het uiter-
mate belangrijk deze psychische klachten bij OSA-patiënten tijdens de klinische zorg 
te monitoren. Het kennisniveau van OSA-patiënten over elementaire slaaphygiëne en 
de toepassing van gedragsinterventies kan de slaapkwaliteit verbeteren en vermoei-
dheid verminderen, en is sterk verbonden met de zelfgerapporteerde gezondheid. 
Gezondheidszorgprofessionals kunnen ook direct psychologische zorg op maat aan-
bevelen, die vroeg in het OSA-traject begint en later kan helpen ernstige problemen 
te voorkomen. Bovendien kan het identificeren van patiënten met symptomen van 
zowel psychische problemen en OSA helpen het diagnostische proces en de behan-
delresultaten door zorgvuldige dosering van farmacotherapie en het gebruik van de 
CPAP-behandeling te verbeteren.
Een andere interessante observatie die uit onze studie naar voren kwam, was 
dat de externe bronnen met betrekking tot sociale steun minder variantie in gezond-
heidsuitkomsten verklaarden in vergelijking met intra-individuele psychologische 
bronnen zoals beheersing en eigen effectiviteit die gericht is op het stoppen van on-
aangename emoties en gedachten of probleemgericht omgaan met zelfredzaamheid. 
Op basis van deze resultaten kunnen we concluderen dat het helpen versterken van 
intra-individuele bronnen bij OSA-patiënten één van de belangrijke beschermende 
strategieën kan zijn, waardoor de negatieve impact van OSA-gerelateerde symptomen 
wordt verzacht. Het aanmoedigen van beheersing van iemands leven en omstan-
digheden en eigen effectiviteit kunnen van groot belang zijn bij het verbeteren van de 
functionele status en het omgaan met de psychische klachten bij OSA-patiënten. Ook 
vonden we een sterk verband tussen sociale steun en één subschaal van functionele 
status, te weten de subschaal intimiteit-seksuele relaties. Daarom zou sociale steun in 
intieme relaties moeten worden aangepakt, ook omdat eerdere studies slechte gezond-
heidsgerelateerde uitkomsten rapporteerden, niet alleen bij OSA-patiënten zelf, maar 
ook bij hun bedpartners.
Hoofdstuk 8 behandelt ook de methodologische overwegingen en toekomstige 
implicaties van het onderzoek voor verder onderzoek en de praktijk. Sterke punten 
van deze studie zijn dat de diagnose OSA gesteld is met behulp van polysomnografie. 
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Resultaten van ons onderzoek kunnen helpen bij het identificeren van bio-psycho-
sociale risicofactoren voor slechte gezondheidsuitkomsten, die kunnen worden aange-
past door gezondheidszorgprofessionals of door de patiënten zelf. Multidisciplinaire 
OSA-zorg kan helpen een verdubbeling van inspanningen te verminderen, versnip-
pering van zorg te minimaliseren, kosten te beheersen, risicobeoordeling voor de 
gevolgen van onbehandelde OSA te verbeteren en kan tot betere behandelstrategieën 
leiden. Al met al heeft ons onderzoek ons ertoe gebracht te concluderen dat een ver-
slechtering van de gezondheidsuitkomsten bij OSA-patiënten mogelijk niet alleen te 
wijten is aan biomedische factoren of aan het effect van OSA zelf. Integendeel, psy-
chologische factoren zoals angst, vijandigheid, de keuze van strategieën met betrek-
king tot eigen effectiviteit of beheersing kunnen een belangrijke rol spelen bij het be-
palen van de ervaring van slechte gezondheid. Een bevestiging van onze resultaten in 
longitudinaal onderzoek is echter nodig.
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Zhrnutie
Obštrukčné spánkové apnoe (OSA) predstavuje jednu z najrozšírenejších porúch 
spánku, ktorá si vyžaduje celoživotnú liečbu. Toto ochorenie má vážne dôsledky nielen 
pre pacientov a ich rodiny, ale aj pre spoločnosť ako celok. Jedným z hlavných cieľov 
klinickej starostlivosti je zlepšiť každodenné fungovanie pacientov a ich well-being. 
Medicínska starostlivosť môže pomôcť zlepšiť fyzické príznaky ochorenia ale exis-
tujúce psychologické symptómy však stále nie je možné u pacientov s OSA úspešne 
vyliečiť. Vzhľadom na to presúva súčasná  spánková medicína primárny dôraz z diag-
nostiky OSA na manažment ochorenia s využitím nových, integrovaných modelov 
starostlivosti. Cieľom tejto štúdie je popísanie úlohy psycho-sociálnych faktorov, ktoré 
boli identifikované ako jeden z kľúčových aspektov pri adaptácii na rôzne chronické 
ochorenia, ale sú menej známe v oblasti OSA. Táto práca sa ďalej snaží prispieť k po-
chopeniu asociácií medzi biomedicínskymi faktormi a  seba-posudzovaným zdravím 
u pacientov s OSA, ktoré boli v predchádzajúcom výskume identifikované ako ambi-
valentné. 
Prvá kapitola poskytuje všeobecný úvod do problematiky OSA. Ďalej opisuje kľú-
čové teoretické konštrukty tejto práce: liečbu kontinuálnym pozitívnym tlakom v dý-
chacích cestách (CPAP), problémy súvisiace so spánkom, anxietu, hostilitu, copingovú 
seba-účinnosť, schopnosť zvládania životných okolností a sociálnu oporu. Výstupy sú-
visiace so seba-posudzovaným zdravím boli identifikované ako kvalita života, funkčný 
stav, úroveň pracovnej funkčnosti  a psychologické symptómy vrátane samovražed-
ných myšlienok. Táto kapitola ďalej definuje konceptuálny model asociácií medzi kon-
štruktmi skúmanými v tejto štúdii a jednotlivé výskumné otázky. 
V druhej kapitole poskytujeme informácie o dizajne štúdie. V tejto kapitole popi-
sujeme výskumnú vzorku, postup zberu údajov, použité nástroje merania a štatistické 
analýzy.
Tretia kapitola skúma efekt CPAP liečby na kvalitu života v porovnaní s placebo 
tabletami, simulovanou CPAP a konzervatívnou liečbou. U pacientov liečených CPAP 
sme nezistili významné rozdiely v celkovej a psychologickej kvalite života v porovnaní 
so skupinou pacientov podstupujúcou kontrolnú liečbu. Na druhej strane sme zistili, 
že fyzická kvalita života sa u pacientov liečených CPAP sa v porovnaní s kontrolnou 
skupinou signifikantne zlepšila. Analýzy ďalej ukázali, že typ kontrolnej skupiny, di-
zajn štúdie, závažnosť ochorenia a risk of bias môžu zohrávať relevantnú úlohu pri 
meraní účinku CPAP na kvalitu života. Na presnejšie stanovenie úrovne účinku CPAP 
liečby na kvalitu života pacientov s OSA je však potrebné väčšie množstvo kvalitných 
štúdií s nízkou úrovňou risk of bias a väčšou výskumnou vzorkou.
Štvrtá kapitola  skúma či závažnosť OSA, problémy súvisiace so spánkom a 
anxieta súvisia s úrovňou pracovnej funkčnosti u pacientov s OSA. Pri overovaní na-
šej výskumnej otázky sme uplatnili kontrolu asociácií vzhľadom na vek, pohlavie a 
typ zamestnania. Ďalším predmetom skúmania bolo posúdenie moderačného efektu 
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anxiety na asociácie medzi problémami súvisiacimi so spánkom a úrovňou pracovnej 
funkčnosti. Zistili sme, že väčšina pracujúcich pacientov s OSA vykazovala zvýšenú 
úroveň anxiety a  zníženú úroveň pracovnej funkčnosti. Výsledky našej štúdie ďalej 
ukázali, že nízka kvalita nočného spánku a zvýšená úroveň anxiety súviseli so zní-
ženou úrovňou pracovnej funkčnosti. Moderačný efekt anxiety na asociáciu medzi 
kvalitou nočného spánku a úrovňou pracovnej funkčnosti bol obzvlášť signifikantný 
u pacientov s lepšou kvalitou spánku, zatiaľ čo moderačný vplyv anxiety na asociáciu 
medzi kvalitou nočného spánku a úrovňou pracovnej funkčnosti bol zanedbateľný 
v prípade nízkej kvality spánku. 
Piata kapitola skúma asociácie medzi hostilitou, copingovou seba-účinnosťou a 
psychologickým distresom u pacientov s OSA. Skúmané asociácie boli kontrolované 
berúc do úvahy sociodemografické, klinické a spánkové premenné. Táto kapitola ďa-
lej skúma, či jednotlivé dimenzie copingovej seba-účinnosti mediujú asociáciu medzi 
hostilitou a psychologickým distresom. Naša štúdia ukázala, že hostilita a nízka úro-
veň copingovej seba-účinnosti boli u pacientov s OSA silne spojené s psychologickým 
distresom. Taktiež sme zistili, že všetky posudzované dimenzie copingovej seba-účin-
nosti mali mediačný efekt na asociáciu medzi hostilitou a psychologickým distresom. 
Táto štúdia ďalej poskytla dôkazy o tom, že najúčinnejšiu copingovú stratégiu u pa-
cientov s OSA predstavuje seba-účinnosť zameraná na zastavenie nepríjemných emó-
cií a myšlienok.
Šiesta kapitola  opisuje výskyt samovražedných myšlienok u pacientov s OSA. 
Skúma tiež súvislosť medzi závažnosťou OSA, problémami súvisiacimi so spánkom, 
sociálnou oporou a samovražednými myšlienkami u pacientov s OSA. Naše zistenia 
naznačujú, že suicidálne myšlienky sú u pacientov s OSA alarmujúco prevalentné 
(20.1%). Nízka kvalita nočného spánku a únava vykazovali priamu súvislosť so samo-
vražednými myšlienkami, avšak naša štúdia nenašla signifikantný vzťah medzi závaž-
nosťou OSA, ospalosťou počas dňa, sociálnou oporou a suicidálnymi myšlienkami. 
Kontrola pre sociodemografické premenné neovplyvnila absentujúcu signifikanciu 
vzťahu medzi ospalosťou počas dňa, sociálnou oporou a samovražednými myšlienka-
mi. Kvalita spánku mala mediačný efekt na vzťah medzi závažnosťou OSA a samovra-
žednými myšlienkami.
Siedma kapitola skúma asociácie medzi sociálnou oporou, úrovňou zvládania ži-
votných okolností, problémami súvisiacimi so spánkom a funkčným stavom u pacien-
tov s OSA. Skúmané asociácie boli kontrolované berúc do úvahy sociodemografické 
a klinické premenné. Táto kapitola zároveň skúma mediačný efekt sociálnej opory 
a úrovne zvládania životných okolností na asociáciu medzi problémami súvisiacimi 
so spánkom a funkčným stavom. Naše výsledky poskytli sugestívne dôkazy o tom, že 
nízka úroveň sociálnej opory, nízka schopnosť zvládania, narušená kvalita nočného 
spánku a denná ospalosť boli u pacientov s OSA spojené s nízkou úrovňou funkčného 
stavu. Zatiaľ čo sociálna opora bola len nevýrazne asociovaná s celkovým funkčným 
stavom, zistili sme signifikantnú asociáciu medzi schopnosťou zvládania a celkovým 
funkčným stavom. Analýzy subškál ukázali, že sociálna opora bola signifikantne aso-
ciovaná s jednou subškálou funkčného statusu, t. j. intimita-sexuálne vzťahy, zatiaľ čo 
schopnosť zvládania bola asociovaná so všetkými subškálami funkčného stavu. Zistili 
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sme, že schopnosť zvládania mala mediačný efekt na asociáciu medzi problémami 
súvisiacimi so spánkom a funkčným stavom. Nepozorovali sme však mediačný efekt 
sociálnej opory na asociáciu medzi  problémami súvisiacimi so spánkom a funkčným 
stavom.
Ôsma kapitola sumarizuje kľúčové zistenia prezentované v kapitolách 3-7, obsa-
huje diskusiu našich zistení v kontexte súčasných vedeckých poznatkov a poskytuje 
implikácie pre prax a ďalší výskum. V súlade s predchádzajúcimi štúdiami, výsledky 
našej metaanalýzy potvrdili, že liečba CPAP môže pomôcť zlepšiť fyzické príznaky 
OSA, zatiaľ čo existujúce psychologické poškodenia často nie je možné úspešne mi-
nimalizovať. Súčasný výskum a klinická prax by sa preto mali zamerať nielen na štan-
dardnú liečbu OSA, ale aj na zabezpečenie efektívneho manažmentu psychologických 
symptómov. Naše zistenia môžu tiež zlepšiť pochopenie problematiky duševného zdra-
via u pacientov s OSA. Naša štúdia poskytla dôkazy o zvýšenej prevalencii celkového 
psychologického distresu u pacientov s OSA, vrátane samovražedných myšlienok a 
anxiety. Preto je následne potrebné zdôrazniť adekvátnosť monitorovania psycholo-
gických symptómov u pacientov s OSA počas klinickej starostlivosti. Vzdelávanie ľudí 
s OSA v oblasti základnej spánkovej hygieny a aplikácie behaviorálnych intervencií 
môže zlepšiť kvalitu spánku a znížiť únavu, ktorá je u týchto pacientov významne 
spojená so seba-posudzovaným zdravím. Zdravotnícki pracovníci môžu pacientom 
priamo odporučiť cielenú a včasnú psychologickú starostlivosť, ktorá môže zamedziť 
neskoršiemu vzniku vážnych problémov. Identifikácia pacientov s prekrývajúcimi sa 
príznakmi duševných porúch a OSA môže naviac pomôcť k zlepšeniu diagnostických 
procesov a výsledkov liečby prostredníctvom starostlivého dávkovania farmakoterapie 
a aplikácie CPAP liečby.
Ďalším zaujímavým pozorovaním, ktoré vyplynulo z našej štúdie, bolo, že externé 
zdroje súvisiace so sociálnou oporou boli menej signifikantne asociované so seba-po-
sudzovaným zdravím v porovnaní s inter-individuálnymi psychologickými zdrojmi, 
ako je celková úroveň zvládania životných okolností a coping zameraný na zastavenie 
nepríjemných emócií a myšlienok. Na základe týchto výsledkov predpokladáme, že 
facilitácia inter-individuálnych zdrojov môže predstavovať jednu z dôležitých ochran-
ných stratégií, pri zmierňovaní negatívneho vplyvu symptómov OSA na seba-posu-
dzované zdravie. Podpora schopnosti zvládania a copingovej seba-účinnosti môže 
preto predstavovať jeden z rozhodujúcich faktorov v rámci zlepšovania funkčného 
stavu a zvládania psychologického distresu u pacientov s OSA. Nesmieme však za-
budnúť na naše zistenie, že sociálna opora bola významne spojená s jednou funkčnou 
subškálou, t.j. intímne-sexuálne vzťahy. Vzhľadom na skutočnosť, že predchádzajúce 
štúdie identifikovali negatívne zdravotné dôsledky OSA nielen u pacientov s týmto 
ochorením, ale u ich partnerov, význam sociálnej opory v partnerských vzťahoch by 
mal byť ďalším predmetom skúmania.  
Ôsma kapitola následne popisuje limity tejto štúdie a sumarizuje odporúčania pre 
klinickú prax a ďalší výskum. Silné stránky tejto štúdie zahŕňajú diagnostiku OSA s 
využitím polysomnografie. Výsledky našej štúdie môžu byť užitočné pri identifikácii 
bio-psycho-sociálnych faktorov, ktoré môžu ovplyvniť zdravie pacientov s OSA, a kto-
ré môžu byť následne manažované zdravotníckymi pracovníkmi a v neposlednom 
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rade aj samotnými pacientmi. Multidisciplinárna starostlivosť o pacientov s OSA 
môže zamedziť duplikovaniu úkonov, minimalizovať fragmentáciu starostlivosti, zní-
žiť náklady na kontrolu, zlepšiť posúdenie rizika následkov neliečeného OSA a viesť 
k efektívnejším stratégiám liečby. Naša štúdia viedla k záveru, že zhoršenie seba-po-
sudzovaného zdravia u pacientov s OSA nemusí byť spôsobené len biomedicínskymi 
faktormi alebo samotným ochorením. Psychologické faktory ako sú anxieta, hostilita, 
typ copingovej seba-účinnosti alebo celková schopnosť zvládať životné okolnosti môžu 
zohrávať kľúčovú úlohu pri určovaní úrovne seba-posudzovaného zdravia u pacientov 
s OSA. Výsledky našej štúdie je však potrebné potvrdiť longitudinálnymi štúdiami.
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Supplements 
Supplement 3.1: TableS3.2 Search strings
Web of Knowledge: (“Sleep apnea” OR “sleep apnoea” OR OSA) AND (“qual-
ity of life” OR “ health status” OR “functional status” OR “self-perceived health” 
OR “self-perceived health” OR “self-rated health” OR “self-rated health”) AND 
(CPAP OR “continuous positive airway pressure”). 
Pubmed: (“Sleep Apnea Syndromes”(Mesh) OR sleep apnea(tiab) OR sleep 
apnoea(tiab) OR OSA(tiab)) AND (“Continuous Positive Airway Pressure”(Mesh) 
OR CPAP(tiab) OR continuous positive airway pressure(tiab)) AND (“Quality 
of Life”(Mesh) OR “Health Status”(Mesh) OR quality of life(tiab) OR health 
status(tiab) OR functional status(tiab) OR self-rated health(tiab) OR self-perceived 
health(tiab)). 
PsycINFO: (DE “Sleep Apnea” OR TI („sleep apnea” OR “sleep apnoea” OR 
OSA) OR AB („sleep apnea” OR “sleep apnoea” OR OSA)) AND ( TI ( “continu-
ous positive airway pressure” OR CPAP ) OR AB ( “continuous positive airway 
pressure” OR CPAP ) ) AND ( DE “Quality of Life” OR TI ( “quality of life” OR 
“health status” OR “functional status” OR “self-rated health” OR “self-perceived 
health” ) OR AB ( “quality of life” OR “health status” OR “functional status” OR 
“self-rated health” OR “self-perceived health” ) ). 
The Cochrane Library: (“sleep apnea” or “sleep apnoea” or OSA:ti,ab,kw) and 
(“continuous positive airway pressure” or CPAP:ti,ab,kw) and (“quality of life” 
or “health status” or “functional status” or “self-rated health” or “self-perceived 
health”:ti,ab,kw)
EMBASE: (((‘sleep apnea’:ti,ab,kw OR ‘sleep apnoea’:ti,ab,kw OR ‘osa’:ti,ab,kw) 
AND ‘continuous positive airway pressure’:ti,ab,kw OR ‘cpap’:ti,ab,kw) AND 
‘quality of life’:ti,ab,kw OR ‘health status’:ti,ab,kw OR ‘self-rated health’:ti,ab,kw 
OR ‘self-perceived health’:ti,ab,kw OR ‘functional status’:ti,ab,kw)).
CINAHL: “sleep apnea OR sleep apnoea OR OSA AND continuous positive air-
way pressure OR CPAP AND quality of life OR health status OR functional status 
OR self-rated health OR self-perceived health on 2019-03-03 09:15 AM”      
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Supplement 3.2: Overview of the included studies: exclusion criteria, sociodemo-
graphic and clinical data, level of compliance with CPAP 
Table S3.4 Overview of the included studies 
Study Exclusion criteria


















lung disease; neurological 
disorder; co-existing sleep 
disorder
Age: 47±12.0 years




2.8±2.0 h/per night 
Engleman 1999,  
Scotland
shift workers; co-existing 
sleep disorder; neurologi-
cal disease; lung disease
Age: 44.0±8.0 years








mental impairment; major 
psychoses; alcohol depen-
dence; learning difficulties
Age: real CPAP: 50.0 (33-71) 
years
Age: sham CPAP: 48.0 (36-68) 
years
Gender: 101 men, 0 women
AHI: NA
Oximeter: >4% SaO2 (dips/h) 
Sham CPAP: 28·5 (10.7–68.7) 
Real CPAP: 32·9 (15.5–63.4)
BMI: real CPAP: 35.1 (25.8-44.3) 
kg/m2
BMI: sham CPAP: 35.0 (26.9-
51.4) kg/m2
ESS: real CPAP: 16.0
ESS: Sham CPAP: 17.0
controls: 4.6 h/per 
night







ease; cardiac disease; less 
than 8 years of formal 
education
Illicit drugs; alcohol abuse
Age: real CPAP: 54±2.0 years
Age: sham CPAP: 52±2.0 years
Gender: 5 female, 49 male
AHI: real CPAP: 54±2.0 events/h
AHI: sham CPAP: 52±2.0 
events/h
BMI: 29.0±1.0 (26.9-51.4) kg/m2
BMI: sham CPAP: (29±0.4) 
kg/m2
ESS: real CPAP: 7.0±0.4










shift workers; diabetes; 
taking medication which 
may alter blood pressure
Age: 50.0 (29-72) years
Gender: 55 males, 13 females
AHI: 35.0 (15-129) events/h
BMI: 30.0 (21-53) kg/m2





disease; hazardous job 
coincidentally with OSA
Age: 54.0±10.0 years























not specified Age: 46.6±1.1 years








history of somnolence 
requiring immediate treat-
ment; shift work; chronic 
sleep restriction; currently 
taking sedatives, antide-
pressants, psychotropics 
or stimulants; an alcohol 
intake of 0.3 standard 
units/24 hours or caffeine 
dependency (unable to 
forego caffeine on testing 
days); had undergone 
upper airway surgery; or 
had any clinically signifi-
cant co-existing disease or 
additional sleep disorders
Age: 50.5 (25-67) years
Gender: 23 male, 6 female
AHI: 21.67.5± events/h
BMI: 3.5 (6.0) kg/m2
ESS: 12.5 (0.8)





respiratory failure Age: real CPAP: 48.1±9.5 years
Age: sham CPAP: 48.7±10.6 
years
Gender: 102 male; 0 female
BMI: real CPAP:  35.8±7.3 kg/m2
BMI: sham CPAP: 34.5±5.0 
kg/m2
ESS: real CPAP: 15.8±4.0
ESS: sham CPAP: 15.2±4.0
controls: 3.9±2.5 h/
per night
real CPAP: 4.7±2.1 h/
per night
Table S3.4 Overview of the included studies - continued
Study Exclusion criteria
Sociodemographic data  and 
clinical data  
Mean (SD/SE, range)
CPAP compliance, 






condition in the past 3 
months; greater than 
fifth grade reading level; 
and no history of other 
sleep disorder, current 
pregnancy, substance 
abuse, sleepiness-related 
driving accident, or sleepi-
ness-sensitive occupation
Age: real CPAP: 49.5±10.9 years
Age: sham CPAP: 51.7±11.9 
years
Gender: 223 patients; 140 
male; 122 female
Black: 79.3%; whites: 76.3%
AHI: real CPAP: 12.8±6.4 
events/h
AHI: sham CPAP: 12.5±6.5 
events/h
BMI: real CPAP:  33.2±6.3 kg/m2
BMI: sham CPAP: 34.2±7.8 
kg/m2
ESS: real CPAP: 15.0±3.4
ESS: sham CPAP: 14.7±3.0
controls: 3.1±2.1 h/
per night





previous treatment for 
OSA with CPAP or surgery, 
oxygen saturation on 
baseline PSG < 75% for > 
10% of the recording time, 
history of motor vehicle 
accident related to sleep-
iness within the past 12 
months, chronic medical 
conditions, use of various 
medications known to 
affect sleep or neurocog-
nitive function, health and 
social factors that may 
impact testing procedures 
(e.g. shift work)
Age: real CPAP: 52.0±12.0 years
Age: sham CPAP: 51.0±12.0 
years
Gender: male; female
AHI: real CPAP: 40.0±24.0 
events/h
AHI: sham CPAP: 41.0±25.0 
events/h
BMI: real CPAP:  NA
BMI: sham CPAP: NA
ESS: real CPAP: 10.3±4.5




real CPAP: 3.69±3.10 
h/per night
CPAP: continuous positive airway pressure
Table S3.4 Overview of the included studies - continued
Study Exclusion criteria
Sociodemographic data  and 
clinical data  
Mean (SD/SE, range)
CPAP compliance, 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure S6.1: Hypothesized model of the relationships among OSA severity, night-time 






F A T I G U E
1. general fatigue 0.87 (0.02)
2. physical fatigue 0.87 (0.02)
3. reduced activity 0.93 (0.02)
4. reduced motivation 0.71 (0.04)
5. mental fatigue 0.84 (0.03)
S O C I A L  S U P P O R T
1. family 0.90 (0.04)
2. friends 0.68 (0.05)
3. significant other 0.88 (0.04)
0.04 (0.01)
0.21** (0.08) 
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